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Abstract. 
The mechanism by which p"agonists induce skeletal muscle hypertrophy is 
believed largely to be through a reduction in protein degradation. These growth 
promoters are also known to effect the activity of the calcium dependent protcinascs 
(calpains) and their specific endogenous inhibitor calpastatin. The changes in activity 
appear to be toward a decrease in the calpain system's protcolytic potential. In this study 
attempts were made to determine whether the altered activity of the enzymes and inhibitor 
were brought about by induced changes in gene expression, as reflected by altered levels 
of specific mRNAs. 
Various strategies were employed to generate oligonuclcotide and cDNA probes 
to calpain i and 11 and calpastatin which would detect their respective mRNAs in L. dorsi 
total RNA samples originating from a bovine growth trial using the ß-agonist cimaterol. 
Semi-quantiative measurements of specific mRNAs using Northern blot analysis 
were related to enzyme and inhibitor activities. In addition ß-agonist"mediated effects on 
muscle RNA and expression of actin and myosin light chain 2 mRNAs were determined 
Using a human calpain cDNA specific hybridization was detected for bovine 
calpain 11 mRNA. which increased by 34% in the L. dorsi of cimaterol treated animals, 
similar to the increase in the enzyme activity, 28%. 
A novel bovine"specilic calpastatin cDNA was generated by the polymerase chain 
reaction and sequence analysis allowed comparison to those already published for other 
species. Using this P( M cDNA as a probe multiple calpastatin mRNAs were detected in 
cattle Ldorsi, as had been observed in rabbit. The predominant mRNA increased by 
160% in cimatcrol treated steers compared to a 76% change in inhibitor activity. 
There changes were in contrast to the essentially unchanged response of muscle 
total RNA and actin and myosin light chain 2 specific mRNAs in treated animals. 
The implications for the calpain system in ß"agonist"induced hypertrophy are 
discussed. 
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Chapter 1. Introduction. 
This thesis examines the calcium activated neutral proteinase, calpain, of skeletal 
muscle and its possible role in muscle growth. Calpain is associated with an endogenous 
specific inhibitor calpastatin and their activities arc ubiquitously distributed in the tissues 
of mammals where there is differential expression of the calpain isoforms, calpain I and 
II. 
Calpains are involved in particular protcolytic events in cells cleaving membrane, 
cytoskeletal and contractile proteins along with various enzymes. Calpain does not 
appear to be a general catabolic enzyme; its role, if any. in muscle protein turnover may 
be to initiate protein degradation by cleaving specific proteins. As calpain is 
nonlysosomal, active at neutral p1-I, and regulated by its own calcium sensitivity it is a 
good candidate for a trigger thereby beginning a chain of proteolytic degradation events 
or irreversible 'activation' of proteins. Although there are other proteinases involved in 
nonlysosomal proteolysis, including pathways that are ATP-dependent and the ubiquitin 
targeting system which have been described in recent reviews (1,2), this thesis is 
primarily concerned with the calpains. Subsequent proteolysis, initiated by calpain, 
could then be taken over by other nonlysosomal or lysosomal systems, the latter being a 
concentrated environment of several proteolytic enzymes which carry out degradation to a 
conclusion. 
ß-Adrenergic agonists act as repartitioning agents by producing an increase in 
skeletal muscle mass and a decrease in fat deposition in livestock. The means by which 
they induce muscle hypertrophy is believed to be achieved by suppressing protein 
degradation resulting in augmented protein accretion. The rate of protein breakdown 
must be dependent on the activities of the proteolydc enzymes. From observations in our 
laboratories calpain and calpastatin activity has been associated with this ß"agonist 
induced skeletal muscle growth. Other proteolytic enzymes may be involved but the 
decrease in protein degradation is concurrent with inhibition of the 'calpain system' by 
changes in the activity status of the calpain isoforms and calpastatin. The effects of the 
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inhibition may be to achieve a decline in the initiating events of proteolysis as described 
above. 
Experiments carried out in this thesis were specifically concerned with an 
examination of this cffcct. particularly whether ß"agonists induce an alteration in gene 
expression of the calpain system's components which could be responsible for the 
changes een in their activities. 
3 
Chapter 2. Literature Rcvicw. 
2.0. Introduction. 
In order to comprehend the possible implications of changes in calpain and 
calpastatin activity in ß-agonist induced skeletal muscle hypertrophy an understanding of 
the calpain system is required. The first sections of this review deal with the structure 
and the possible activation mechanisms of the calpains along with an examination of 
calpastatin and its interaction with and inhibition of the enzyme. The identified substrates 
of calpain mediated proteolysis are then discussed with particular reference to those of 
skeletal muscle and states of altered protein turnover where the calpain system is thought 
to be involved. 
A brief review of ß-agonist induced skeletal muscle hypertrophy and an appraisal 
of studies carried out so far on the relationship of the calpain system to this type of 
muscle growth is discussed. Finally there is an examination of the possible means by 
which ß-adrenergie agonist"mediated induction of cAMP could bring about increases in 
the activities of enzymes and/or protein expression with particular reference to the calpain 
system. 
2.1.0. The C21p21ns. 
Calcium activated neutral protcinascs (CANP), also known as calpains, are 
intracc1Iu1ar nonlysosomal thiol (cysteine) protcinases. They have a neutral pH optimum 
and are absolutely dependent on calcium ions for proteolytic activity. There are at least 
two isoforms of the enzymes with diffcrcnt calcium sensitivities: 
Calpain I (tCANP) activated at xM concentrations of Cat+. 
Calpain II (mCANP) activated at mM concentrations of Ca2{. 
Early purification procedures identified an isoform of calpain from pig skeletal 
muscle (3) which required 0.57mM Ca2+ for half maximal activity. This is now called 
calpain 11 and has been isolated from many tissues across mammalian species and been 
identified in fish (4) and crab muscle (5). The second isoform of calpain, calpain I, was 
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first isolated in canine cardiac muscle and has subsequently been purified in other species 
(6,7,8). The distribution of calpain is probably ubiquitous in mammalian tissues and 
cells but the activity of the two Isoforms varies (9.10). In human and rat erythrocytes 
only a calpain I isofotm was identified by Murachi ct al (9). although it was called calpain 
11 by PPonurmoli et al (11). With a half maximal activity at a Ca2+ concentration of 40.50 
µtß1 the erythrocyte calpain would be calpain I by current definition as native calpain 11 is 
not active at these calcium concentrations. 
In some tissues, like chicken skeletal muscle. where only a calpain II type 
isofotm was reported to be present (7,12), it has subsequently been found that there are 
probably three isofotms. 7 bey were identified by their calcium requirements for activity 
as a calpain I, calpain 11 and a 'high' calcium requiring Isoform (13). Such variation in 
the distribution and activity of the calpain isoforms may be, in part, due to the presence of 
the specific protein inhibitor to calpain, calpastatin, and the autolytic change in the 
isofonns, which alter their calcium sensitivity, causing stimulation but ultimately lead to a 
loss of activity. 
Full understanding of the calpain isoforms will emerge as the genes are sequenced 
and the activation characteristics along with the physiological roles of the isoforms are 
described. 
2.1.1. The Subunit Structure of Calpain. 
Both calpain I and II art composed of 2 subunits to give a heterodimer consisting 
of approximately 80 kDa and 30 kDa proteins in each isoform. The 80 kDa large subunit 
contains the catalytic capability. The primary sequence predicted from cDNA analysis 
was first determined for the chicken skeletal muscle large subunit (14). Subsequently 
cDNAs for the calpain I and II large subunits from rabbit and human have been isolated 
(15.17). The cDNA sequence of 30 kDa small subunit has also been determined for pig, 
rabbit, human and cattle (18.21). The small subunit is common to both isoforms of the 
enzyme (22). It follows that the calcium sensitivity of calpain isoforms is attributable to 
their large subunits. 
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The 80kDa (arge subunit. 
Both calpain I and II contain the same domain structure in their large subunits, as 
shown in Figure 1 (23). The large subunit consists of four domains. Domain It contains 
the proteinase activity, identified as the cystcinc protcinasc type In nature from its 
homology to the similar enzymes cathepsin D, 11 and papain (14). The amino acid 
residues responsible for the catalytic activity are cystcine and histidinc at positions 108 
and 265 in the primary sequence. Domain IV has been identified as the 'calmodulin"like' 
Ca2+ binding domain, as it contains E"F hand motifs which bind Ca2+ (24), similar to 
those in sequences like calmodulin, troponin C and myosin light chain (14). Four E"F 
hands, each a helix-loop-helix structure, were identified in the chicken skeletal muscle 
calpain and the other isoforms which have been isolated. Domains I and III have no 
homology with any other known protein sequence (23). 
Comparison of primary sequences of chicken calpain with both isoforms of 
human have shown a high homology across isoforms and species in domain II (Table 1). 
Domain IV has variation in sequence homology, which is expected as the domain is 
responsible for the calcium sensitivity. Domain III is homologous across the isoforms. 
It is suggested that domain III links the calcium binding characteristics of domain IV to 
the catalytic properties in domain I1(17). Domain 1, the amino terminal, differs in size 
and homology between calpain isoforms (Table 1). This domain is involved in the 
autolytic activation of calpain so homologies may indicate similar activation mechanisms. 
The 30KDa small subunit. 
The small subunit is also divided into distinct domains (Figure 1). The N- 
temninal domain V is rich in glycine residues and is believed to be involved in membrane 
interaction as it is hydrophobic in nature (25) (Figure 1). The C-terminal domain IV' is 
similar to domain IV in the large subunit (19.23) in that it contains four proposed E-F 
hand structural motifs. From site directed mutagenesis studies on the small subunit 
domain IV' the capacity and position of the active calcium binding E"F hands of both 
domain IV' and IV have been identified (26). Of the eight potential sites five are thought 
to be capable of binding calcium ions. This had been confi in earlier studies where 
I The word 'homology' is used to indicate that the similarity of the nucleotide and 
deduced amino acid sequences of a group of proteins is due to them evolving from a common 
ancestral gene. 
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Table 1: Amino acid homology among the calpain large subunits of chicken (14) and the 
two isofomns of human (16,17). Taken from Imajoh et al (17). 
Homology bctwcen 
Domains 
Calpain species I 
compared 
Human calpain II vs 51 
human calpain I 
Human calpain 11 vs 70 
chicken calpain 
Human calpain I vs 51 
chicken calpain 
II III IV Total 
73 62 48 62 
75 64 53 66 
78 71 65 70 
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In chicken calpain 5.6 moles calcium ions bound per mole of calpain (27). Three of the 
sites arc occupied in the large subunit and two in the small. Domain IV' has also been 
identified as the point of association between the large and small subunit. 
The small subunit is clearly involved in the calcium binding of the enzyme, but is 
identical in both Isoforms (22). Association of calcium ions to the small subunit may 
trigger some conformational change in the large subunit leading to its conversion to an 
active form as the calcium sensitivity of the enzyme appears to be attributable to the large 
subunit. 
p94 
Calpains appear to be ubiquitous in their tissue distribution although the isoforms 
do vary In their expression. In addition a calpain"like protein p94 encoded by a recently 
isolated cDNA from rat and human has been identified as being specific to skeletal muscle 
(28). The sequenced cDNA encoded a protein of 821 amino acids of calculated molecular 
weight 94kDa, which was homologous to calpain I and 11 large subunits, 54% and 51% 
respectively. Sorimachi et al (28,29) suggested that the protein was calpain large 
subunit"like and that it could be divided into four domains with cysteine proteinase and 
calmodulin-like binding regions, domain II and IV. It is not known whether p94 is 
associated with the small subunit like the other isoforms. The predictions of the'calpain- 
like' nature of the protein was based on its cDNA sequence but it has yet to be isolated as 
a functional calcium sensitive proteinase. 
The predicted primary sequence of p94 does contain novel stretches which are 
insisted into the calpain sequence in domains 1.11 and III (Figure 2). nose into domain 
11 and III may affect the possible proteolytic function of the putative enzyme (29). The 
domain II insert between the cystcine and histidine residues involved in enzyme activity 
may prevent proteinase action. Interestingly the insertion into domain III has some 
primary sequence homology to a"actinin and dystrophin (29), so that it may have binding 
capability to other proteins 
. 
There is also a sequence which is homologous to one in 
domain V of the small subunit and thought to be involved in the autolytic cleavage of this 
domain. Cleavage in this region of p94 could mean that the enzyme could become 
y 
Figure 2: The proposed domain structure of p94 (29). 
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dissociated from its calcium binding domain, thcrtby becoming constitutively active. 
The skeletal muscle-specific expression of p94 is of particular interest, if it is a 
calpain"like proteinase, as protein turnover is an important metabolic function in the tissue 
and a regulating proteinasc may have critical role in muscle growth and metabolism. 
2.1.2. Activation of Calpain 
Physiological free calcium concentrations within cells arc thought to be in the 
micromolar range or less (300.1200nM). For calpain I the calcium concentration 
required for half"maximal activation is in the range 45.5011M Ca2+ for bovine skeletal 
muscle calpain 1 (32). Bovine skeletal muscle calpain 11 needs 700-750itM Ca2+ for 
half. maximal activity (32). The calcium dependence values are similar in most species so 
far studied. An obvious question is how does calpain become active at the low calcium 
concentrations present in vivo ? 
Autolytic activation of calpains. 
Several mechanisms have been proposed for the activation of calpain isoforms by 
autolysis in the presence of Ca2+ which decreases their calcium requirement for activity 
(23.30-34). Autolytic activation of calpain was first observed in chicken skeletal muscle 
calpain. The enzyme reduced its Ca2+ sensitivity from 400µM to 30µM when incubated 
with 0.5mN1 calcium for two minutes at 0°C, as well as showing cleavage of the purified 
enzyme during autolysis on SDS-PAGE (35,36). Autolysis of both calpain isoforms has 
been observed; each of the subunits is truncated to a slightly smaller size and their 
calcium sensitivity for activation is increased. Calpain II isoforms reduce their calcium 
requirement from 500-1000µM to below 150.100µM and calpain I from 50 to 0.6-2µM. 
During autolysis the small subunit appears to undergo the same pattern of degradation in 
both isoforms as determined by SDS"PAGE. Approximately 90 amino acids are 
removed from the N-terminal domain V, the molecular weight is reduced by 30% to 18- 
20kDa. The autolysis of the large subunits does not appear to be the same in both 
isoforms. Calpain II is not as noticeably reduced in size as calpain I which is cleaved to 
approximately 76kDa as determined from SDS-PAGE (30,31). In the rabbit skeletal 
muscle isofonns 27 amino acids arc removed from the N"tcrminus of calpain 1, whilst 19 
are cleaved from calpain 11(30). It is the removal of the N"terminal fragment from the 
80kDa subunit which gives the change in calcium sensitivity (37). 
Autolysis leads to decreased stability of the subunits. Prolonged incubation of 
calpain 11 with high levels of calcium (mM) leads to its eventual degradation with loss of 
activity (38). Autolytic activation could alternatively be viewed as the first step in the 
removal of calpain activity and a means by which prolonged calpain"mediated proteolysis 
is avoided. 
The effects of phospholipids on autolysis. 
Although the modification of the N"tcrminus of the small subunit appears not to 
affect the changes in calcium sensitivity of the isoforms (37) it does have a function in the 
autolytic activation. Autolysis of calpain Il has been shown to take place at lower calcium 
concentrations than normally required in the presence of a specific phospholipid. A 
reduction from 680µm to 871AI calcium for half maximal rate of autolysis of bovine 
smooth muscle calpain II is seen in the presence of SOIAI phosphatidylinositol (39). 
This effect is negated when the N"tcrminus of the small subunit is removed, so that it 
must be essential for the association of calpain II to the phosphatidylinositol (40). In 
liposomes of the phospholipid used for these experiments the binding of calpain II does 
not require calcium (30,41). However calpain association to biological membranes is 
reported to be induced in the presence of calcium (30,42,43). Most of these observations 
are on calpain I (42,43). Increases in calcium concentration (1.21M) lead to membrane 
association of the enzyme where it is autolysed to a low calcium requiring form in the 
lipid environment (42,43). The association of the erythrocyte calpain Ito the membrane 
led to an increased degradation of the membrane proteins such as spectrin (43). The 
effect of calcium on the calpain 11 association to biological membranes has not been 
studied to the same extent. One of the reasons is that the cells used for the observations 
are relatively easily isolated single cells, such as erythrocytes, which only contain the 
calpain I isoform. 
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A proposed mechanism for the activation of calpains. 
This was based on the above observations and a proposed mechanism suggested 
by Mellgren (49) is described in Figure 3. From in vitm measurements cytosolic calpain 
would not be active at the intracellular free Ca2+ concentration, especially calpain it. The 
enzyme may associate with the phospholipids in the membranes via the N"tcrminus of the 
small subunit, in a calcium dependent step [1). Autolysis of the large subunit then takes 
place in the lipid environment at lower calcium concentration than required In the cytosol, 
leading to activation of the enzyme at the membrane 121. Dissociation fron the membrane 
is achieved by autolytic cleavage of the N-terminal glycine-rich hydrophobic domain in 
the small subunit 131 and [4]. This autolysed cytosolic calpain may be active. However 
the intracellular free Ca2+ concentration is possibly not high enough for activation of 
autolysed calpain. Inactivation of the enzyme is caused by further autolytic fragmentation 
[5]. 
Cytosolic autolysis of calpain II is unlikely to occur as the Ca2+ concentrations 
required are believed to be well above those which are physiological " the mechanism for 
the activation of cytosolie calpain I is different and is dealt with in a subsequent section. 
In the presence of cytosolic 'activators', which lower the calcium requirements for 
activation. calpain may autolyse and become active in this environment (6). The 
activators appear to be specific to calpain II (4548) and have been variously identified as 
proteins (45,46), small peptides (47) and a catabolic product of L"leucine, 
isovalerylcamitine (48). The ability of the activators to reduce the calcium sensitivity of 
calpain 11 varies. Some are unable to achieve a high reduction in calcium dependence 
(47) so either role in the activation scheme of calpain is questionable. 
Further autolysis of the enzyme probably results in inactivation [7]. 
Ii 
Figure 3: A nxxicl for the activation of calpain. 
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The proenzymc theory of calpain activation. 
Based on the model above it has been suggested that isolated calpains are 
essentially proenzymcs which require autolysis for activity, especially caipain 11 (30). 
Incubation of calpain 11 in the presence of millimolar calcium and substrate results in the 
autolytic degradation and a decrease in the calcium concentration required for activity 
(32). The calcium concentrations required for the assay of calpain 11 activity and also for 
autolysis, are equivalent. Acccording to the procnzymc theory the calpain is being 
converted to its 'active' form at the calcium concentration present, and then is in an 
environment where it can be active as a protcinase (30). It is difficult to prove the 
proenzyme theory. This might be done by careful kinetic analysis of the rate of 
production of protcolytie fragments from the substrate. There would be an expected lag 
phase of cleavage whilst the procnzyme is converted to an active state. 
For calpain I the procnzyme theory is less clearly defined. Calpain I has been 
shown to be active at calcium concentrations below that required for autolysis (31,32). 
Bovine calpain I requires 50itht Ca2+ for half maximal rate of activity and 21011M for 
half maximal rate of autolysis. In the presence of phosphatidylinositol the half maximal 
rate of autolysis was at 150}trt. 
The effects of membrane associated proteins on calpain I activation. 
A different mechanism for the autolytic activation of calpain I has been proposed 
with the enzyme using membrane proteins as specific binding substrates (33,34,44). In 
erythrocytes calpain I association to 'inside-out' membranes does result in the 
degradation of proteins identified with membranes. The binding of calpain I to the 
erythrocyte membranes is thought to be via membrane proteins, as proteinase digestion of 
inside-out membranes reduces the degree of calpain I association (d4). Removal of 
phospholipid by digestion with phospholipases C and A2, as well as Incubation with 
Triton X-100 failed to affect the calpain I binding (34,44). The lack of a large decrease in 
Ca2+ required for autolysis in the presence of phosphatidyl inositol in vitro (32) of 
calpain I (unlike calpain II) may be because the autolytic activation of calpain I is achieved 
through a different mechanism. The binding of calpain I to membranes is calcium 
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sensitive (33,43), wheicas this effect on calpain It is not known. Autolysis of calpain I 
does take place on phospholipid depleted membranes at micromoiar calcium 
concentrations (1.41M), although changes in enzyme activity were not assessed (34). 
It can be concluded that calpain I binds via membrane proteins to 'insidc"out' 
vesicles (33.34.44). Proteins which arc cytosolic substrates for calpain I and also the 
inhibitor calpastatin might be expected to inhibit the binding of calpain Ito the membrane. 
Whether a truncated calpain I trimmed small subunit with no N"terminus will still bind to 
biological membranes through this membrane proteinlsubstrate association has yet to be 
reported. Cytosolic protein 'activators' have been identified for calpain It (45.46). as yet 
none of these 'activators' have been isolated for calpain 1. Membrane associated calpain I 
'binding proteins' maybe similar to these 'activators'. 
Since calpain I binding to membranes has been linked with subsequent 
degradation of membrane proteins (33,43), autolytic activation by this mechanism would 
almost inevitably result in membrane damage. However the requirement for a rise in 
calcium concentration for the binding may be a critical factor in regulating this 
mechanism. A technical consideration may be that in the system studied the membranes 
have been damaged. thereby exposing the membrane associated proteins to 
unphysiological proteolytic cleavage invite. 
A proposed mechanism for calpain I activation. 
From the in An evidence discussed above calpain I activation in vivo may be 
different to the mechanism proposed in Figure 3. Figure 4 illustrates a possible activation 
scheme for calpain I. It associates with membranes and this is dependent on increased 
Ca2+ levels. The association and subsequent activation may be through phospholipid 
interaction with the small subunit, but membrane proteins which act as binding/substrate 
sites may also be involved (I). Activation of the membrane associated calpain I in the 
presence of calcium involves autolysis of the large subunit [2). This active form then 
may degrade its associated binding protein. Binding could be maintained by the N. 
terminus of the small subunit, cleavage of this region (3) leading to the dissociation of the 
membrane autolysed form 141 which would be active. Further autolysis leads to 
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inactivation (5). 
Autolysis of calpain I in the cytosol requhes higher calcium concentrations than 
activation of the intact enzyme, so is unlikely to take place. Calpain I may be active in the 
cytosol when the local calcium concentration rises above 10µM (6j, unlike calpain It. 
Further increases in calcium would probably lead to the eventual degradation of the 
calpain (7j, possibly via an autolysed active intermediate. 
Differences in the calpain I and 11 activation mechanisms. 
From the In vitro observations on the activation mechanisms of calpain 1 and 11 
and their differences. Figure 3 is more likely to be true for the activation of calpain Ii. 
This is because the diagram is based on the initial studies on calpain activation which 
were carried out on calpain II. 
The association of calpain It to biological membranes, and its possible calcium 
dependence. has not been studied in as much detail as calpain I. Involvement of 
phospholipids. especially phosphatidylinositol, appears to be of more significance in 
calpain II autolytic activation (32,39.41). The binding of calpain I to membrane proteins 
appears to influence its association to membranes more than phosphotipids (33,34,44). 
he investigation of the role of these factors in activation of calpain has been 
biased to one isoform. Erythrocytes and neutrophils only contain calpain I so the study 
of the association of calpain isoforms to membrane proteins was dictated by the cells 
used. The interaction of calpain iT with biological membranes would ideally need to be 
studied on membranes isolated from cells containing this isoform, which is technically 
more difficult to achieve than from cells such as erythrocytes. In contrast calpain II is 
more easily isolated in bulk than calpain I and can readily be used in vitro on synthetic 
membranes consisting of predetermined phospholipids. 
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2.1.3. Summary 
Although the proposed proenzyme theory of activation for calpain has been 
questioned by some groups working in the field, cytosolic calpain 11 would still seem to 
require a reduction in its calcium requirement for activation to be functional at 
physiological calcium levels. even if it is active in its unautolysed state. From the work 
of Cong et al (32) calpain I could be active without the need for autolysis, but an increase 
in calcium sensitivity would be required for full protcolytic activity. Local fluctuations of 
calcium concentration may reach the lower range needed for native calpain I activation. 
Autolysis is the means by which both calpain I and 11 can be active at lower 
calcium concentrations than their unautolysed states. In vitro studies have shown 
autolysis does require higher than physiological calcium concentrations. By associating to 
membranes both isoforms can achieve autolysis at reduced calcium concentrations. but 
the mechanism by which the two enzymes bind to the membranes appears to be different. 
Activity in the cytosol is also affected by factors which are apparently isoform specific, 
such as the calpain 11-specific activators. These different activation mechanisms for each 
isoform may indicate a different role for their proteolytic action. 
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2.2.0. Calpastatin. 
Calpastatin is a highly specific endogenous inhibitor to both isoforms of calpain. 
It was discovered in rat liver and was reported to be associated with and inhibitory to 
calpain activity (50). Calpastatin has subsequently been identified in various tissues but 
as with calpain the activity of the inhibitor varies. In skeletal muscle there is usually more 
calpastatin than the combined activity of calpain (9). This again raises the question of 
how can calpain ever be active in muscle cells ? This will be considered at a later stage In 
the review. after first describing the characteristics of the inhibitor. 
2.2.1. The Structure of Ca1pastatin. 
When isolating calpastatin care has to be taken as the inhibitor is very susceptible 
to protcolytic cleavage (50,51). This has led to confusion concerning the exact size of the 
inhibitor as determined by SDS"PAGE and its stoichiometry of inhibition, which ranges 
from 3-10 mol calpain/mol calpastatin dependent on the tissue from which it was isolated 
(30). It seems clear however that a mole of inhibitor will inhibit more than one mole of 
calpain (30). From purification studies calpastatin has been classified into two groups, 
liver and erythrocyte types. The erythrocyte type is smaller at 68.79kDa (4,30), whilst 
the liver calpastatin is 107-170kDa (30). 
The primary structure of the inhibitor has been determined from the cDNAs 
isolated from rabbit liver (52), pig cardiac muscle (53) and human liver (54) calpastatin 
mRNA, the three consisting of 718,713,698 amino acids respectively. 
The primary sequence of calpastatin can be divided into five domains, domain L 
and domains 14 each being approximately 140 amino acids long. The domains 1.4 are 
mutually homologous and have been identified as containing the inhibitory capacity 
(Figure 5). The calculated molecular weight for pig calpastatin Is 77kDa, whilst its 
molecular weight determined by SDS"PAGE gave a value of 107kDL This discrepancy 
between the calculated and the observed molecular weight may be due to post- 
transcriptional modification. Such modification was identified in the erythrocyte inhibitor 
where N-terminal analysis showed that it was a truncated form of the full length protein. 
?O 
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The erythrocyte inhibitor starts at residue 290, whilst the liver calpastatin starts at residue 
80 of the cDNA encoded primary sequence (30), shown in flgurc S. The erythrocyte 
inhibitor thus lacks one of the inhibitory domains, whilst the liver calpastatin contains all 
four domains, the L domain being truncated. It is proposed that calpastatin is further 
post-transcriptionally modified to cause the anomalous behaviour on SDS"PAGE which 
gives a larger estimation of calpastatin size (30). Ucmori ct al have suggested that 
because calpastatin is rich in proline residues it is this which affects its mobility on SDS- 
PAGE (56). 
Identification of the peptide sequence in calpastatin responsible for 
inhibition of calpain. 
The two groups, led by Suzuki and Murachi, involved in producing the cDNAs 
for calpastatin have tried to identify whether each of the homologous domains 
individually had inhibitory activity against calpain (57,58). The cloned domains 
expressed in E. coli were likely to have no post- translational modifications which may 
take place in mammalian cells, but each still retain inhibitory capacity. 
Using deletion mutagenesis of domain 3 the regions within a domain required for 
inhibitory activity were identified (59). From these studies along with comparisons of 
the domain sequences with those within the same primary structure and across species the 
conserved regions indicated in Figure 5 were determined (60). Deletion of the amino and 
carboxyl ends of domain 3 identified regions which when lost lead to a reduction in the 
inhibitory capacity of the calpastatin fragment. These regions were predicted to form a- 
helical secondary structures, and are conserved across domains and species. Point 
mutation substitutions in a region in the middle of the domain identified a 'central 
consensus equence'. Mutation in this region caused virtual complete loss of inhibitory 
activity in the domain fragment. Using the domain 3 fragment the mechanism of 
calpastatin inhibition has been postulated to be competitive. Although domain 3 has been 
identified as one of the weaker inhibitory domains (60) the observations on the conserved 
inhibitory sequence have been confirmed in domain I of the calpastatin sequence (56,61). 
The assertion that calpastatin Is a competitive inhibitor has also been confirmed using a 
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synthetic pcptide from domain 3 (60). 
Subsequent work on the central consensus region has tried to identify the minimal 
amino acid sequence required for inhibitory activity against calpain. Such a peptide could 
potentially be used as a specific inhibitor against calpain proteolysis. Both Suzuki's and 
Murachi's groups have used synthetic peptides and deletion mutations to determine the 
minimal consensus equence with inhibitory capability (56.59.61). When a short peptide 
sequence of up to 34 residues was used the inhibition tended to be greater against calpain 
li than calpain I (60). whilst when the complete domain was used the inhibition of the 
isoforms was reversed (59). This suggested that calpain I requires the tx"hclical regions 
at the amino and carboxyl termini. The peptide fragments do not contain these 
sequences. 
Both Suzuki"s and Murachi's groups agree that the inhibitory peptide is based on 
the sequence; 
Thr"llc"P o Pro- X 
-'1)T-Arg 
where X can be variable. However this peptide sequence alone is not sufficient to inhibit 
calpain activity. 
Suzuki"s group (60) suggested the basic inhibitory sequence is; 
RE 
LGXKDXTIPPXYRXLL. 
Whilst hfurachi s (56) group have suggested a'AM"scqucncc' of;
RE 
LGXKDXTIPPXYR 
which lacks three C-terminal residues of Suzuki's sequence. Murachi ct al (56) 
considered this sequence to be the basic one required in inhibitory peptides. The shortest 
peptide with the capability of 50% inhibition of calpain was of 18 residues based on the 
above sequence (56). However all the peptides have lower inhibitory activity than the 
full length domain fragment (60). 
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2.2.2. The Interaction of Calpastatin with Calpain. 
The interaction of calpastatin with calpain requires calcium In A The calcium 
required for binding is thought to interact with calpain as calpastatin contains no 
Identifiable calcium binding E"F hand sites (52.54). Kapprell and Goll (62) have shown 
that both unautolysed and autolyscd isoforms of calpain have different calcium 
requirements for their association to calpastatin. In vitra. Their observations revealed that 
the free calcium concentration required for half maximal association of calpain to 
calpastatin is less than that needed for half maximal protcolytic activity of autolyscd and 
unautolysed calpain II and autolysed calpain 1. For unautolysed calpain I the half 
maximal calcium concentration for enzyme activity was 3411M, whilst the half maximal 
binding of calpain Ito calpastatin was at 42µ1A calcium. The native calpain I could be 
active in the range of 10.34 tM whilst the other forms would be inactive in the presence 
of calcium and calpastatin. This study suggested that autolysed forms of calpain, 
although they have a greater calcium sensitivity for activity than the unautolysed 
isoforms, would not be active unless calpastatin was removed from their environment. 
However in vivo the interaction of calpain with calpastatin may be affected by factors 
similar to those affecting calpain and its autolysis. The involvement of biological and 
artificial membranes was not investigated in the study, but this interaction is known to 
have a critical effect on calpain activity as described in section 2.1.2. (30.33,39,40). The 
question might be asked is calpastatin an effective Inhibitor In this membrane 
environment ? 
Calpastatin has been isolated associated to the sarcolemma of cardiac muscle (63). 
The affiliation is thought to be through the L-domain of the inhibitor as proteolytically 
cleaved calpastatin lacking this domain does not associate with phospholipids (64). The 
erythrocyte type inhibitor, which lacks domain L (30), does not bind to the erythrocyte 
membrane nor does it bind to phospholipids (63). The L domain interaction is believed 
to be through the hydrophobic and basic amino acids which would associate with 
phospholipids reported to be 'acidic'. phosphatidylinositol /scrinc, but not with the so 
called 'neutral' onm phosphatidylcholinelcthanolamine (64). Although calpastatin does 
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appear to bind to membranes the effect of this on calpain's activity at the membrane has 
not been investigated, 
Autolysis and calpastatin cleavage in the calpain"calpastatin complex. 
Calpastatin complexed to calpain i and II was shown to be fragmented even when 
there was sufficient inhibitor present to cause complete inhibition of the enzyme (65). 
This suggested that calpastatin was a suicide inhibitor/substrate of calpain This had been 
observed earlier by Mellgren et al (66), although they suggested that excess calpain was 
required for the degradation of calpastatin. Nakamura ct al (65) also found that calpain 
underwent autolysis in the calpain-calpastatin complex. However these observations 
were made using high calcium concentrations above those required for half maximal 
binding of calpain to calpastatin in vitro. which is below that needed for half maximal 
activity of the calpain II isoform. The calcium concentrations used for experiments on 
calpain I and II binding to calpastatin were also above those at which full autolysis of the 
isoforms had been observed, 250µNt and 6mM1 respectively (see section 2.1.2. ). 
Mellgren et al have suggested that autolysis did not take place in the complex (66), but In 
their study the observations were from SDS"PAGE which may have not been loaded with 
sufficient protein to see the autolytic fragments. Nakamura et al (33) have also reported 
that calpastatin will inhibit the binding of calpain Ito membranes. However they reported 
that calpain I associates to membranes at approximately lt (33), well below the half 
maximal binding value determined for native calpain I association to calpastatin In vitro 
which was 421LM, in the absence of membranes (62). 
How does calpain become active In vivo In the presence of calpastatin ? 
Although from Kapprell and Goll's study (62) on calpain-calpastatin binding and 
its calcium dependence it would appear that most of the calpain activity both native and 
autolysed is inhibited in vitro, native calpain I was active at a Ca2+ range which could be 
attainable by local fluctuations of calcium i. e. 10-34µ11i Cat 
. 
They also acknowledged 
that vivo there may be additional factors that reduce the calcium concentration for 
calpain activity below that required for their binding to calpastatin in A. Such factors 
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could also be responsible for calpain 11 activation at physiologically attainable levels 
which otherwise appear to negate its activity in yjo. 
Such factors or activators were described earlier having been isolated by 
Pontrcmoli ct al, and appear to have their effects chiefly on calpain 11 (45.46.48). Some 
of the activators are capable of lowering the inhibitory capacity of calpastatin against 
calpain 11 in vitro (45,46). Such activators in vivo may combine activation of calpain 11 
and repression of calpastatin inhibition. 
The other criteria of calpastatin-calpain interaction is that they must be physically 
in the same location. From the limited immunolocalisation data available this apparently 
is the case in muscle cells (31). although the immunotluorcsccnce was not very clear. 
Proteolysis of calpastatin may be a critical factor in the modification of the 
inhibitory capacity of the protein. Extraction procedures for calpastatin have shown how 
susceptible it is (51.67). The evidence that calpastatin is a suicide substrate (65) along 
with its proteolytic susceptibility may account for the high levels of calpastatin expression 
in cells, generally being much greater than calpain activity. But this could be a means of 
overcoming calpastatin inhibition in a localised area of a cell during high calpain activity. 
2.2.3. A Proposed Mechanism for Interaction of Caipastatin with Calpain. 
Figure 6 shows an illustration of the possible mechanism of calpastatin interaction 
with calpain. and thatby the possible means by which calpain may be active in vivo even 
in the presence of calputnin. 
Unautolyscd calpain I could be active in the cytosol when calcium concentrations 
reach the lower end of its activity requiremen4 at approximately lOitM (11. However if 
local calcium concentrations do increase further. above 40µM, this would cause the 
association of calpastatin to calpain 121. for both isoforn s. 
In order for calpain I and 11 to be active at physiological Ca2+ concentration 
association with the membrane is required, as described in section 2.1.2.. The 
mechanism of interaction with the plasma membrane and subsequent autolysis may be 
diffcrcnt for each isoform The autolysed cyiosolic calpains itltased from the 
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Figurc 6: A proposed mcchanism of calpastatin i tcraction with calpain. 
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membr2ne are thought to be inhibitcd by caipastatin without bclng active 131. Although 
calpain I may be active in the cytosoi calpain 11 Is not, but it may be activated in this 
environment by the association with specific activators. These apparently prevent 
calpastatin inhibition but have no effect on calpain I (section 2.1.2. ). 
Calpastatin can inhibit more than one molcculc of calpain 14) but will become 
degraded as it is thought to be a suicide inhibitor/substrate. It appears that removal of 
calcium from the environment of the calpain-calpastatin complex releases calpastatin 
fragments some of which still retain inhibitory activity (65). The implication of this i 
y observation in vivo is not known. 
A small proportion of the calpastatin is associated with the membrane through the 
L domain 15). This membrane-bound calpastatin is believed to bind calpain in the 
presence of calcium (6) and could act in competition with the membrane binding/substrate 
proteins which are involved in calpain i association to the membrane. The exact calcium 
concentration at which this takes place is not known nor whether active or inactive 
membrane associated calpain will also bind to the inhibitor located on the membrane (71. 
Association of several calpain proteins to the membrane bound calpastatin probably leads 
to its dissociation from the membrane following the cleavage of domain L from the 
inhibitor and further proteolysis of the calpastatin in the cytosol (8). 
The model for this calpain-calp statin interaction and its effect on cal 'n mediated 
proteolysis is based on the observations reported in this review but shoul considered as 
being speculative. 
2.2.4. Summary 
Calpas atin is a specific endogenous inhibitor for calpain. Its intcraction with 
calpain is calcium dependent and the concentration at which the calpastatin-cal pain 
complex is formed is different for each isoform. From In vitro observations it appears 
that the binding of calpain to calpastatin occurs close to or below the calcium 
concentration required for activation. The calcium required for the formation of the 
calpain-calpastatin complex Is believed to associate with calpain. The enzyme probably 
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undergoes a conformational change in order to bind to calpastatin. These regulatory 
mechanisms suggest that calpain mediated proteolysis is under tight regulation. 
However. In vivo the inhibitory effects of calpastatin may be affected by other factors 
such as interaction with membranes and calpain activators which may allow the loosening 
of the inhibition constraints. 
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2.3.0. Substrates for Calpain and Its Involvcmcnt In Protein Turnover. 
ßipain substrates can be broadly categorised Into groups of; 
I) Myofbrillar proteins 
ii) Membrane proteins 
iii) Cyioskeletal proteins 
iv) Receptor proteins 
v) Enzymes. 
Many of the substrates for calpain do belong to more than one of these groups. The first 
category to be considered is the role of calpain in the degradation of myofibrillar proteins. 
2.3.1. Calpain's Role In Skeletal Muscle Myotibriilar Protein 
Degradation. 
hlyofibrillar protein substrates. 
One of the first effects of calpain protcolytic action was indicated in skeletal 
muscle protein degradation (3). In isolated myofibrils incubated with calpain li at mM 
calcium concentrations there was removal of the Mine whose position is shown in 
Figure 7. The elimination of the Z"line releases proteins associated with it including a- 
actinin, which is not a substrate for calpain, and zeelins that are (68,69). The specific 
substrates within the Z. lines which are degraded by calpain and lead to its dissolution arc 
not known. Most of the initial studies were carried out using calpain 11, however calpain 
I is also capable of removing dines from myofibrils (70). 
Various purified myofibrillar proteins have been shown to be calpain substrates 
including troponin. tropomyosin and C-protein (71). Isolated myosin is degraded but as 
%ith most calpain substrates it is specifically cleaved in cc uin positions (72). The large 
cytoskeletal proteins titin and nebulin are also protcolytically fragmented (73). These are 
thought to be involved in the maintenance of sarcomcre structure, the large protein titan 
spanning half its length from Mine: to hf-line. 
Although these myofibrillar proteins arc substrates, such studies do not 
conclusively prove that they arc degraded jn. The repeatedobservations that calpain 
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Figure 7: Schematic diagram of muscle mpfbril urcomere structure. 
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degrades Mines in myofibrils does suggest its involvement in muscle turnover. By 
removing Vines and degrading thin calpain could be a means of 'loosening' the 
myotbrillar structure thereby allowing other protcinases to carry out the major protcolytic 
events involved in protein turnover of muscle. Calpain has been immunolocaliscd at the 
Mines and the surrounding 1-binds (74.75), but in other studies it has been seen 
distributed throughout the cytosol (31,76) and at the plasma membrane (77). Both 
calpain I and 11 have been associated with the specific degradation of numerous 
membrane proteins to be discussed in section 2.3.2.. 
Calpain activity in skeletal muscle protein turnover. 
It is difficult to prove that calpain is involved in the cycle of protein turnover in 
skeletal muscle as there are no absolutely specific inhibitors to calpain. span from the 
possible exception of calpastatin which will not penetrate membranes and furthermore is 
susceptible to proteolysis. Most of the inhibitors used in the early experiments to 
determine the role of calpain are general cysteine proteinase inhibitors. Although the 
specificity of some of the more recent synthetic inhibitors is quiet high the homology of 
the cysteine protcinases around their catalytic domain males it difficult to obtain absolute 
specificity toward calpain (78). This also suggests that in order for calpastatin to be 
specific toward calpain there is likely to be some other interaction of the inhibitor with the 
enzyme as it mcognized that the synthetic inhibitors associate with the active site of the 
enzyme. 
An example of use of a cysteine proteinase inhibitor to implicate calpains in 
muscle protein turnover was described by Badalamente ct al (79) who used the inhibitor 
lcupcpdn to facilitate the recovery of dcncrvated muscle after nerve lesion and subsequent 
repair. They suggested that it was by inhibition of calpain in the tissue that recovery was 
enhanced. However lcupeptin is known to be a general cystelne protelnase inhibitor 
(78), so that such results do not exclude the role of calpsin in muscle degradation but they 
do not confirm it unequivocally. 
Although calpain is likely to be implicated in muscle protein turnover there are 
few definitive results proving its direct involvement. There have been several studies on 
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isolated skeletal muscle that relate the calcium activated protcolytic systems in muscle 
protein turnover to other protein degradation mechanisms. In YJ protein turnover 
experiments are difficult to interpret as they use cystcine protcinase inhibitors and/or 
calcium ionophorcs to indicate that calpains are put of the increased calcium induced 
proteolysis (80-82). While Rodemann et at (80) reached the conclusion that calpain was 
not involved in general proteolysis. Zeman ct at (81) and 1=uruno et at (82) drew the 
opposite conclusion. The differences in the studies are usually caused by lack of 
consensus on the specificity of the inhibitors and whether they reach all the sites of 
calpain activity. Overall the use of methods to increase free calcium leads to the elevation 
of proteolysis, and the employment of calpainlcysteine protcinasc inhibitors tends to 
prevent this calcium induced increase in protein degradation (81,82). Such evidence 
supports the likelihood of calpain being involved at some stage in muscle protein 
turnover. 
Augmented calpain activity associated with skeletal muscle atrophy. 
An increase in calpain activity has been observed where there arc states of 
elevated degradation of muscle proteins. This can considered to be further evidence that 
calpain may be involved in the turnover of myofibrillar proteins. Induced atrophy caused 
by vitamin E deficiency resulted in an increase of 3.6 times the control levels of the total 
calpain activity in rabbit skeletal muscle (83). Ultrastructural observations of changes in 
the myofibrils showed a decrease in Z-line density. 
Muscular dystrophy also results in changes in the activity of the components of 
the calpain system (84.88). 'hure arge few studies where all the components of the 
calpain system have been separated and their activity assessed. When all the studies arc 
considered they give conflicting results. In human Duchenne muscular dystrophy an 
increase in calpain I and II was observed with no change in calpastatin activity (85). 
However in dystrophic hamster muscle there was an increase in both calpain isofomu 
and calpastatin activities at four weeks old, but at ten weeks there was no change in 
calpain I and II but an incur= in ca1 ; tin activity (86). 
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Increases In calpastatin activity along with calpain 11 were seen In mice and 
hamsters (86,87). The difference in the observations may be due to the age at which the 
assessment of activity was made, especially in the genetic models of muscular dystrophy 
in laboratory animals. Initial events In these dystrophic animals involve degeneration of 
the fibres which is closely followed by on going regeneration by activation of satellite 
cells. The two processes arc taking place simultaneously. In mdx mice this 
counterbalancing effect of increased muscle protein synthesis results in animals that are 
never severely weakened and grow larger and stronger than the wild type animals (89). 
Such events may require an initial increase In calpain mediated proteolysis, but 
subsequently, as the regeneration becomes more prominent, Inhibition of calpain by 
calpastatin increases. 
Tiere Is an increase in free calcium in skeletal muscle cells of dystrophic (mdx) 
mice which could activate calpain (90). The involvement of other protcolytic systems in 
muscular dystrophy is not discounted but the genetic disease does appear to entail 
enhanced calpain activity which could be further stimulated by increases in intracellular 
free calcium. The degradation pattern of muscle proteins is similar to that observed when 
isolated myofibrils are digested with calpain (3), and this, along with changes in the 
calpain activity. does suggest an involvement in muscle protein turnover in this 
myopathy. 
Further evidence of calpain"induccd proteolysis in protein degradation was 
observed in denervated muscle undergoing atrophy. when calpain levels were increased 
and calpastatin levels were decreased. leading to an increase in protcolytic potential in the 
calpain system (91). 
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2.3.2. Other Substrates for Calpain. 
Calpain susceptibility occurs in a wide range of substrates but as with the 
degradation of muscle proteins the substrates of calpain mediated proteolysis can be 
identified as specific proteins. 
Membrane associated calpain substrates. 
As described above calpains are known to associate with membranes via 
phospholipid into action and possibly via specific substrate or membrane protein binding 
association. The enzyme has been shown to fragment some of the proteins lining the 
cytosolic side of the membrane; these include spectrin (92), band 3 protein (92), fodrins 
(93,94) and band 4.1 proteins (92). Calpain has been implicated in the rcanangemcnt of 
cell membrane structural proteins (49). There is a variation in the distribution of calpain 
11 between nonfusing myoblasts and their fusing counterparts (95). In cells that have the 
capability of fusing. calpain 11 is predominantly associated with the plasma membrane, 
whilst in nonfusing cells it is mainly cytosolic. The induced fusion of rat erythrocytes in 
the presence of calcium can be inhibited in the presence of EGTA and cysteine protcinase 
inhibitors (49). Calpain could act by removing the submembrane proteins to expose the 
lipid bilayer which would be more susceptible to fusing with similar membranes. There 
is evidence of changes in the activity of calpain during the formation of skeletal 
muscle myotubes. Kaur and Sanwal (96) observed an increase in total calpain activity in 
the supernatant of centrifuged myotube homogenates, and also described the decrease of 
a endogenous inhibitor to calpain, which they failed to identify but was probably 
calpastatin. This was expressed before fusion and extracts from the prefusion cells 
would inhibit the total calpain activity seen in the fusing myoblasts. Kaur and Sanwal 
further suggested that this inhibitor could regulate the enzyme activity by being destroyed 
in myoblast fusion without the need for changes in the gene expression of the enzyme, 
although the latter cannot be ruled out. 
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Cyloskcictal calpain substrates. 
Several cytoskcietal proteins have been identified as substrates for calpain 
including the intermediate filament proteins vimcntin and dcsmin (97). the microtubulc" 
associated protein Tau which has been implicated In Althcimcr's disease (98). and the 
microtubule protein tubulin (99.100). Calpain 11 has been found associated with cell 
adhesion plaques, that are implicated in the cytoslºclcton and cell motility. which contain a 
substrate for calpain. talin In their structure (101). Cal pain digestion could possibly lead 
to the dissolution of the plaque and the rearrangement of the cytoskclcton. 
Calpain II has been connected with the structural alterations seen in mitosis (102). 
Microinjection of calpain 11 initiated the onset of mitosis. and calpain Immunolocaliraation 
moved to the mitotic chromosomes from being associated with the membrane. From her 
observations Schollmeyer (102) suggested that calpain 11 was active at the cytosolic 
calcium concentration which is well below that required in A. The study also indicated 
that calpain migrated within the cell during the course of mitosis. This may be a means 
by which the enzyme could overcome the effects of calpastatin. 
All these studies have shown that calpain may be responsible for alterations In the 
cytoskeletal structure of cells. In order for a cell to become capable of fusing or undergo 
cytoskeletal rearrangement proteolysis has to be carried out to remove cellular structure 
already present. As calpain is specific to many of the cytoskelctal proteins, under the 
s 
influence of the inhibitory control and activated by changes in the calcium for limited 
proteolytic degradation may be achieved. Other evidence which points to this role Is 
calpain's association with specific areas of cytoskclctal anchoring and the large scale 
rearrangement seen in mitosis. 
Calpain mediated proteolysis of receptors. 
Several receptors are also sensitive to proteolysis by calpain. Including the 
membrane associated receptors for EGF (103) and the a"adrencrgic agonists (104). as 
well as the cytosolic receptors for progesterone (105) and ocstradiol (106). Again 
proteolytic fragmentation is specific to key sites and not random which may suggest a 
possible involvement in down regulation or translocation. 
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Proteolysis of protein kinnse C: an cxatnple of calpain action on enzymes. 
The Involvement of calpain in an event which can be interpreted either as enzyme 
activation or down regulation Is the protcolytic fragmentation of protein kinase C 
(107,108). The cleavage of the membrane associated protein kinase C produces a 
fragment that is active as a kinase but does not require calcium or phospholipids for 
activity. unlike native protein kinase C, the regulatory domain having been removed from 
the kinase domain (107). There is more than one Isoform of protein kinase C (109): three 
of the isofomu, type I (gamma), type It (beta I and beta 11) and type Ill (alpha) have been 
shown to be proteolytically cleaved by calpain I and 11 (110). Calpain I is the more 
effective of the two enzymes: It cleaves the various kinases at different rates and 
preferentially the diacylglycerol activated form in the same region of the enzyme. The 
catalytic fragment, the kinase domain, is active and has the potential to phosphorylate 
substrates which are not exposed to the membranc"bound active protein kinase C 
(107,108). Calpain mediated proteolysis may be the first step in the activation of a 
cytosolic kinase which phosphorylates a different spectrum of substrates to cAMP 
dependent protein kinase, but also effects metabolic events in the same manner. 
However, an alternative view is that the cleavage of protein kinase C may be the first step 
in the complete degradation of the enzyme i. e. 'down-regulation'. 
A proposed mechanism is outlined in Figure 8. The stimulation of diacylglyccrol 
production with the coincident release of inositol phosphates by a rtceptor-mcdiated event 
activates the membrane associated protein kinase C in the presence of calcium ions (1j. 
This membrane bound active protein kinase C Is then on to cleavage by calpain which 
probably associates with the membrane due to elevation of the calcium concentration (2). 
The resulting proteolysis of protein kinase C 131 produces a mcmbrane"Independent 
kinase which is capable of phosphorylating cytosolic substrates (4), but is also further 
degraded to an inactive form (5). 
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2.3.3. A Proposed Mechanism by %thich Calpain Mediated Proteolysis 
Sctccthely and Specifically Cleaves Substrates. 
A model for the selective protcolytic action of calpain on substrates has been 
proposed by Wang et al (111). based on their observations of calcium sensitive 
calmodulin"binding proteins that arge substrates for calpain. They observed that a group 
of calmodulin"binding enzymes could be activated by calpain mediatcd"protcolysis and 
that their fragmentation was different in the presence and absence of calmodulin (1 11). 
The specificity of calpain in this type of cleavage was proposed to act through the 
recognition of the 'PEST' sequence in these proteins. These have been identified as 
regions enriched with praline (P), glutamic acid M. scrine (S). aspartic acid (D) and 
threonine M. The hypothesis. put forward by Rogers et al (112), suggested that scrine 
and thrconine are possible phosphorylation sites, and this in combination with the 
aspartic and glutamic acid would give a negative charge to the PEST region making it a 
possible Ca2+ binding region. The increase in calcium in the vicinity of these regions 
could activate calpain thereby leading to proteolysis (1). 
The observations that calmodulin"binding proteins. such as a"fodrin, which were 
calpain substrates and contained PEST sequences led Wang ct al (I 11) to propose that the 
PEST regions were recognised by calpain. They also suggested that the PEST region's 
negative charge attracts calcium and that calpain is activated at this site then cleaves at a 
position next to the PEST sequence, Figure 9a. The calmodulin binding site could act to 
protect the cleavage site or cause a conformational change to expose new cleavage 
regions, Figure 9b. This is a hypothetical model based on computer searches for PEST 
regions and calmodulin-binding sites in protein sequences which also are calpain 
substrates. Although there; have been observations of altered calpain cleavage patterns of 
proteins or the inhibition of proteolysis by the substrate binding calmodulin, there is no 
definite evidence for the interrelationship between the two. 
Wang et al (I 11) also tried to identify PEST sequences In other calpain substrates. 
However not all calpain substrates have identifiable PEST sequences present. It was 
suggested that this may be due to there being two groups of calpain substrates; those 
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Figur 9: A model for PEST sequence mcdiatcd calpain rotcolytic action (a) and 
its modification by calmodulin interaction with the substrate (b) (111). 
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degraded by the PEST recognition mechanism and those which are subjected to 
protcolysis by some other means. 
PEST dircctcd protein dcgrndation could tcnd to glee specific fragments. Similar 
fragmentation of proteins by calpain proteolysis does suggest hat calpain recognition of 
sites is under the influence of some other factor, like the PEST sequence. rather than the 
random interaction of the cystcine protcinase active site with the primary amino acid 
sequence. The PEST hypothesis gives an added dimension of sensitivity in calpain 
proteolysis as well as proposing a means of increasing calcium concentrations In the 
immediate vicinity of the substrate to be cleaved. 
2.3.4. Summary 
Although calpain does act on muscle m}ofibrillar structurc. it is also capable of 
cleaving a range of substrates as described above. The protcolysis appears to produce 
specific fragmentation of proteins. It is possible that calpain Is Involved In a more 
regulatory capacity than a general proteolytic enzyme which may have indirect 
implications on protein turnover. Calpain appears to have the capacity to Irreversibly 
activate enzymes such as protein kinase C which is proteolytically cleaved and released 
into another dimension where it is active. This altered kinase activity could have 
implications on the metabolic status of the cell as it is known to affect the rate and pattern 
of gene expression. 
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2.4.0. The ß"Adrencrgic Agonists and their Effects on Skeletal Muscle 
Growth with Relevance to Calpain and Calpastatin Activity. 
In the previous section the possible role of the calpain system in muscle protein 
turnover was examined. From the observations of a number of other groups the calpains 
do act on specific myofibrillar proteins, as well as proteolytically controlling the activity 
of enzymes and receptors involved in metabolic regulation. In order for muscle growth 
to take place there has to be net protein deposition. At its simplest his can be achieved by 
increased protein synthesis and/or decreased degradation. If calpain is involved in the 
be 
process of muscle protein turnover a decrease in its activity couldLone of the means by 
which increased muscle growth could be achieved. This could conceivably be through a 
decrease in activity of calpain by a reduction in the quantity of the enzyme or by Increased 
inhibition of the activity already present by agents such as calpastatin. 
The effect of changing growth rate on the activity of calpain and calpastatin has 
been examined in our laboratories by Ballard et al (113). In these experiments, chickens 
were grown at different rates by varying the level of dietary protein. The rate of growth 
was significantly increased in the presence of a greater proportion of protein in their diet. 
When the activities of calpain and calpastatin were assessed there was no statistically 
significant change in either of them. 
A further growth study in our laboratories by Higgins et al (114). on lambs, 
examined the components of the calpain system, calpain 1, It and calpastatin, in animals 
on two diets which gave different growth rates. The Longissimus dorsi (Ldorsi) muscle 
was examined. It was of lower weight and cross sectional area in the restricted intake 
group but showed no change in the calpain system activity. However when lambs were 
fed at the higher intake level plus the ß"agonist clenbuterol (a gift from Hochringer 
Ingleheim Vetmedica Gmbh), at 2ppm for six weeks, there was a significant increase in 
the weight and cross-sectional area of the L. dorsi along with a significant change in the 
activities of all three components of the calpain system relative to the controls on the 
higher dietary intake. Calpain II and calpastatin increased in activity (units/kg) by 99% 
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and 130% respectively of their control values whilst calpain i activity fell by 14% (Table 
2. A. ). 
The effects of ß"agonists on skclclai muscle. 
The p"agonists are known to act as rcpanitioning agents. that Is they increase 
skeletal muscle growth whilst decreasing body fat (115). Muscle growth is achieved 
through hypertrophy and the effect appears to be restricted to skeletal muscle (115). The 
mechanism of action by ß"agonists is believed to be through decreased protein 
breakdown (116.118). However some studies have suggested increased synthesis may 
also be responsible for changes in net deposition (119.120) as well as the decreased 
degradation. The observations may be partially dependent on the dose, the mode by 
which it was given (injection or orally), after what period the synthetic rate was assessed 
and the type of agonist used. 
The action of ß"agonists appears to be directly through the ß"receptor, as 
stimulation by injection of the ß-agonist clenbuterol intraperitoneally into rats led to an 
increase in muscle cAr1P (120). These effects as well as those on growth were abolished 
by administration by injection of propranolol (a D-antagonist) before the dose of 
clenbuterol. 
Figure 10 shows the possible means by which ß-adrtnergic agonists could induce 
skeletal muscle hypertrophy. The evidence points to ß-agonists acting directly through 
[3-receptors causing a rise in intracellular cAMMP via adenylate cyclase stimulation (1) with 
subsequent activation of CAMP dependent protein kinase (protein kinase A), thus having 
an of ect on muscle protein turnover by protein phosphorylation events. Alternatively ß- 
agonists could act in a paracrine manner on nonmuscle cells (21 stimulating the release of 
hormones or other growth factors (3]. which activate or regulate growth independently or 
in conjunction with the direct effects of ß-agonists on muscle. 
As the ß-agonist effect on increased protein deposition in skeletal muscle appears 
to be specific then the post-receptor events after stimulation must be different in muscle to 
other tissues. Protein degradation appears to be involved in the response to ß-agonlsts as 
there Is a recognized decrease in treated animals. If this is the cast then there must be a 
. 
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decrease in the proteolytic activity mediated by a reduction of the expression of the 
proteinascs involved or an increase in their inhibition. 
The effects of ß"agonists on the skeletal muscle caipain system. 
In the experiment carried out by Higgins et al (114), there was an increase In the 
activity of the inhibitor and calpain 11, along with a decrease in calpain 1, shown in Table 
2. A... The possible implications for such changes can be rationaliscd by the following 
explanation. As calpain 11 is not active at physiological calcium concentrations metro 
then the most probable effect of the increase in calpastatin activity would be to inhibit 
calpain i, whose activity decreased although not significantly in the lamb trial, thcrcby 
potentially reducing the capacity for calpain mediated protoolysis. 
The observations of Higgins et at (114) were subsequently confirmed by 
Kretchmar ct al (121). They reported an increase in calpain 11 and calpastatin activity, 
with a decrease in calpain I in the Ldorsi of lambs on a diet containing 4ppm of the ß- 
agonist L-634.969 for 6 weeks (Table 2.13. ) Although the percentage changes are not as 
great as those seen in Higgins et al they followed the same trend. The change in the 
Ldorsi wet weight and cross sectional area was not reported for the muscle of the treated 
animals (121). However Kretchmar ct al (122) did observe the typical ß-agonist"induccd 
muscle hypertrophy in a subsequent lamb growth trial using L-644.969 at an equivalent 
dose and for the same time period as they had described in their initial study (121). 
Earlier observations by Wang and Beennan (123) on changes in the activity of 
calpain on the treatment of lambs for 3 or 6 weeks with the ß-agonist cimaterol at I Oppm 
in their diet showed a decrease in calpain 1.55% and 70%, at 3 and 6 weeks respectively, 
with non-significant changes in 'total' calpain of 13% and 24%, at 3 and 6 weeks. There 
were the usual effects of increased protein deposition on skeletal muscle, and increase in 
cross sectional area and weight. They measured the activities from supernatants of 
centrifuged crude homogenates of L. dorsi using different calcium concentrations in the 
assays to distinguish between the calpain I and 'total' calpain activities, 250µM and SmM 
calcium respectively. These measurements arc complicated by interactions of the 
inhibitor with both isofornns of calpain and autolysis of the enzyme. Such anomalies are 
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Table 2: Comparison of the cffccts of p-agonists on the activities of calpain 1,11 and 
calpastatin in skeletal muscle. All activity determinations were carricd out on Ldorsi 
muscle, except C where the assays were on a combined sample of biceps fcmoris, 
gastrocemius and semimcmbranosus. 
control ß-agonist % signif. 
change 
A. (n=6) (n=6) 
(unitslkg muscle) 
Lamb trial Calpain 1 570 490 44 NS 
Higgins Calpain 11 1250 2880 130 p< 0.05 
ct al, (114) Calpastatin 2740 5440 99 p< 0.05 
B. (call) (nut 1) 
(unitslkg muscles) 
Iamb trial Calpain 1 550 500 
-10 p< 0.05 Kretchmar Calpain 11 650 950 41 p< 0.05 
ct al, (121) Calpastaän 1250 2200 74 p< 0.05 
C. (n=6) (n=6) (units/g protein) 
Rabbit trial Calpain I 10.3 4.3 
. 
58 p< 0.05 
Forsberg Calpain II 48.8 21.0 
. 
56 p< 0.05 
ct al, (124) Calpastatin 290.0 138.0 
. 
52 p< 0.05 
NS 
= non-significance p> 0.05 
a These values were expressed graphically by Kretchmu ct a1 (124) using a 
different definition of units so the values shown are approximations 
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reduced by the use of ion-exchange chromatography to separate the activities so that they 
are assessed individually. as in Higgins et al (114) and Krctchmar et Al (121). The study 
does give an indication of the overall effect of treatment of 1. agonists on the skeletal 
muscle calpain system. Wang and i3ccrman (123) observed an apparent decrease in the 
calpain mediated proteolytic potential at low calcium concentrations, this could have been 
caused by an increase in calpastatin activity or a dccreasc In calpain activity at this calcium 
concentration (2501AS), or both as seen In the observations of Iliggins et &1(114) and 
Krctchmar et al (121). 
Forsberg et at (124) studied the effect of the ß-agonist cimatcrol on rabbits and 
recorded different results to the ones seen in lambs(I 14,121). In rabbits fed cimaterol at 
10 ppm for 5 weeks there was a decrease in the activity of calpain I. II and calpastatin 
(Table 2. C. ). The assays were carried out on a mixed group of muscles which showed a 
significant increase in weight in response to ß"agonist treatment. However it is not 
known whether the expression of the calpain system components is the same in different 
muscles let alone the response of the calpain system in different types of muscle to [3" 
agonist. The difference to the observations discussed above may have been due to the 
species used and possibly the extraction procedure. Calpastatin is susceptible to 
proteolysis (51,67). and in Forsberg et al methodology they dialysed the supernatant of 
the centrifuged crude homogenate for 24 hours before separation of the components of 
the calpain system on ion-exchange chromatography. This may have allowed proteolytic 
cleavage of the calpastatin to take place. In support of this they reported that calpastatin 
activity did not elute as a discrete peak and 'small quantities of additional calpastatin 
activity' eluted following the calpain I on DEAESephacel columns. This suggests that 
calpastatin activity may have been present in the calpain I peak thereby reducing the true 
activity. The spread of inhibitor elution also implies degradation of the Inc calpastatin 
molecule which could lead to its reduced activity. The reduction in calpain Ii activity 
where previous reports have shown an elevation may be caused by inhibition by 
proteolytic fragments of calpastatin which has been observed in other studies (65), 
described in section 2.2.3.. 
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Bcta"agonist mediated ctfccts on cathepsins. 
In addition to assessing the activities of the calpain system, both Forsberg et at 
(124) and Kretchmaret al (121) examined the cathepsins. The majority of cathcpsins arc 
cystcinc protcinases whilst cathcpsins D and E are aspaniý. 
-orsbcrg ct at (124) found no 
change in cathcpsin B and D activity, whilst Kretchmer ct al (121) found a decrease in 
cathepsin B specific activity and an increase in cathepsin 11. McElligott et a1 (125) 
reported that clenbutuol treatment of rats for a week caused no change in cathepsin B and 
D activity in the EDL and gastrocnemius muscles whilst solcus muscle showed an 
increase. At two weeks there was decreased activity of cathcpsin B In the muscles which 
had shown no change at one week, with the solcus response the same. namely an 
increase (126). These proteinases are compartmentalized in lysosomcs so that their 
activity is modulated. Also there arc inhibitors of the cathepsin B and It which could 
influence the activity of the enzymes assayed if they are not removed, as in the calpain 
system. 
Unlike some of the cathepsins. which require low p11 for activity and are largely 
compartmentalized in the acidic environment of the lysosomes (127). ealpains may have 
an important regulatory role in protein turnover. From the observations with the effect of 
ß"agonists the activities of calpains are altered and from the influence of the inhibitor 
there is a probable decrease in the proteolytic capacity of the system 
The effects of ß"agonists on skeletal muscle atrophy. 
The reduction of proteolysis by the use of ß"agonists has been investigated in 
studies on metabolic states where there is known muscle atrophy. A reduction of the 
severity of muscle atrophy induced by denervation was achieved by the use of the P. 
agonist clenbuterol, described by Zeman et at (128) in rats. Denetvation of skeletal 
muscle has been shown to increase calpain activity whilst decreasing calpastatin (91). The 
effect of a-agonist treatment on the calpain system of skeletal muscle may be partially 
responsible for the reversal of the atrophy in denervated muscles by suppressing calpain 
mediated proteolysis. 
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The calpain system has been implicated in the atrophy scan in muscular dystrophy 
(84.88), as described In section 2.3.1.. The effect of clenbuterol was studied on 
dystrophic (mdx) mice (129). Treatment with the ß-agonist resulted In the recovery of 
body composition toward that of the controls. The mdx mice have higher body fat. lower 
protein content and reduced muscle mass. Clenbuterol treatment Increased the muscle 
mass to a level greater than that for the treated normal mice. As with denervation atrophy 
it could be speculated that the [l. agonists affected the activity of calpain by increasing the 
inhibitory capacity of calpastatin thereby decreasing protein degradation. I Iowever as 
described earlier there, arc problems in studying mdx mice as a model of human Duchene 
muscular dystrophy. The mdx animals may not have been In a state of true atrophy as 
regeneration processes arc also seen in their skeletal muscles. This further complicates 
the interpretation of the observations with relevance to the calpain system. 
In both these cases of altered proteolytic status the exact role of calpain Is not 
known, therefore the case for ß-agonists mediating their effect by inhibiting calpain 
action is speculation. However there is strong evidence that calpain is involved in the 
muscle hypertrophy induced by ß"agonists. 
2.4.1. Summary 
Beta-agonist induced skeletal muscle hypertrophy appears to be brought about by 
reduced protein degradation and as well as a possible increase in synthesis resulting in 
protein accretion. Examination of the calpain system in treated animals indicates there is 
probably inhibition of its proteolytic potential brought about by an Increase in calpastatin 
activity. The lack of changes in the activities of the calpain system components seen 
when growth is regulated by diet is probably due to the change in protein turnover not 
being through the same mechanisms as ß"agonist induced hypertrophy, namely a 
significant reduction in protein degradation 
Use of ß-agonists in states of increased skeletal muscle atrophy. where calpain 
activity has been implicated. have shown that the agonists reduce skeletal muscle 
wasting. This may be mediated through diminished calpain activity. 
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2.5.0. The Effect or Rcccplor"induccd cAhill on the Regulation of 
Enzyme Activity. 
As described in the previous section calpain and calpastatin activity is altcrcd in 
skeletal muscle by the cffccts of ß"agonists. Apparently the ß-agonists do not act directly 
on calpain by intermolecular interaction as there was no change in activity when cimatcrol 
was added to calpain (123). Accordingly. one or other of the known cAMP. mediated 
stimulatory mechanism may be called into play. 
2. S. 1. Possible Phosphorylation Induced Changes in the Activity of the 
Calpain System Mediated by the Secondary Messenger cAMP. 
In the skeletal muscle growth response ß"adrencrgic agonists presumably act 
through post ß-receptor-mediated events similar to those in other tissues. The [3. agonists 
bind to ß"reccptors which then interact with G"protcins and in turn these stimulate 
adenylate cyclase leading to an increase in CAMP levels, subsequently activating cAMP" 
dependent protein kinase. The kinase activates by phosphorylation enzymes which are 
involved in generally degadative metabolic processes, for example the enzyme activation 
cascade leading to glycogcnolysis. This type of regulation may have effects on the 
calpain system by mediating reversible changes in activity. 
Murachi's group have described the phosphorylation of calpastatin (130). 
Transfection of the T-cells gives increased expression of calpastatin (130). In these cells 
labelling of calpastatin in vivo with 132Pj-onhophosphate in the presence and absence of 
phorbol esters was detected. Phosphorylated calpastatin was subsequently shown 
associated with the cell membrane whilst nonphosphorylated inhibitor was located in the 
cytosol. There was no apparent change in the proportion of phosphorylated calpastatin 
associated with the membrane when phosphorylation took place in the presence or 
absence of phorbol ester. 
The significance of this phosphorylation in terns of activity is not known but 
Aturachi suggested that such phosphorylation might involve protein kinuc C activated by 
phorbol ester. It is known that although protein kinase C and CAMP-dependent protein 
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kinasc usually work in different secondary messenger signalling pathways they will act 
on the same protein and can cause similar cellular responses (131). Although the role of 
calpastatin phosphorylation has not been determined. It seems likely to bring about the 
redistribution of the inhibitor hence affecting the local distribution and thereby calpain 
activity. 
Zimmmmn and Schlacpfcr (132) described the isolation of kinase activity 
associated with both calpain I and 11 from skeletal muscle. They obscured that both 
calpain I and It were phosphorylatcd by this kinase in vim and that the phosphorylation 
of calpain II was cAhIP-depcndent. Phosphorylation had no cffect on the calcium 
sensitivity of the isoforms but reduced their specific activities. However Adachi ct a1 
(133) were unable to detect any phosphorylation of calpain I and 11 i vivo. 
2.5.2. The Role of cAMP in the Control or Gene Expression at the Level 
of Transcription and Translation. 
The modulation of enzyme activity by cAAMP induced phosphorylation is not the 
only possible mechanisms by which altered activity could be seen. Cyclic AMP is also 
known to regulate gene expression and this could result in an increased activity of calpain 
and calpastatin. The work- carried out in this thesis was undertaken in order to study the 
possible regulation of calpain and calpastatin activity at the level of transcription and 
translation. 
Cyclic AMP"mediated regulation of gene expression has been implicated at 
various levels; 
i) Transcription; various genes arc thought to be regulated by 'cAMMP"responsive 
regions' within promoters (13 3.135). 
ii) Post. transcription/Prctranslation; this includes several steps involved in the processing 
of the primary transcripts into mRNA and its transport o the translational machinery. The 
stability of the mRNA is believed to be affected by changes In intracellular cAMP 
concentration (136-138). 
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iii) Translation; the production of the protein encoded by certain mRNAs is affected by 
changes in cAMP. Although this may not be a direct effect on the translational 
machinery. for example on phosphorylation of the ribosomal complexes, mRNA 
sequence or processing at levels i) and ii) can increase translationally efficiency (139). 
Cyclic AAMP"lnduced gene transcription. 
Regulation of expression of a few genes has been shown to take place via 
activation of transcription through the CAMP responsive clement (CR1). This Is a 
sequence which is based on a palindromic motif, TGACOTCA (134). Various gene 
promoters have CREs within them and respond to cAMP. Including somatostatin (140), 
proenkephalin (141). a human chorionic gonadotrophin (142) and 02"adrencrgic 
receptor genes (143). 
The exact characterisation f CREs has yet to be achieved; whether the CRI: alone 
is sufficient to completely regulate gene transcription is not known. Several genes with 
5' CREs have altered transcription rates when exposed to CAMP (134,135) Including the 
ß2"adrenergic receptor gene (143) which binds the protein involved in the activation of 
the CRE sequence, namely the CRE binding protein (CREB) (144). Other cAMP 
responsive clement binding proteins have been identified, the binding protein CRE-BPI 
(147) and a novel I20kDa binding protein (148). The CRE motif has been shown to be 
able to promote CAMP stimulation of transcription at a distance from the initiation codon 
in the DNA sequence and independent of orientation, a classification characteristic of an 
'enhancer clement'. Promoters are limited to the immediate S' sequence of the gene, but 
enhancer sequences can also be located in this region. Some enhancers are required for 
basal transcription which is a characteristic of a promoter sequence, but they cannot 
induce gene transcription by themselves. There is evidence that CREs have dual role as 
both basal and inducible transcription enhancer elements (134,145.146). An example of 
this is the ß2-adrenergic CRE sequence which when subjected to mutation removed 
transcription initiation activity from the promoter of the gene (143). 
Both CRE-BPI and CREB cDNAs indicate the presence of leucine zippers in 
their protein sequence (147,149). The leucine zipper is thought to be involved in the 
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dimcrization of transcription activating proteins (150). For example the activator proteins 
Jun and Fos form a hctcrodimcr. then bind to activator protein I (API) binding sites in 
promoters. Monomers of Fos will not bind to DNA but on forming a hctcrodimer with 
the protein Jun it will interact with DNA (150). suggesting a conformational change 
required for binding. 
The CREB protein can be phosphorylated InvjuQ and In vivo. In vitro the 
phosphorylation is carried out by cAAMP-dcpendent protein kinase (protein kinase A). 
The phosphorylated CREB will bind the CRE containing promoter of somatostatin and 
stimulate transcription as well as form dimcrs with transcriptional activity. 
Phosphorylation of CREB is essential for transcriptional activity. dimerization of the 
protein is also thought to be involved in the binding of CREB to DNA (151). Multiple 
phosphorylation sites for a variety of kinascs have been identified in the CREB protein 
(149). However the implications of these plus the interaction of phosphorylation and 
dimerization have yet to be elucidated. Recent studies have shown that both CRE"BP1 
and CREB will form hetcrodimcrs with the Jun protein (152,153) but whether this 
heterodimer formation takes place in vivo and any functional significance is not known. 
This heterodimer formation may play a role in transcription factor crosstalk allowing 
modulated expression of related genes. 
The ability of CAMP induced phosphorylation to mediate changes in transcription 
allows rapid induction of mRNA for the genes without the need fore nova synthesis of 
the transcription activating factors. Most of the genes known to be activated by increases 
in CAMP do so very rapidly. the peal- of transcript production is often less than a hour in 
cells in culture (134.135). The effects of long term exposure to cAMP analogues or 
stimulation of (-agonists on gene transcription has not been investigated in such 
experiments. 
A different cAMP responsive sequence called the activator protein 2 (AP2) 
binding site has also been identified. The sequence is found in the promoters of several 
genes including metallothionein IIA (154), growth hormone (155) and Prolactin (156). 
Transcription from promoters containing AP2 elements is induced by phorbol esters and 
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forskolin. which activate protein kinase C and increase cAAMP concentration respectively. 
The protein AP2 will bind AP2 elements in the promoter regions of genes containing the 
sequence (157). 
Cyclic AMP"induccd changes in niRNA stability. 
Although certain genes have been shown to have increased transcription rotes 
resulting from the activation of CAMP production. and the subsequent kinasc"mediatcd 
activation of CREs or AP2 binding sites. there is evidence that cAMP also has in effect 
on mRNA stability. 
Various mRNA have different half-lives some spanning several hours. He ß- 
globulin, others, like c-foss have a very short half-life of around 30 minutes in cell 
culture. The modification of the stability of mRNA would be a efficient way of increasing 
the production of a specific protein. The half-life of the mRNA transcripts for 
phosphoenolpyruvate carboxykinase (PEP-CK) is prolonged on the incubation of P'PO- 
2B rat hepatoma cells with the cAMP analogue dibut)ryl cAMP (1h2-cAMP). There was 
no change in the stability of total cellular RNA indicating a specific effect on PEP-CK 
mRNA (137). 
An example of increased degradation of mRNA. stimulated by the CAMP 
analogue 8-bromo-cyclic AMP (8.13r-cAMP), was seen in the increased turnover of 
mRNA for tyrosine aminotransferase in 11.4 rat hepatoma cells (138). The mechanism of 
this CAMP-mediated regulation of mRNA stability is not understood. 
Lactate dehydrogenase expression is an example where the mechanisms of 
transcription. mRNA stability and efficiency of translation have been reported to be 
effected by cAMP (136). Stimulation of C6 gliornz cells with either the ß"agonist 
isoprotcrcnol or dibutyryl CAMP lead to a two-fold increase in mRNA for lactate 
dehydrogenase CAMP. brought about by an increase in the half-life of the newly 
synthesised mRNA. Two populations of mRNA were identified, one with a half-life of 
50 minutes the other at 2-5 hours (136). The suggestion that two different pools of 
lactate dchydrogenase mRNA were differentially regulated was also implied when the ja 
yin translation of the isolated mRNA was examined. 11cm was a 8.10 fold Increase to 
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lactate dehydrogenase mRNA expression caused by an Increased cfficiency of translation. 
Jungmann et al (136) suggested that the mRNA produced by cAMP Induction was 
structurally different, although from Northern analysis of treated and nontreated cellular 
mRNA there was no difference in size. They believed the difference in the mRNAs was 
in their 3' noncoding regions and this gave the mRNA the potential for efficient 
translation. If this was the case the effect of cAMP was brought about by transcriptional 
or post-transcriptional modification of mRNA as the In-vltffi translation assay is 
independent of influence of cAAMP on the translation machinery as might be seen in vivo. 
The studies on tyrosine aminotransfcrasc or PEP-Ch did not examine the translation 
efficiency of the mRNA they isolated. 
The 3' untranslatcd region along with its poly(A)+ tail appears to be involved in 
the control of mRNA translation (158). Stability of mRNA is thought to be affected by 
the presence of the AU-rich motif which interacted with poly(A) binding proteins (PADP) 
normally thought to stabilise the mRNAs poly(A) tracts preventing their degradation. 
The consensus equence UAUUUAU is found in the 3'untranslated region of mRNAs 
which target them to rapid turnover. Jungmann et at (136) suggested that the lactate 
dehydrogenase mRNA synthesised in the induced state was modified at the 
3'nontranslated end which both affected stability and efficiency. The exact mechanism 
by which the untranslated regions target mRNA for varying rates of turnover as well as 
changes in translation efficiency is not known. The involvement of cAAMP. although 
coincident with the changes in mRNA stability for the examples indicated, has not been 
positively shown to change the processes involved in mRNA turnover for cAMP induced 
changes in gene expression. 
Figure 11 shows the various possible mechanism by which gene and resulting 
protein expression could be mediated by cAMP. Stimulation of ß-adrenergic receptors 
by ß"agonists causes the intracellular increase of cAAMP. Increased transcription of 
specific genes is induced by elements associated %ith promoters that respond via CREs 
or activating protein 2 (AP2) binding sites (1j. The stability of mRNA Is also affected by 
changes in intracellular cAMP (2), there being an increase or decrease in half-life of 
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mRNA mediated by changes in degradation 13). It is not known if these changes acre 
through protein kinase A activation. The efficiency of translation (4) may be due to a 
change in the mRNA characteristics mediated by cAMP causing transcriptional/post. 
transcriptional modifications resulting in altered translational efficiency. 
2.5.3. The Possible Effects of ß"Agonists on the Calpain and Calpastatin 
Genes Expression. 
In the experiments described in this thesis effects of long-term exposure of 
animals to ß-agonists on the expression of specific mRNAs encoding the components of 
the calpain system have been investigated. Any change in the level of expression need 
not necessarily indicate increased gene transcription but may involve mRNA stability 
effects. as described above. However such changes in mRNA would indicate that the ß" 
agonists' mechanism of action was not solely post. translational modification of activity 
by CAMP linse activity. 
The gene structures of human calpain 11 large subunit (159) and the human small 
subunit (160) have been described The number of human calpain subunit genes and their 
chromosomal allocation indicates one gene for each subunit; calpain I and Ii large 
subunits, p94 (the'calpain"like' molecule) and the small subunit. None of the genes are 
located on the same chromosome (161). There is less infonnation on the gene structure 
of calpastatin. only a small pan of the human gene has been sequenced (61). 
The promoter region of calpain 11 large subunit has been sequenced by data cz a1 
(159). From the promoter sequence analysis of the calpain it large subunit they 
suggested that the gene was that of a so called 'housekeeping' protein, by comparison 
with other similar gene promoters, and the small subunit has a very similar S' promoter 
region in its gene (160). Within the promoter region were several consensus equences 
for enhancer/promoter elements including a potential API binding site and a strong 
repeating negative enhancer. whose exact Identity was not determined. Some of these 
elements were also found in the small subunit gene. The APi binding site Is under the 
influence of phorbol esters which stimulate protein kinase C. The response of calpain II 
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large subunit mRNA expression to phorbol esters has not yet been investigated, so 
whether the API site does confer sensitivity to these agents is not known. 
Rata et al (159) did not identify any CRC or AP2 consensus equences, although 
they did not state whether they searched for such enhancer elements. From this work it 
appears that the gene may not be responsive to cAMP but, until the experiments ca: ricd 
out in this thesis, studies have not been carried out on the examination of calpain mRNA 
expression after stimulation through this secondary messenger system. 
The promoter region of calpastatin gene has yet to be isolated, therefore its 
composition remains unknown. As with calpain mRNA there is no data concerning 
changes of the inhibitor mRNA expression in response to increases in intracellular 
CAMP. 
Recent observations of Barka et al (162) have identified a cystcine protcinase 
inhibitor. cystatin S. whose mRNA and protein expression was induced In the salivary 
glands of rats when they were fed f 3"adrenergic agonists. The mRNA for this protein 
was undetectable in the glands of untreated rats but on treatment with ß"agonists high 
levels of mRNA for the protein were detected. The rat salivary cystatin S gene has not 
been mapped but the gene in human salivary glands does contain a sequence similar to the 
CREs already isolated. Although cystatin S is a cysteine proteinase inhibitor there is no 
known relationship to calpastatin. The primary sequence of the pig inhibitor was 
compared against sequences of the'cystatin superfamily' by Takano et al (53) especially 
the consensus inhibitory sequence gln"val"val"ala"gly which was identified in the 
cystatins (163). It was concluded that calpastatins are probably a different family of 
cystcine proteinase inhibitors which are specific to calpain (53). The cystatins arc 
cysteine proteinase inhibitors but perhaps the only similarity to calpastatin Is In their 
response to ß-agonists. however one of the aims of the work carried out In this thesis 
was a similar Investigation to that on cystatin S. namely whether ß-agonists induced an 
increase in calpastatin mRNA. 
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2.5.4 Summary 
changes in cAMP could havc cffccts on calpain and calpastatin activity. It 
appears that direct phosphorylation of calpastatin may have an effect on it: subecllular 
distribution. The role of phosphorylation on the activity of the calpain system has not 
been comprehensively analysed particularly with respcct to cAMP activated kinase cffccu 
on calpastatin Vitro and in vivo. 
Cyclic AMP mediated effects on gene expression do appear to be a means by 
which increased expression of the components of the calpain system could be brought 
about, if the relevant genes do contain cnhancujpromotcr elements that respond to cAMP 
either directly or indirectly. 
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2.6. Overall Summary 
The exact physiological role for calpain in skeletal muscle-has yet to be 
determined. From in 
-vitro studies the enzyme's substrates 
include some myofibriilar 
proteins and it is associated with states of skeletal muscle atrophy. I ow'ever, calpain 
does not appear to be a general catabolic enzyme. Its proteolytic action may be to loosen 
myofibril structure initiating further protein degradation by other proteinases. or 
alternatively it could cleave other enzymes in venibly'activating' them with an ensuing 
catabolic effect. 
ß-agonist induced skeletal muscle hypertrophy appears to be achieved through 
decreased protein degradation and possibly an increase in protein synthesis. Although 
other proteinases may reduce their activity, the calpain system is the one which has been 
monitored and shown to have the capacity to decline in activity which may partially 
account for the diminished protein breakdown. This enzyme is also of interest because of 
its cytosolic distribution and its activation characteristics, being regulated by its own 
calcium sensitivity and a specific inhibitor. This apparently tightly regulated enzyme may 
be trigger for initiating further proteolysis. 
The effects of ß"agonists appear to be mediated through cAAMP. As discussed 
above this could induce changes in activity of calpain and calpastatin at the level of direct 
phosphorylation or increased gene expression. The work in this thesis is concerned with 
the examination of the effects on gene expression at the mRNA level in ß-agonist induced 
skeletal muscle hypertrophy. particularly the effects on the calpain system. 
The following sections describe the techniques employed for the isolation of intact 
total RNA from skeletal muscle and the development of effective hybridization probes to 
be used to try and quantify any changes in the level of mRNA for calpain and calpastatin 
in the muscles of ß-agonist treated animals. 
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Chapter 3. Materials and h1clhods 
3.0 Materials. 
The tissue samples used for the development of total RNA cxtraction techniques 
and the total RNA preparations used for DNA hybridization probe assessment were 
obtained from various sources within the faculty. 
Chicken tissue samples were from Ross broilers at 2.4 weeks old and fed a 
conventional starter diet. They were selected without reference to sex. Bovine (Fr scan 
steers) and ovine (Suffolk x pun lotest, %-ethcrs) samples were obtained from animal 
trials within the Department. The steers were fed a 70% dry grass 30% barley pellet or a 
grass silage diet ad libitum, whilst the wcthers were fed ad lbltum on a pellet diet 
consisting of (g/kg): barley (225), oats (450). grassmeal (200), mineral mix (25) and 
Nutramol (Rumenco, Burton-on-Trent) (100). All the samples were removed from the 
animals directly after slaughter, frozen in liquid nitrogen then stoned at "200C or 40°C 
until uscd. which was up to a maximum period of 4 months. 
All chemicals were analytical grade or electrophoresis grade, where available of 
relevant. For RNA and DNA manipulations chemicals and solutions were nucleic acid 
grade or they were at least analytical grade. The source of specialized chemicals, such as 
radioisotopes and enzymes are given in the text of the appropriate method. All other 
chemicals were obtained from BDII, Fisons or Sigma. 
Solutions were made in sterile water and sterilized either by autoclaving at 120°C 
for 20 minutes or by passing through a 0.22µm sterile filter. Water used for nucleic acid 
manipulations was sterile, dcionized and distilled. All glass and plastic laboratory 
equipment was soaked overnight in aIM UCI acid bath before being cleaned thoroughly 
then rinsed in distilled water and was then sterilized by autoclaving. 
Specialized equipment used in the course of the project included the following: 
Pyc SPS-400 UV/VIS Spectrophotometer. 
Centrifuges; Beckman J2.21. 
MSE 18 
Bench top microfuge; 1leraeus (Christ) Biofuge A. 
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Electrophoresis apparatus: 
Polyacrylamidc gels: Shandon Vcnical Slab Unit. 
Agarosc gels; F3io. Rsd. N ini"SubTM DNA Cell. 
Gallcnkarp Submarine gel syftenn, 'M W cd l' and Wins-ccll'. 
Sequencing el; Uio-Rad, Sequi"GcnR Nucleic Acid Sequencing Ccli. 
Power supplies; Bio-Rad power supply unit. 
Chandos power pack. 
Slot blot apparatus; Bio-Rad. Bio. DotR SF apparatus. 
Dot blot apparatus; Bethesda Research Laboratories (I3RL) I lybri"Dot Manifold. 
PCR heating block; Ilybaid. 
Transilluminator, UVP Inc. Transilluminator. 
Liquid scintillation counter, Intcrt chnique SL30 Liquid Scintillation Spccuvphotomctcr. 
All other apparatus was commonly used laboratory equipment such as water baths, pli 
meters etc. 
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3.1. Measurement of Calpain and Caipastatin Mikity In Skeletal muscle. 
The components of the calpain system, calpain t and it as well as calpastatin, 
were isolated from skeletal muscle by anion exchange chromatography on Fast Protein 
Liquid Chromatography (FPLC) Mono Q columns (Pharnucia) as In Higgins et at (114). 
Fresh muscle (2.4g) was finely chopped, or frozen tissue was ground to a powder In 
liquid nitrogen, then homogenized on ice with three volumes of buffer A (20mM 
Tris/HQ p117.5,5m, %1 EDTA. 10mNI 2"mcrcaptocthanol) on setting '5' of a Polytron 
homogenizer. After centrifugation for 20 minutes at 30000g and 40C the supernatant of 
crude homogenate was filtered through 0.45µm then 0.22µm pore filters (Millipore). 
The filtrate was then loaded onto the Mono Q column which had been pre-equilibrated 
with buffer A. The column was washed with buffer A until the O. D. of the fractions 
eluting began to fall to the base line. Proteins were eluted with a salt gradient Buffer I3 
(20mal TriOIC1 p17.5. SmM EDTA, 10mM 2"mczvaptocthanol, 1.OM sodium chloride) 
was mixed with buffer A in a gradient from 0.1 N1 upto 0.6M salt, over 20m1, using a 
FPLC programme. 
Calpain and calpastatin activity was assessed in the fractions from the salt gradient 
based on the production of TCA"soluble peptides from cascin originally described by 
Ishiura et al (235). The assay mix was 0. Sml consisting of; 0.2% (w/v) heat-denatured 
casein. 80mM sodium glycerophosphate p117.5.10WN12-mercaptocthanol with 10mM 
calcium chloride or 10m'ý1 EDTA as a control to which was added aim! of each fraction 
from across the salt gradient. The reaction was incubated at 300C for 30 minutes. then 
the proteins precipitated by adding 0.5m1 10% (w/v) TCA. Calpain activity was detected 
as an increase in TCA soluble peptides in the presence of ß2+ over the background in 
the absence of the ions as determined by absorbance at 280nm. The fractions containing 
activity were pooled and the total units of activity per kilognim of muscle determined after 
testing dilutions of the enzyme pool for linearity. One unit of enzyme activity was 
defined as the quantity of enzyme which produced an incr asc in absorbance at 280nm of 
one at 300C for 30 minutes in this system. 
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Calpastatin activity was measured across the salt gradient using a similar assay 
system as that for calpain (114). Inhibition of pooled calpain 11 was determined in the 
presence of calcium ions. Each suspected inhibitor sample (0.1ml) was added to an 
assay tube containing a fixed quantity of active calpain 11 or heat-denatured inactive 
calpain (0.1ml) along with the assay solution (0.5m1) as described above. The decrease 
in absorbance at 280nm produced by the addition of a inhibitor sample was compared 
with a control of the change in absorbance produced by the calpain 11 alone. defined as 
100% activity. Dilutions of the pooled inhibitor were used to obtain a linear regression 
line. From the relationship of the percentage inhibition against the quantity of Inhibitor 
pool present the amount of inhibitor giving 50% Inhibition of the calpain present was 
measured. One unit of inhibitor was the quantity required to inhibit one unit of calpain 11 
activity at 300C for 30 minutes. 
T ese extraction procedures and assay conditions were modified for the analysis 
of the cimaterol bovine trial samples by introducing a hydrophobic chromatography step 
before FPLC as described by Etherington et al (236). To the supernatant of the 
centrifuged crude homogenate from 2g of muscle was added sodium chloride to a 
concentration of 0.3M. This was loaded onto a phenyl"scpharose (Phaxmacia) column 
(2m1) pre-equilibrated with buffer A containing 0.3M sodium chloride. The calpastatin 
activity was washed through the column with an equal loading volume of buffer A. 
containing 0.3Ai sodium chloride. Calpain was then removed from the column using 
50% ethylene glycol in buffer A (four column volumes. 8m1). The calpain and 
calpastatin pools were diluted fivefold with buffer A then each subjected to 
chromatograhy on the Mono Q FPLC column as described above. 
From the salt gradient from the FPLC separation the location of the calpain I and 
II. along with calpastatin activity was determined and fractions pooled separately. The 
activity of the calpain isofomu and calpastatin werk determined as dcsaibed above. The 
inclusion of a hydrophobic step was reported to improve the separation of calpastatin and 
calpain which in some samples are incompletely resolved (236). 
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3.2. Extraction and Manipulation of RNA. 
3.2.1. Extraction of Total RNA from Skeletal Muscle by a Phenol 
/Chloroform Based Method. 
Skeletal muscle from the species chosen was dissected after slaughter, frozen in 
liquid nitrogen and then stored at "400C or "20°C. Total RNA was extracted by a 
phenol/chloroform method which was modified for the preparation of total RNA from 
skeletal muscle (164). The muscle sample was ground to a powder In liquid nitrogen and 
up to 8g was used for extraction of total RNA. To the muscle powder was added 15 
volumes of Homogenizing buffer. 5OmN1 sodium chloride, 10mh1 magnesium acetate. 
0.2M Tris"acetate p118.5.1.3% (v/v) Triton-X100 at 4°C. The mixture was 
homogenized on ice with a Polytron homogenizer at setting's' for 15 seconds. To the 
homogenate was added SDS to 1% (w/v) and EDTA to 2m! ýi, the mixture was then 
passed through two layers of muslin. The filtered homogenate was shaken for 10 
minutes with an equal volume of phenol/chloroform 1: 1(v/v) " the phenol was saturated 
with Homogenizing buffer (30ml/100ml phenol) 
- 
for 10 minutes at room temperature. 
After centrifugation at 7.500g for 10 minutes at 200C the upper aqueous phase was 
removed and stored on Ice. 
The interface and organic phase was then re-extracted with 15 times the original 
muscle weight of Extraction buffo; 0.1hi sodium acetate, 2mM EDTA. Q1M Tris"acetate 
p19.0. The mixture was shaken for 5 minutes at room temperature then centrifuged as 
above. The aqueous phase was removed and combined with the first aqueous phase. 
Using a quarter volume (approximate 60m1) of phenoUchloroform 1: 1, the combined 
aqueous phases were re-extracted by shaking at room temperature for 5 minutes. After 
re-centrifugation the aqueous phase containing the RNA was removed. Precipitation of 
RNA was carried out by adding 0.1 volume of 3M sodium acetate p115.5 and 2.5 
volumes of ethanol to the aqueous phase then leaving at "20°C overnight (165). 
The RNA was recovered by centrifugation at 7. SOOg for 60 minutes at 4°C, The 
pellet was redissolved in water to approximately 1mg/ml and then cleaned to remove 
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contaminating DNA (165). An equal volume of EM lithium chloride was added and the 
RNA left to precipitate for at least 2 hours at "2000. RNA was recovered by 
centrifugation at 7.500g for 40 minutes at 40C. The procedure was repeated once. 
Finally the RNA was rcprtcipitated twice with 0.1 volume of 3M potassium (or sodium) 
acetate p115.5 and 2.5 volumes of ethanol overnight at 
-2000 (section 3.2.4) 
The RNA was recovered as described in the paragraph above and the pellet dried 
in a vacuum desiccator. The pellet was redissolved in water to 1mg/ml (2m1), rc" 
extracted with phcnol-chlorofonn and precipitated using 0.3M potassium acetate pl15.5 
and 2.5 volumes ethanol (section 3.2.4). 
RNA pellets were redissolved to approximately l mg/ml In watcr then stored at 
-700C in suitable aliquots. The quantity of RNA was evaluated by speetrophotometrie 
analysis at 260nm (section 3.2.5) and then examined on nondenaturing agarose 
electrophoresis (section 3.2.6). 
3.2.2. Extraction or Total RNA from Skeletal Muscle by a Guanidinium 
Thiocyanate Based Method. 
Total RNA was isolated according to the procedure of Chomczynski and Sacchi 
(166). 
Muscle was ground to a powder under liquid nitrogen then homogenized for 15 
seconds at room temperature in 10 volumes of solution U; 4M guanidinium thiocyanate, 
25mM sodium citrate p11 7.0.0.5% (w/v) sodium dodecyl sucosinate, O. IM 2- 
mercaptoethanol. It was then mixed with 0.1 volume of 2M sodium acetate p114.1 
volume phenol (water saturated) and 0.2 volume ehloroform: iso-amyl alcohol mixture 
(49: 1). with shaking after each addition. The acidic guanidinium thiocyanate"phenol" 
chloroform mixture was shaken for 10 seconds and then cooled on ice for 15 minutes. 
After centrifugation for 20 minutes at 40C and 10,000g. the RNA w as precipitated with 1 
volume of isopropanol at "200C for , at least 1 hour. Centrifugation was repeated 
under the sane conditions and the RNA pellet redissolved in 0.3 volume of solution D 
and reprecipitated with I volume of isopropanol at "200C. Finally after centrifugation the 
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pellet was washed in 75% ethanol. rc"ccntrifugcd and then dried. The RNA was 
redissolved in water then quantified and cxamincd as described in section 3.2.5 and 
3.2.6. 
3.2.3. Selection of Poly(A)+ RNA from Total RNA. 
Poly(A)+ RNA was selected using affinity chromatography on a oligo"d(T) 
cellulose column (167,168). The Poly(A)+ RNA was isolated by a single or double 
passage through a column depending on the purity of Poly(A)» RNA required. The 
appropriate quantity of oligo. d(T) cellulose (Phan cia, Sigma). subject to its binding 
capacity and the amount of RNA to be loaded, was suspended in elution buffer, 10mM 
Tris"HCI p117.5. lmMM EDTA. and poured into a 1"Sml pasteur pipette column. The 
packed column was washed with 5 column volumes of binding buffer, 10mM Tris"IIC1 
pH 7.5. imM EDTA, MINI sodium chloride, 0.1% (w/v) SDS. The total RNA was 
redissolved to 1"5mg/ml in water, heated to 630C for S minutes. cooled, then diluted 
with an equal volume of double strength binding buffer. 
RNA was applied to the column followed by one column volume of binding 
buffer once all the RNA had been loaded onto the column. The eluted fraction from the 
column was heated to 65°C for 5 minutes and reapplied; this was then repeated. When 
the RNA had been loaded the column was washed with 5.10 column volumes of binding 
buffer then 5 column volumes of wash buffer, 10mM Tris-11(3 pli 7.5,1mM EDTA, 
0.1M sodium chloride. 
Poly(A)+ RNA was eluted with 2.3 column volumes of elution buffer in less than 
0.5 column volume fractions. To further enrich the Poly(A)+ RNA over Poly(A)" RNA 
the eluted fractions were heated to 6500 for three minutes and an equal volume of two 
times binding buffer added. The RNA was applied to the column, then washing and 
elution steps were repeated. 
The Poly(A)+ RNA was precipitated from the eluted fractions as described in 
section 3.2.4. After being dried it was dissolved in water and stored at 
. 
7000. 
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3.2.4. Extraction and Precipitation of RNA and i)NA In solution. 
Contaminants were removed from RNA and DNA in solution prior to use In 
various techniques, like PCR and jam translation, by phenol/chloroform extraction 
followed by ethanol precipitation (169). 
An equal volume of phrnoVchloroform (T. E. p1! 7.6 saturated phenol, 3: 10 
T. E.: phenol 
- 
T. E. defined in appendix C) was added to the aqueous solution of 
RNAIDNA to be extracted. The solutions were vortexed for 10.1S seconds. then 
centrifuged for 3 minutes at 14.000g in a microfuge at room temperature. The upper 
aqueous phase was removed and the process repeated as rcquiraL 
Nucleic acids in the aqueous phase were then precipitated. 
For DNA 0.1 volume of 3M sodium acetate p11 S. S was added followed by 2 
volumes of ethanol. To precipitate the DNA the sample was either stored at 
. 
2000 
overnight or at 
-70°C for 30 minutes. Centrifugation at 14,000 g for 15 minutes at 40C 
pellcted the DNA and this was then washed in 70% ethanol by gently vonening the pellet 
After repeating the centrifugation for 10 minutes the pellet was dried in a vacuum 
desiccator then redissolved in water and stored at 40C. 
To prevent co-precipitation of dNTPs with DNA an alternative salt was used. 
Half a volume of 7.5Rt ammonium acetate was added to the sample followed by 2.5.3.0 
volumes of ethanol. precipitation was carried out at "700C for 15 minutes. This 
technique was not used directly before the use of phosphorylation or tailing enzymes as 
ammonium ions are reported to be inhibitory (169). 
For RNA in aqueous olution which required precipitation ethanol was also used. 
One tenth volume of 3M sodium, potassium or ammonium acctatc pl15. S, or 0.1 volume 
of SM lithium chloride along with 2.5 volumes of ethanol was added to the RNA sample. 
The solution was then treated as the DNA. The dried RNA was dissolved in water and 
stored at 
-20°C or long term at -7000. 
The choice of salt used was dependent on the application of the RNA In 
subsequent steps. For Poly(A)+ RNA purification, total RNA was precipitated with 
sodium acetate due to the presence of SDS in the oligo iM cellulose chromatography 
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bufers. In vitro translations require the absence of sodium and chloride ions for efficient 
translation of mRNA. therefore the salt chosen was either potassium or ammonium 
acetate. Lithium ions were not used when the RNA was to be neuen transcribed as they 
inhibit the enzyme Reverse Transcriptase. 
3.2.5. Determination of RNA and DNA Conccntration in Solution. 
The concentration. and to some degree the qualitity. of RNA and DNA dissolved 
in water could be assessed by scanning spcctmphotomcuy in a icm path length quarts 
cuvcttc. Five to ten µ1 of RNA or DNA was diluted into Im1 of water and then scanned 
from 380 to 200nm. The concentration of the nucleic acid was determined by its 
absorbance at 260nm using the following values: 
For DNA, an absorbance of 1 in a Icm path length cuvcttc is approximately 
equivalent to 5OµglmL 
For RNA, an absorbance of I in a 1cm path length cuvette is approximately 
equivalent to 40µg/ml. 
For oligonucleotides of known sequence the concentration for aI cm path length 
was calculated using the sum of the extinction coefficients of each base (167): 
dGTP 11.7 mVµmol 
dCTP 
- 
7.3 mVµmol 
dATP 
=15.4 mVpmol 
dTii' e 8.8 m1lµmol 
and the equation. Absorbance =r 
-c., 
where e is the extinction coefficient and c is the oonccmration. 
3.2.6. Nondenaturing Agarose gel Electrophoresis. 
Examination of RNA and DNA after cxtraction was carried out using agarosc gel 
electrophoresis (170). The integrity of the rRNA bands in the RNA samples arc to some 
extent an indication of the quality of the RNA. Elatmphot 1s v. is c, cd out using 1% 
(w/v) agazosc for fragments greater than lkb and 1.5% (w/v) aguosc for fragments less 
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than I. 5kb, in I xTBE buffer p118.3 (appcndix C) Ina mini gel system with A gel volume 
of 30 mis. 
The nucleic acid was dissolved in water. I. 4 ig in a volume of 10}tl. Hind I11 or 
Eco Ri/ilind III restriction enzyme digestcd lambda DNA markcrs (appcndix E3) were 
used to calibrate the gel. Approximatcly 0.5.1.0N8 of mukcr DNA was used per track. 
To the samples was added 0.1 volume of loading buffer, 30% (w/v) Ficoll, 0.25% (w/v) 
Bromophcnol blue, 0.25% (w/v) Xylcne cyanole FV, 0.2M EDTA p118 in 10xT13E. 
The gel was loaded and run in 1 xTIE for approximately 2 hours at 70 V. 
To visualise the nucleic acid the gcl was soaked in a 111g/ml solution of cthidium 
bromide for 10 minutes. destained in water for 5 minutes, then placed on a 
transilluminator. 
3.2.7. Denaturing Agarosc Ccl Elccirophorests: 
1. Glyoxai Denaturing Gcl System. 
RNA was clectrophorescd on 1% (w/v) agarose gel using the glyoxal denaturing 
method (171,172). A 16 well, 20x2ocm. 250m1 horizontal bed 1% (w/v) agarose gel 
was cast using 10mM1 sodium phosphate pH 6.5 as the gcl bufcr. RNA and DNA 
marken (less than 2N g RNA) w= redissolved in 5l of vier and the following added; 
Final conc. 
4µl dcioniud glyoul iM 
31iI 1&OmM sodium phosphate IOmM 
buffcr pii 6.5 
12µl DMSO SO(v/v) 
The mixture was incubated at SO°C for 1 hour, chilled on ice and S1A of loading 
buffer. 0.05% (w/v) bromophenol blue. 0.05% (w/v) Xylenc cyanolc Fr-, 30% (w/v) 
Ficoll, 10mMM sodium phosphate pH 6.5. was added. The gel was run at 100 V for 4 
hours in 10mM sodium phosphate pli 6.5 until the lading dye was two thirds the way 
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down the get. The running buffer was changed cvcry hour to prevent dcglyoxalstion of 
the RNA due to the p1I rising above pi 18. 
Total RNA or DNA markers could be visualised aller electrophoresis by staining 
the gel with lµg/ml ethidium bromide then viewing with UV Illumination. Glyoxal was 
removed from the gel by soaking for 30 minutes in SOmM sodium hydroxide, then for 
three 10 minute intervals in 50mM sodium phosphate p116.5. In the last wash ethidium 
bromide, 1µg/ml, was added to the buffer. the nucleic acid was then visualiscd by U. V 
on a transilluminator. 
II. Formaldehyde Denaturing Ccl System. 
A 16 well, 20x2Ocm. 250m1 gel containing 1% (w/v) agarosc. 6.6% (w/v) 
formaldehyde (2.2x1) and IWOPS buffer p117 (appendix C) was cast (170,173,174). 
Appropriate amounts of RNA (less than SO}tg) and approximately ? }tg of Hind 111 
digested lambda DNA markers were dissolved in 1391 of water and to these samples was 
added, 
Final cons 
250 dcioniud Fommamide 50% (v/v) 
591 lOxMOPS Ix 
8µI Fomnºldchy dc (37% v/v) 6% (v/v) 
The mixture was then incubated at 65°C for 5 minutes. chilled on ice and 5 xl of 
loading buffer, 30% (w/v) Ficoll. 1mMM EDTA. 0.25% (w/v) Bromphenol blur, 0.25% 
(w/v) Xylenc Cyanole FF. was added. The gel was run in I WOPS buffer overnight at 
approximately 30 V with one change of running buffer. 
After clectrophoresis the DNA markers were visualized by cthidium bromide 
staining (as described above), after first removing the fomuldehyde from the gcl by 
soaking it in 0. l hi ammonium acetate, %%ith several changes, for at least 2 hours. 
For both glyoxal and formaldchyde gels DNA lambda markers (appendix ß) and 
rRNAs, which were assumed to be approximately 4.74.8kb and 2 0.1.8kb for the 28S 
and 18S subunits respcctivcly. wcre used as size indicators. The section of the gel 
71 
containing the site mwkcrs was cut away from the part to be used for Northern blotting 
so that the subsequent autoradiographs could be calibrated with the marken at a later 
data. The section was stained with cthidium bromide, after the denaturant had been 
removed, then viewed on a transilluminator as described in section 3.2.6.. 
3.2.8. Transfcr of RNA to Nylon Membranes by Capillary Elution from 
Agarose Gels (Northern Blotting). 
Northern blotting was carricd out with nylon mcmbrancs (Ilybond"N. 
Amersham) according to the protocol suggested by the manufacture (173). 
The agarose gel which had been subjectcd to dcnaturing clccuopi cris by one of 
the methods described in section 3.2.7. was cut to a minimal sire. Two pieces of 3MM 
Whatman filter were cut to be a wick on which the gel was placed. The wick and the gel 
were supported above a reservoir buffer of 20xSSC or 20xSSPE (sec appendix Q. On 
top of the gel was placed the flybond"N membrane which was the exact size of the gel. 
The buffer was drawn up through the gel by a stack of absorbent paper on top of the 
ilybond"N membrane. The stack consisted of 3 layers of 31NMM Whatman filter paper 
above which were 2 layers of absorbent baby nappies. The stack was held in position by 
a 0.5-1 kg Knight. levelled to prevent uneven blotting. Care was taken not to short circuit 
the blotting procedure by the absorbent stack touching the %ick or gel directly. 
Blotting was carried out overnight. up to a period of 24 hours. Prolonging the 
blotting time does not significantly in=se the quantity of RNA transfmcd (175). After 
blotting the membrane was removed from the gel and air dried. The RNA is then fixed 
to the membrane by UV transillumination for 4 minutes. then baked at 8(PC for 2 hours. 
The membranes wine stored at 40C In sealed plastic bags. 
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3.2.9. Formnmldc. Formaldchydc Dcnaturing Dot/Slot blotting. 
RNA (less than 4ONg). was dissol cd in 4001 of wxtcr and mixcd with; 
Final cone. 
Rd dcioniud fonnlmidc 50% (W/v) 
28µl fonnaldchydc (37% w'/v) 7% (WIV) 
8µl 20xSSC 1x 
incubated at 68°C for 15 minutes, then cooled on ice. The samples were diluted using 
IxSSC to give a series of half dilutions. the number of which varied according to the 
number of slots available. Once diluted 2 %olumcs of 2OxSSC was added. 
For dot blotting a piece of Ilybond-N was cut to site and then placed on top of a 
piece of Whi «'hatman filter paper soaked in IOxSSC in the apparatus (DRL). 
Alternatively, using the slot blot apparatus (Bio"rad) a llybond-N membrane was 
positioned as described by the manufacturer of the apparatus. For both dot and slot 
blotting a vacuum was applied so that the sample could be loaded onto the membrane then 
washed with 2k250µ1 of IOxSSG. The membrane was then removed from the apparatus 
and air-dried The RNA was fixed to the flybond-N and stored as previously described 
(section 3.2.8. ). 
3.2.10. Vitro Translation. 
in vitro translation was car ied out using the rabbit reticulocyte lysate system 
(176.177). The lysate was produced by the John Innes Research institute and was a gift 
from the Plant Physiology section within the Faculty. The stock lysatc was endogcnous 
mRNA-depleted and contained the following; potassium ions (as potassium chloride) at 
35mM. magnesium ions (as magnesium chloride) at 2.4mM. calcium ions (as calcium 
chloride) at 3.0mM, calf liver tRNA at 50}tg/ml (IIochringer Mannheim) and crcatine 
phosphokinase at 6-12 U/ml (Sigma). 
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For the iyit translation of rRNA the mixtum containcd the following; 
finit conc. 
0.4µ1 2M Potassium accute (Arncnham) 10ChnM 
0.4µ1 12(kn. M Magnesium acetate (Amuiham) 2.2mM 
0.4µ1 0.2M (reatinc phosphate (Sigma) 8mM 
0.4111 1mM Amino acid mix minus 0.04mM 
Irmcthioninc (Ami ham) 
0.5µ1 0.2mgln1 Chlorimmphenicol (Signa) 10119W 
1.0}tl 10mCi/m1(>1000 Cilmmol)1435S). Mcthioninc 
In viva labelling ade (Amcszham) < 10pmo1 
6.0}tl Rabbit Rcdcuioc)1c L) tc 60'3 (w/v) 
1.01 Taal RNA 1.4 Iigl or water 0.1.0.4 ig/ml 
For each batch of tnmslations all the components wci mixed together in a awl of 
'translation cocktail' then 9. l111 added to lNt of total RNA or water, as a blank. The 
samples were incubated for 1.5 hours at 300C. At the cnd of the time period 2µl of each 
translation was removed to determine the incorporation of 35S Into TCA precipitable 
protein. The volume was spotted onto a small square of Whatman No. I filter paper and 
allowed to air dry. The filters were then submerged in the following: 
i) Ice cold 10% (w/v) TCA. 1 % (w/v) L-Nlcthioninc for 10 minutes, 
ii) Boiling 10% (w! v) TCA for 10 minutes, 
iiii) 10% (w/v) TCA for 10 minutes. 
iv) Ethanol for 2 minutes. 
Filters were air dried, placed in 5m1 or scintillation liquid and counted In the 14C 
channel of a scintillation counter. 
Using the values determined for 35S incorporation equivalent quantities of counts 
(less that 100,000cpnxhrack) were loaded onto 1.5mm thick SDS"polyacrylamide gel 
(section 3.2.11. ) from the remaining translation mix. Care was taken not to overload the 
gel. The maximum quantity of protein recommended for a 1.5mm gel is 1.5mg 
approximately equivalent to 151l of lysate, as it contains up to 100mg/ml haemoglobin. 
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An equal volume of 'SDS"mix' (section 3.2.11. ) was added to the 1ysate. the mixture 
was heated in a boiling water bath for 2 minutes and the samples then loaded along with 
nonradioactive molecular weight maskers. The gel was run overnight at < IDmA until 
the indicator dye had reached the bottom of the gel. 
Using 10% (v/v) glacial arctic acid, 10% (s/v) gl)tcro1 and 15% (v/v) propan"2 
of the gel was foxed then imprcgnatcd with autoradiography enhancer CCn3hanccTM) for 
I hour, follow by washing in water for 30 minutes. Gel drying was carried out under 
vacuum at 6500 for 2 hours in a gcl dry-cr (ßio"rad). 
The gel was autoradiogaphed %ith Fuji RX film at "700C 
3.2.11. SDS"Poiyacr)lamide Ccl Elcclrophoresis. 
Separation of radioactively labelled and non"labcllcd proteins was cared out by 
8% or 10% SDS-poly-acrylunide gel clcctrophorcsis (SDS-PAGE) (178). 
Gels were cast using a stock of 30% (w/v) acrylamidc solution; 30% (w/v) 
acrylamidc, 0.8% (w/v) N, N'-methylcne bisacrylamidc, in a 1.5mm thick, 2Ox2Ocm gel 
casting system using the following solutions: 
Volume for Final 
acquired % (w/v) acrylamide conc. 
8% 10% 
30% (w/v) stock 13.3m1 16.7m1 / 
aaylamidc 
1 hi Tris-HCI pH8.8 19.0mI 19.0m1 0.38Ai 
1% (w/v) S DS 5. Om1 S. OmI 0.1 % (w1v) 
1EMED 30µI 20µ1 0.04% (v/v) 
Water added up to a final volume of Samt 
To 10ml of the appropriate stock solution was added 20µ1 of cxtra TCMED 
followed by O. 5mI of freshly prepared 5% (w/v) ammonium pcrsulphatc. This was 
mixed and immediately used to produce a Ink proof se31 down the spacers and the 
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bottom of the gel. To the rcmaining gel solution was addcd 0. äm15% (w/v) ammonium 
pcrsulphatc. the gel then being cast so that enough space remained for the stacking gel, 
i. e. 2.3cm short of the top. Overlaying with watet ensured a sharp interface on top of the 
gel. 
After at least 2 hours the water on the top of the gei was rrmovcd and the stacking 
gel applied. This consisted of the following; 
Volume final conc. 
30% (w/v) stock Acrylamidc 1.7m1 5.1 % (w/v) 
IM Tris-IIQ p116.8 1.26ml 0.126M1 
1% (w/v) SDS 1.0ml 0.1 % (w/v) 
TEMED 20µl 0.2% (v/v) 
Final volume made up to 1Om! with water 
Polymerization of the stacking gel was carried out with 0.4m1 of 5% (w/v) 
ammonium persulphatc. The solution was poured onto the gel and a 10mm or 5mm tooth 
comb inscrted. 
Once set the comb was removed and the gel placed in a clcctmphorcsis apparatus 
with the running buffo; 190mM glycine. 25mM1 Tris, 0.1% (w/v) SDS. To the samples 
was added an equal volume of'SDS"mix'; 0.12SM Trü"IICI p116.8.20% (v/v) glycerol, 
4% (w/v) SDS. 1% (v/v) (1.4M) 2"mercaptocthanol. The mixture was heated for 2 
minutes in a boiling water bath, then loaded onto the gel. 
After running the gel at 30 mA through the day or 10 mA overnight it was fixed 
and stained (non-radioactive gels) in; 0.05% (w/v) coomassic blue. 0,05% (w/v) 
naphthol black. 10% NO propan"2-ol. 15% (v/v) glacial acetic acid for at least 2 hours. 
then dcstained in 10% (v/v) glacial acetic acid. 
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3.2.12. Assessment or the Protein Concentration of Total RNA Samples. 
The protein concentration of the samples containing extracted total RNA was 
mcasurcd using a protcin assay kit (Uio"Rad) according to the manufacturcr's 
insmutions. The 'micro range' of protein determination was used. A standard curve 
was constructed using BSA In a suitable concentration rungs (O. 25ig4tl). 
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3.3. Synthesis of Hybridization probes; OligonuclcolIdes and i'CR 
Generated "cDNA. 
3.3.1. Synthesis of Oligonucicotidcs. 
Oligonuclcotidcs wwcre made by the AFRC Institute or Aninul Physiology and 
Gcnctics Resc=h, ©abraham, Cambridge or the Department of Applied Biochemistry 
and Food Sciencc (Microbiology action), Faculty of Agicultural and Food Scicnccs. 
Nottingham Univcrsity. 
3.3.2. Labciling of Oligonucloolidcs by Polynucicolidc kinase. 
The oligonuclootides were dissolvcd in water to a concentration of 1OPmoW1 and 
stored at -200C. The oligonucleotides were supplied with a5 hydroxyl group so that 
polynucleotide kinase was used to label dirrctly %ithout he need to dephosphorylatc. 
A typical reaction consisted of the following in S0µ1; 
Final conc. 
2}tl Oligonucleotide (24pmol) 0.411M 
10µl 100µCß (y32P]ATP < 0.41iM 
(>5000 Ci/mmol) (c? 0pmol) 
10µl O. 5N1 Tris"IICI p117.6 0.1At 
0.111 Magnesium acetate 20nt\l 
10µl 0.05A1 DIT 1( M 
13111 Watcr / 
5µ1 Polynucleotide Kinase (4 U4t1) 20U 
The reaction mix was incubated for I hour at 37°C. 
The ratio of oligonucleotide to AlP was varied during the course of the 
development of labelling and hybridization experiments according to how much (y- 
32p]ATp was available. The quantity of oligonuclcotide used was 20-40pmol (O. 25- 
0. Spg) of 39mcr oligonuclcotidc 1. This was labcllcd with tither cquimolar or a molar 
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ratio of 3: 2 oligonucleotide to radioactively labelled ATP. Reducing the AT! ' 
" concentration did not appear to affect its labelling as much as the age of the 
polynucleotide kinase. The enzyme seems to be unstable under the conditions used In the 
reaction. 
The incorporation of 32r into the oligonuclcotide was monitorcd by denaturing 
polyacrylamide-urea elcctrophoresis of fractions clutcd from a Scphadcx 0.50 column 
separation of the products (3.4.10. and 3.4.11. ). 
According to the number of filters to be probed. the volumc of the oligonuclcotide 
to be used as a probe was variable However the concentration of the probe in the 
hybridization solution was always 10"I5ng/ml. 
3.3.3. Labelling of Oligonuclcotides by Specific Oligonucicotidc Primer 
Extension. 
An oligonucleodde complementary to the sequence required as a probe was used 
as a template and a smaller oligonuclcotidc complementary to the 3'cnd of the template as 
a primer. This was then extended 5' to 3' using the Klenow Fragment (Dochringer) 
(179). 
The oligonuclcotidc was radioactively labcllcd using [a"32PjdCTP (3000 
Cilmmol) (Amersham), with the following reaction components in a final volume of 
2094 
Final cons. 
2µI Extension 600mhI Tris"HCI p117.5 GOmtii 
buffer 600mMi sodium chloride 60mß! 
60mMi Magnesium chloride 6mM 
lp 4OmMM DTT 2m. Ni 
lµ1 Template oligonuclootide 
at approx. 5Ong/µl 
Continued on following page 
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Final conc. 
141 Primer otigonucleotidc at a4 fold 
molar excess over tcmplate / 
This mixture was hcatcd to 55°C for 10 minutes. COMM to 
room tcmpcraturc. thcn the following addod; 
4d 
5d 
1. Sµ1 
Trinucloodde mix each 
dNTP at 100µM 
50µß [a"32P]dCrP 0.83µA! 
(3000 CVmmot) 
Water 
16.6pmo) 
I 
After equilibrating at 4°C for S minutm the enzyme was added; 
2,5µ1 Kienow Fragment (2U4t1) 5 Units 
The reaction was incubated on ice for 2.3 hours. stopped by the addition of 2itl of 
0.2At EDTA pU8 and heated to 65°C for 5 minutes. 
The incorporation of 32P into the oligonucleotide was monitored by denaturing 
polyacrylamide urca electrophoresis of fractions from Sephadex ß"50 liquid 
chromatography separation of the products (3.4.10 and 3.4.11). 
The quantity of the probe loaded per filter hybridization was < Sng/m1. 
3.3.4. Synthesis of cDNA by the Polymerase Chain Reaction (PCR) 
Introduction. 
Fast strand cDNA was synthesised from the mRNA of choice and a selected 
region was then specifically amplified by PCR (180.182). First strand cDNA 
complementary to mRNA was made using oligo-d() or a specific oligonucleotide as a 
primer and Reverse Transcriptase. The oligonuclcotide primers were complementary to 
the 3'end of mRNA. so called 3'oligos. The complementary first strand cDNA was 
made S to 3' with respect to the DNA toward the S' end of the mRNA. 
1OµM (cach &MI) 
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Ile second PCR oligonucleotide primer (Yollgo). was located at the Ycnd of the 
mRNA. complementary to the ncwly-synthesised first strand cD. VA. The cDNA was 
amplified into double stranded cDNA bct%ktcn the 2 oligonuclcotides using PCR. This Is 
illustrated in Figure 24 (section 4.1.2. ) %Ocre both means or priming first strand cDNA 
are shown along with the subsequent PCR amplification of the required sequence. 
Although oligo-d(T) was used as the primer for first strand cDNA It was not the Yoligo 
of choice for PCR. A Yoligo complementary to the mRNA sequence was used. SW to 
1000 bp downstrc= of the Yoligo PCR primer. 
7be oligonucleotides used in PCR as primers %%= at least 16 nucicotides long, 
ideal, ly 20-24 nucicotidm To aid cloning of the amplified sequence Into vcctors the PCR 
oUgonucleotide usually had restriction cndonuclease sequences added to their 5' termini 
plus some extra 'nonsense' nucleofides to faciliute rcstricdon digest (167). 
PCR amplification of cDNA made from mRNA was carried out by one of two 
methods as outlined below. 
1. 'Method 1: PCR amplification or AMV rcvcrse transcrIP12Se gencratcd 
first strand cDNA. 
Synthesis of first strand cDNA from mRNA was achieved using ANIV Reverse 
Transcriptase (NBL), oligo-dM (or a specific TPCR oligonucleodde) and either 4pg 
poly(A)+ RNA or ICýig total RNA (183). 
For the reaction AMV was diluted 10 fold in-, 
10% glycuol 
10mrt potassium phosphatc pll 7.4 
0.2% Triton X"100 
2mM DTF 
and then equilibrated on ice for 30 minutes. 
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1bc reaction was carried out in a final volunx of 4NI consisting of the followingr. 
flrwi conc 
Tris"11C1 pit 8.3 50mM 
AMMV potassium chloride MIN 
buffcr Magnesium chloidc 10mM 
EDTA 1 m. MM 
DWI' 1mM 
BSA. Nucleic Acid grade (Phannacia) 1O ig/m1 
Oligo-d(T)12.18 (Phamtuia) 
or specific 3'PCR oligo 10Ng/m1 
dNTPs (Phamucia) each at 1 mM 
Spcrmidinc-IICI 0.5mM 
Sodium pyrophosphate 4mM 
RNAasin (Pharmacia) 40.80 Units 
Dilute AIM Revene 
Trsnscriptuc 10 Units 
Poly(A)+ RNA 0.1p&1 
or total RNA 0.251jg4t1 
The RNA was diluted into I Oµ1 and heated to 7000 for 3.5 minutes before it was 
added to the reaction mix. Two to four µl of the reaction mix was rcmovcd and 'spiked' 
" with 1-2µ(S [ac-32P]dCTP. to monitor the progress of the reaction at the end of the 
incubation period on a denaturing polyacrylamidelurca gel (section 3.4.11. ). 
The reaction mixture was incubated at 420C for 45 minutes, then cleaned once 
with an equal volume of phenol (FE saturated p117.6) and then with phenolchloroform 
and precipitated with ethanol and 2. SM ammonium acetate (section 3.2.4). 
82 
Using 20 and 200ng of the first strand cDNA, gcncratcd by a specific 3' PCR 
oligo or oligo-d(T) primers. the cDNA sequence was amplified ri3 i'CR with S' and 3' 
PCR oligonuclcotidcs 500-1000 bp apart (184), as described in section 4.1.2.. 
PCR was carried out with the following components in a final -. olumc of 1M11; 
Fnal conc. 
Potassium chloride SOrnM 
PCR Tris-i1CO piff 8.4 10mM 
buffer Ma um chloride 2.5m. Mi 
Gelatin 200i&/m) 
dNTPs (Phannacia) each at 0.2mM 
5' oligonucleotide 10Clpmol 
3' oligonuclcotide lOOpmo1 
First strand cDNA 2Ong of 200ng 
his was overlaid with 104i1 of mineral oil (Sim). The reaction was incubated 
in a programrnable heating block (Hybaid). The mix was heated to 95°C for 5 minutes to 
denature the nucleic acid, cooled to 500C then incubated for 2 minutes to allow annealing 
of the oligonucleotides. At this point 2 units of Taq polymerase ai. s added. The heating 
block then raised the temperature to 68-700C for 15 minutes to allow elongation of the 
primers to take place. Subsequent cycles consisted of; I min at 950C, 2 min at 5000 and 
15 min at 687000 The cycle was repeated for 3540 times. At the end of the cycling 
period the temperature was held at 700C for 30 min to allow mannealing of the products. 
The mineral oil was removed and 5.10111 of the PCR solution analysed on an 
agarose nondenaturing gel (3.2.6. ). The remaining mixture was phtnoVchloroform 
cxtractcd and cthanol prccipitatcd (scction 3.2.4. ). 
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11. Method 11: Direct i'CR amplification or AMMLV reverse transcrlplase 
gcncratcd first strand cDNA without intermediate precipitation. 
I acknowledge the help of Dr R. S. Gilmour in the application of this technique 
developed at the laboratories of the AFRC Institute of Animal Physiology and Gcnctics 
Research. i3abraham. Cambridge. 
Total RNA (20µg) was first cleaned by cxtraction twicc with phcnoVchloroform 
and precipitated with ethanol plus 0.311 potassium acetate (section 3.2.4). The dried 
pellet was redissolved in 1Oµ1 of water with 15.30ng of oligo d(T)12.18. Annealing of 
the oligo-d(T) to the poly(A) tracts of the mRNA was carried out by heating the RNA to 
750C for 5 minutes, to denature secondary structure, then cooling to 370C 
To the oligo-d(T) annealed RNA were added the components of the reverse 
transcriptasc reaction in a final volume of 2Oµ1; 
Final conc 
MLMLV Tris"HO p118.3 SQmM 
buffcr Magnesium chloride 8mM 
DTP 10mM 
BSA, Nucleic acid grade (Pharmacia) 0.251tg4t1 
dN7Ps (Pharmacia) cacti at 2.5mM 
RNAasin (Pha=cia) 20 UNrrs 
MMLV rcvax minscriptase (Phammcia) 40 UNITS 
The reaction was incubated at 37°C for 2 hours. At the end of the Incubation the 
20µ1 was diluted to 100pl with water. From this dilute volume was taken 0.2,0.4 and 
l0pl to be used In PCR. These volumes were further diluted into the 10(kt1 of PCR 
reaction mix consisting of the same components as described in section 3.3.4. (1). PCR 
temperature cycling was carried out as described above (section 3.3.4. (i)) with 2 units of 
Taq polymerase, for 35-40 cycles. The products were examined on nondenaturing 
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agarose gel (section 3.2.6). The remaining solution was then extracted and precipitated 
as previously dcscribcd (section 3.2.4). 
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3.4 cDNA Manipulation, Probe Labclfing, lI)bridi: atlon. 
3.4.1. Ligation or Cohesive Termini. 
Plasmid and the DNA to be ligated into it were digested with restriction 
cndonucleases, the fragments with the cohesive termini being isolated by nondenaturin8 
agarose gel electrophoresis and elcctnxlution (section 3.2.6 and 3.4.7. ). Approximately 
Song of plasmid was used in ligation reactions with the DNA to be ligated into the vector 
at 1: 1 and/or 3: 1, DNA: vcctor molar ratio (167,187). 
The reaction was carried out in a final volume of 10µ1 with the appropriate molar 
ratio of cDNA to plasmid in the following: Ligation buffer (20mM Tris-NCI p117.6, 
10mM Magnesium chloride, l0mM DTT), 0.6mM ATP. 5ng/µl plastid and I unit T4 
DNA Lipase (13oehringer). It was incubated for 1 hour at 22°C, then chilled on ice 
before being used in the transformation of compctent cells (set below). 
Where cohesive ends of a plasmid were to be rcligated. 100ng of plasmid was 
used in the reaction volume above, with no foreign DNA present. 
3.4.2. Transformation or E. coli. 
Competent Cells were produced using a modified calcium chloride procedurt 
(169). A 4ml LB culture (appendix D) of the appropriate strain of F-coli was grown 
overnight at 370C from a colony off stock minimal plates. Using O. Sml of the ov=Ight 
culture 50ml of LB broth %-as inoculated, incub3ted to in absotbancc of 0.55 at 6ODnm, 
then cooled on ice. From the chilled media 20ml %-as taken and cenuifuged for 7 minutes 
at 3,750g at 40C All the supernatant wzs carefully removed then. on ice, 2n-J of Ice-cold 
O. JNJ calcium chloride was added. The cells were gently resuspended and left to 
incubate. on ice. for I hour. After incubation 0.2ml of the cells was rcrnoved WO 5PI of 
the ligadon Hix from the ligation reaction (25-50ng DNA) was added. Ile cells were 
then left for 30 minutes on ice. after which they were 'hcat-shocked' at 420C for 3 
minutes, then placed back on ice for 20 minutes. To this suspension of transformed cells 
was added O. W of LB broth and the cells were then Incubated with shaking at 370C for 
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45 minutes. The cells Were plated out onto Lia plates containing the appropriate antibiotic 
using a range of volumes of the culture; 50.100 and 200N1. 
3.4.3. Growth or E. cola for the Preparation of I lasmids 
Cells containing the required plasmid. for example those from frozen glycerol 
stocks (see below) were plated out onto LB agar plates (appendix D) containing the 
appropriate antibiotic; SOpg/ml Ampicillin or 12.5p&/ml Tetracycline (169,186). 
Alternatively for freshly transformed cells a variety of culture volumes were used; $0. 
100 and 200µ1. 
Cells were allowed to grow overnight or until colonies became distinct. 
Individual colonies were then 'pickcd-ofr, 4ml of LB broth containing the relevant 
antibiodc inoculated and the medium incubated overnight in a rowy shaker at 370C 7be 
cells were then used for mini-preps (scction 3.4.4) or for inoculation and subsequent 
ovcmight incubation of up to I litrc of LD broth containing antibiotic for large scale 
plasmid preparadons. 
Small LB cultums (4ml) were also used for storage cultures; glycerol was added 
to 1 15-20%. the medium was mixed and then stored at -700C In I ml W iquots. 
3.4.4. Small Scale Plasmid Preparations; 'Mini-Preps'. 
Mini-preps were carried out using the method of Manixtis et al (167). This 
included the phenoVchloroform extraction of the DNA in the supernatant of the bacterial 
lysate (centrifuged to remove cell debris) before ethanol precipitation of the DNA. This 
allowed easier restriction endonuclease digest analysis. 
3.4.5. Large Scale Preparations or Plasmids; 'Ataxl. Prcps' 
Maxi-preps were carried out using a Qiascn plasmid kit with Qiagen $00 columns 
(Ilybaid) according to the manufacturer's specifications. 
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3.4.6. Restriction Endonuclease Digest of DNA 
Using the appropriate restriction cridonucleasc (NBL, Dochringcr) and their 
buffirs (as supplied). various qu3ntitics of DNA wcrc digested. For the prcpsration of 
cDNA Inserts from plasmids. 50-100lig of DNA was subjected to restriction 
cndonuclease digestion at approximatcly I Uni*g of DNA In 10(ol of solution with the 
appropriate buffer. 
For less than INg of DNA. reaction volunxs were 20pl with the minimium of 
approximately 10 Units of enzyme in the relevant buffer. With muldple restricdon 
cndonuclease digests the reactions were carried out in succession with ethanol 
prccipiudon bct%%tcn each step. 
Most restriction endonuclease reactions werc incubated at 370C for 2 hours. Cam 
was taken to minimize 'starting activity' of certain restriction cndonucleasm such as rxo 
Rl, by keeping the digest tinxs as short as possible and the cnzyrne concentration low 
(187). 
3.4.7. Preparation or ONA Inserts rrom Plasmids 
After digestion of the plasmid with the relevant restric6cm cridonucleasc to excise 
the cDNA inscrt. the DNA was subjected to nondcn3turing agarose gel cloctrophorcsis. 
stained with ethidiurn bromide and the cDNA insert cut from the gcL Ile cDNA insert in 
the gel was placed into dialysis tubing, prep3red by boiling in 2% (w/v) sodium 
hydrogen carbonate and 10-1 EDTA for 10 minutes, then soaking In water for 10 
minutes. The dialysis tubing, %-as filled with 0-5xTBE and "ed. DNA was then 
clectnxluted from the gel in 0.5xTBE running buffer at 100 V for 4 hours. Before 
switching off the current the polarity was reversed for 5 minutes. 7be DNA solution was 
then removed from the dialysis b3g. pficnol/chloroforin extracted and ethanol procipitated 
(section 3.2.4). 7be dried DNA was redissolvcd In water and stored at 40C 
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3.4.8. DNA Sequencing 
DNA sequencing was carried out using a T7Scqucncing kit (i'hannacia). The kit 
uses the didcoxy method of sequencing (188). The procedure was carried out as 
specified by the manufacturer using 35S in the form of (cx"35SjdATPaS to label the 
products. Tbc reaction procedure is summarized below. 
For each reaction 1.5"2pg of plasmid containing the cDNA to be sequenced was 
used. Ibis was alkali denatured with sodium hydroxide at a final concentration of OAM. 
After incubation at room temperature for 10 minutes the DNA was precipitated with 
ethanol on iccý centrifuged to a pellet. wished In 70% ethanol. then briefly dried. 7be 
pellet was redissolved in l0pl of water and annealed to the appropriate quantity of 
primer. In most cases this was 10: 1 primer to template ratio. Annealing was carried out 
using the solution and instructions provided in the kit. as were the labelling and 
termination reactions. Once annealed the primer %%-as extended and labelled In a Yto 3' 
direction using 17 polymerasc. a mixture of d4WPs and ICL33SIdATPaS (> 1000 
CVmmol) (Amersham) at room tcmpenturc for 5 minutes. The labelling mix was then 
split into 4. an equal volume going to one of four terminating solutions which contained 
the dcoxynucleotides (dNTP) for extension. but c3ch having a different 
dideoxynuclcotide (ddNTP) present. Ile four reactions were: Incubated at 370C for 5 
Hnutes, the elongating fragments being teminated by the appropriate ddNTP at diffc=t 
lengths where the corresponding dNTP would have occurred In the scquckc. Either 
, long' or "short' ddNIP/dNTPs terminating reaction mixes wcm used. These produced 
up to 1000 or 500 bp fragments respectively by varying the ratio of ddNTP to its 
corresponding dNTP present in mch solution. 
At the end of the incubation period the reution was terminated by adding the 
, STOP' loading buffer provided in the kit. 7be producu of the four reactions werc then 
subjected to clectrophoresis on sequencing gels. 
Denaturing polyacrylamide-urc3 clectrophoresis was carried out on a Sequi-Gen 
Nucleic Acid sequencing ccil system (Dio-Rad) 4Ox2lcm, using different strengths of 
p0ly3Cfyla: m1de (5-8%) 0.4mm thick gels according to the minufactu=ls Instructions. 
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The clectrophoresis apparatus glass plates were thoroughly cleaned by washing 
with 0.1% (w/v) SDS, ethanol, 0.5A1 sodium hydroxide and water in succession. then 
dried. The non"notchcd plate was then coated with binding silane; 0.1% (v/v) delta' 
mcthacryloxypropyl trimethoxysilane (Sigma). 1.75% (vlv) glacial acetic acid in 5m1 
ethanol, allowed to dry. wiped with ethanol and then polished. 7 be notched plate was 
coated with 10 ml ethanol containing 5% (v/v) Sigmacotc (Sigma), allowed to dry then 
polished thoroughly. The apparatus was assembled with 0.4mm spaccn. 
A 60ml solution containing the appropriate % acrylamide" 7M urea was made 
according to the following; 
Quantities rtquirod for the stmngth 
% (w/v) acrylamide gel 
5% 6% 8% 
40% (wlv) stock 7.5m1 9m1 12m1 
aaylamide 
IOxTBE 6m1 6m1 6m1 
Ursa 25.2g 25.2g 25.2g 
To seal the bottom of the gel a fiter wick was soaked with 10m1 of 
acrylamidclurca solution and polymcriscd with 125µ1 10% (w/v) ammonium pcrsulphate, 
501il TEMED. The bottom of the gel was placed on top of the wick, the pol)rme izing 
solution being drawn into the gap to seal it. 
To cast the gel the remaining solution was poured from the top. polymcrizcd with 
150µ1 10% (w/v) ammonium persulphate and 60i1 'IEh1ED. A shuks tooth or squuc- 
well comb was insened into the gel and it was allowed to set for at least 2 hours at a So 
inclination. 
Before loading the sequencing reaction samples the wells were washed out and 
the gel was prerun at 40 W in a running buffer of IxTBE for 30 minutes. 11rce 
microlitres of each of the four sequencing m actions was removed from the relevant stock 
solution and heated to 75-BOOC for 2 minutes then 2µl immediately loaded onto the gel, 
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side by side, in the terminating ddNTP order or T. Cý 0. A. The gel was run At 40 W 
until the Xylcne cyanole Fr- dye had run to the bottom. then the second loading was 
applied onto the gel. 'Me last lo3ding. either the sccond or third, wit allowed to migr2te 
until the bromophcnol blue was at or near the bottom or the gel. The cuncnt was 
switched off, the plates carefully separated and the plate with the gel atuchcd was soaked 
for 20-30 minutes In 10% (v/v) glacial acetic acid, 10% (v/v) nxthinol In distilled water. 
The gel was air-dricd overnight or at 550C for 3 hours. Once dry It was 
autoradiographcd using 11ypcrfilmTNl-Pmax (Amershim) for 1-2 nights at room 
temperature. 
3.4.9. Preparation of Radioactively Labelled cDNA Probes: 
Two methods of cDIVA probe labelling wuc used, 
1. Nick Translation. 
This was carried out using a Nick Translation Kit (Amersham) and (cc-32PjdCTP 
3000 Ci/mmol (Amersham). According to the manufacturers of the kit the maximal 
specific activity achieved is 0. Sx108 dpm4ig using 1"2pg DNA and SOiCi of Ia-32Pj 
dCIP (3000Ci/mmol). 
In the reaction 1-2µg of DNA was used in 100µl of the following reaction mix; 
Final conc. 
10µl 1.2µg DNA 0.01-0.020g4tl 
20gl Trinucloodde mix (each 20pNl (each dNTP) 
dN P at 100µA1) 
5jd 5OµCi (a-32PJdCTP (30(Mmmol) 0.167µM 
55W water I 
1Uµ1 Enzyme solution Pol 13 Units 
DNA=1 100 pg 
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The reaction was incubatcd at 370C for 1 hour. dilutcd to 1OOil with TH bufrcr 
p11 7.6 and the reaction products separated by chromatography on Scphadcx ß"50 
(section 3.4.10). 
3.4.10. Chromatography or Radloactively-12bellcd Nucleic Acid on 
Sephadex G-50 and Assessment or 32P Incorporation. 
71c products of radioactive labelling reactions. 32p labelled cDNAs and 
oligonucleotides. were separated from unincorporated Isotope by chromatography 
through Sephadex G-50. Small columns, 5-6cm in length. were nude in pastcur pipettes 
with Sephadex G-50 suspended in TE pli 7.6. IMe radioactive labelling reaction 
products were loaded onto the column once it had been washed in 4 column volumes of 
TE buffer pH 7.6-71c column was then washed with TE buffer pit 7.6 and fractions of 
approximately 2001d were collected until all the activity had passed through judged by a 
gciger counter. From och fruction 2pl was taken and placed in 5ml of scintilladon fluid 
then counted in a scintillation counter in a preset 32p channel. From a graph or counts 
present (cpm) against the fraction number an indication of the cfficicncy of the isotope 
incorporation could be made by comparison of the relative am" of incorporated and 
unincorporated isotope. Figure 12 shows a typical separation. A c1m peak of labelled 
probe can be seen as the first peak- 
Those fracdons which showed incorporation of 32p Into probe were pooled and 
20 of this counted to determine the approximate specific activity of the probe (cpnv'ýg). 
Using the total activity of the pooled probe the volume of the pool to be used for 
Northem or dot/slot blot hybridization was evaIU31ed. 71c acti%ity required for probe 
hybridization was approximately 14xlO7cpnV5OrW. the exact amount varybg acconling 
to the probe used. The concentration of the probe In the hybridization solution depcnded 
on the labelling procedure used as the specific activity of nick translitcd probes was less 
than that of random prime labelled probes, approximatcly 10 (old less. For random 
prime probes the concentration in hybridization solutions was approximately I ng/ml. for 
nick translation probes approximately 10- 1 5nS/ml. 
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The reaction was incubated at 10-150C for over one and half hours. At the end of 
the incubation period the reaction products were separated by chromatography on a 
Scphadcx G"50 column (section 3.4.10). 
If. Random Prime Labelling. 
This method uses less cDNA and is able to produce probes of higher specific 
activity than nick translation. Unlike nick translation, In random primed reactions a new 
complementary strand is synthesised from a range of hexanucicotide primers by Klcnow 
Fragment According to the manufacturers of the random primed DNA labelling Kit 
(Bochringer) it should give 1.8x109 dpmlpg when using 50µG of Ca-32PJdCTI' (3000 
Cilmmol) (Amersham) and 25ng of DNA. However the more DNA used the lower the 
specific activity achieved. Accordingly with 2pg the activity is 0.3x10$ dpm ig. near 
that of nick translation. 
When using this method the quantity of probe to be labelled and the amount of 
activity used for hybridization techniques was carefully assessed to prevent high 
background on filters. For labelling experiments 25-50ng (or kis) or the cDNA was 
used per reaction. 7bis was approxinuicly assessed as the quantity of cDNA Insert just 
visible on a agamsc nondenaturing el smined with ethidium brornide. 
DNA was first heat denatured at 95°C for 10 minutes. then the reaction was 
caned out in a final volume of 20µ1 with the following components 
91A 25-5Ong cDNA 
3µI Thnucle dde mix each 
dNTP at 0.1670.1 
2µl IN Reaction Buffer plus 
random hexanuckotide mix 
511 Sopci [a. 32PjdC'TP 3000 ( lmmol 
lµi Kienow Fragment 
Final conc. 
I. 25ng4t1 
2511M (cach dNTP) 
Ix 
0.83jxM 
2 Unit 
93 
Figure 12: ne Sephadex G-50 separation of 32p, random prime labelled human calpain 
It large subunit cDNA (O. Ipg). 'Me cDNA was labelled using a random prinwr labelling 
kit using the conditions as described In section 3.4.9. H.. 7be f2dioactlvcly labelled 
products were separated on a Sephidex G-50 colum and 21il of c4ch 200 Id traction was 
assesscd for activity (scction 3.4.10. ). Fractions 6.8 %%-cre ustd for hybridlution 
experiments. 
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3.4.11. Denaturing Polyacrylamidc"Urca Denaturing Ccl Elcctrophoresls 
(UREA-PAGE). 
To check incorporation of radioisotpc into oligonuclcotidcs and ionic cDNA 
probes, samples were subjected to denaturing gel clcctrophoresis (170), after separation 
on Sephadex G"50 (section 3.4.10). 
For 3040 met oligonucicocidcs 20% (w/v) acrylamidc"7At urea gels were used, 
for longer sequences the percentage of aerylamide v-as reduced down to 3.5%. 
Gels were cast using a stock of 40% acrylamide solution; 38% NO acrylamidc, 
2% (w/v) NN-methylene bisacrylamidc. am-ording to the (o11ov ing; 
Quantity for final gel Final 
of required % (w/v) acrylamide conc. 
20% 3.5% 
40% (w/v) stock 25n-1 4.38m1 / 
acrylamide 
Urea 21 g 21g iM 
1 OxTBE 5m1 Sm] 1x 
Water was added to a final of Volume of SOmI 
To the appropriate solution was added 54d TEMED. A plug to seal the gel was 
made using lOn-d of the 50H stock, to which was added in extm IV M- IM and then 
polymerized with OAml of 10% (w/v) ammonium pasulphateý Once the sealing strip 
had set the main gel was cast by adding 1.3ml of 10% Wv) ammonium persulphate to 
the remaining 40rrd of stock solution. A suitable size comb was Insened ircaly Into the 
gel. polymerization was allowed to take place for at least 2 houm 
The gel was run in a reservoir buffer of lxTßE. Two to five }il samples of 
fractions were diluted with 151il formamide and 0.1 volu= of rn3rkcr dye solution 
(0.25% (wtv) bromophenol blue. 0.25% (wIv) xylene cy3nole M- was added. ne 
loading mix was heated to IOOOC for 2 minutes, then loaded on to the gel. After running 
at 20 W. until the brornophenol blue had migrated two-thirds the way down, the wet gel 
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was removed from the APP3ratus. covered with cling film and automdiographcd directly 
with Kodak- AR or Fuji RX film for a time Period according to the quantity of Isotope 
loaded. 
3.4.12. Northern and Dot/Slot Illot Filter 11)briditallon with 
Radioactively Labelled Probes: 
1. Prehybriditation. 
Nylon Hybond-N membranes to be hybridized %ith r2dioactive labcllcd probes 
were first prchybridized according to the nunufacturer's rccommendadons (Amcnham). 
lie prthybridization solution consisted of-. 6xSSC, UDcnhardt's solution 
- 
0.1% 
(w/v) BSA. 0.1% ('1v) F'C'11- 0-1% (w/v) Polyvinylpyrollidone and 0.3% (wlv) sDS. 
To this was added sonicated salmon sperm DNA (Sigma) heat denatured at IOOOC for lo 
minutes to a concentration 0.1mg/mI. For Northern blots of up to 400cm, 2,40-sornIs of 
prehybridization solution was used; for slot1dot blots up to 120cm2.20-25mls. 
An alternative system used for prehybridit3tion replaced 6xSSC with 5xSSPC- 
and included 50% form3mide in the solution shown above- Thc same volumes for 
prehybridization were used as above. 
For both solutions the appmpri3te volumc was added to the m=bmnc in a plutic 
bag which was scaled so that it contained the minimal number of air bubbles. For 
solutions containing SSC, prehybridization was caiTicd out at 550C For those with 
formamide present 420C was used. Both Wcre left overnight (up to 18 hours). 
II Hybridization. 
After prehybridizadon the predetermined qu and ty of radioacti%tly-Libelled probe 
was added to the prehybridization solution, follouing Its scparafion by chromatogT3phy 
and an assessment of isotope incorporation. as described In section 3A. 10. 
The double stranded cDNA probes utm denatured by heating to I ODOC for 5.10 
minutes. Tic probe was then added to and thoroughly mixed with the prehybridization 
solution which became the hybridization solution. Care %rIs t3kcn not to Introduce the 
probe directly onto the membrane and air bubbles Into the b&g. Ilybridiz, 2tion wis 
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allowed to take place at 550C overnight (up to 24 hourt). r-or hybridimlon solutions 
containing fonmmide. the Incub3tion Impermure was 4M 
III Posthybridiza lion Washing and Autur2diogr2phy. 
After hybridization the membrane was washcd at a set temperature and sill 
concentration. Ile rirst wash was at the hybridintion temperature and ult concentration. 
550C and 6xSSC for 20 minutes. then rcpcatcd. 7he mcmbranc %-as autoradiograpNA at 
-700C with Kodak AR or Fuji RX film with two Intensifying scmcni in in 
autoradiography cassette. Carc %%-as t ken not to allow the membrane to dry out when 
washing or during autoradiognphy. 
After the Initial wash the membrane was treated at a higher stringency by 
increasing temperature in 50C incren-tnts and lowering the ult concentraton andwhere 
appropri3te incorporating SDS into the washing procedure. The washes %%= carried out 
for two periods of 15-20 minutes. The conditions of subsequent washing at Incmasingly 
higher stringency were dependent on the activity on the membrane. nc highest 
stringency wash was at 650C with 0.1 xSSC. 0.1 % (w/v) SDS. 
For hybridizaCions done in 50% fornumide the membranes were washed In a 
similar fashion. 77he first wash was at room temperature with USSPE, 0.1% (wtv) 
SDS, then the temperature was inc=scd to 420C for subsequent washes with docrculng 
salt concentration. 
3.4.13. Removal of Hybridization Probes from Northern Blots. 
Initial methods involved soaking the membrane In boiling 0.1% (, A, /v) SDS. 
allowing the solution to cool. then repeating this once. The Northern was then 
autoradiognphed to check for the rt=val of the r3dio3cti-tv probe. The procedure %ku 
repeated if activity was still visible on the rnernbrane filter. 
IMe boiling solutions used in the procedure described abovc had a tendency to 
produce membrane darn3ge- An alternative method was thcrcforc adopted. 11r. Northern 
was immersed in 50% formamide, WSPE for at least I hour at 650C After Incubation 
the membrane was rinsed in O. lxSSPE twice. Ile damp membrane was then 
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autoradiographcd to check for the removal of probe. The procedure was repeated if 
activity remained. 
Stripped membranes were stored in scaled plastic bags at 40C 
3.4.14. Analysis of Autoradlographs. 
Autoradiographs produced from slot/dot blots, Northerns wo in vi transl3tions 
were scanned on an Ultrascan XLTNI Laser Densitometcr (LKB). 
71c scanning data was stored on disc then analysed using the Cclican XLTNI 
Software Package (LKB). Ws Package allowed the determination of the arC4 under 
absorbance peaks displayed on the computer monitor. The baseline for the cvaluzition of 
the peak area can be selected by the programme in various ways using difTmnt criteria. 
or can be chosen manually to give a linear baselinc. Manual selection was used where a 
single peak: was to be assessed from several prcsent on the scan, or where definite p-Caks 
could be seen and aligned across smns but due to the limitadons of the paranxtcrs choscn 
they %%tre ignored by the automatic baseline sclccdon. 
For both methods of baseline determination the intcgodon programme In the 
package would then evaluate the peak area above the baseline- 71ese peak area values 
were used for comparative purposes on samples off the &am blot. 
3.4-IS. Statistical Analysis or Data. 
Data was expressed as the mean plus or minus the standard error or the mean. 
Tests for significance between values obtained rrom the an3lysis or dot, slot and 
Northern blots as well as in vin transl3dons wcre nude using a Students t-test (189). A 
signiricance level or 5% was adopted for all comparisons. 
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Chapter 4. Results 
4.0. Preparation of Total RNA and its charactcrisation by InY! 
translation. 
Ile aim of the project described in this thesis was to examine whether the 
changes in activity of the calpain system components associated with f agonist induced 
skeletal muscle hypertrophy (114) was also found in the expression of their respective 
mRNAs. 
In order to achieve this aim developmental work had tint to be caMcd out, which 
Is described chronologically in the first two sections of this chaptcr. 
This first section (section 4.0. ) is concerned with the development of techniques 
for the isolation of total RNA from skeletal muscle and its subsequent characterization by 
113 vitTo translation. 
The second section (section 4.1. ) deals with the attempts to prcpue specific 
probes for the detec6on of the mRNA for the components of the c3lpain system In the 
total RNA isolated from chicken and cattle skeletal muscle, For the calpains this Initially 
involved the use of oligonucleoddes then eventually cDNAs f0c the large subuniu. am in 
the case of calpastatin a cDNA generated by the polymer= "n reacdon. 
Finally section 4.2, describes the use of these developed techniques and probes to 
quantify the specific mRNAs for actin. myosin light chiln 2. calpain I and 11 1,2rge 
subunits as well as calpastatin in bovine muscle of anim3ls treated with the growth 
promoting ß-agonist cimaterol. 
4.0.1. Extraction of Total RNA from Skeletal Muscle. 
To analyst any changes in specific mRNA of the skcktal muscles of 13-a ergic 
agonist mated animals the total RNA used had to be Intact as well as frce from 
contaminant DNA and protein. However the extracticm procedure had to be MIAtIvcly 
quick s6 that samples from animal trials could be processod. 
RNA extraction procedures are required to fulfil the following basic aitak: 
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1. Inhibit endogenous ribonucleascs. 
2- Deproteinise the RNA. 
3. Physically separate the RNA from the other Components In the homogenatc. 
71cre are two min types of RNA cxtraction procedures which dl'ffcr In the 
protein denaturing agent that Is used, namely phcnoVchlorofonn or gusnidinium Wis. 
For total RNA extraction experiments. and the bovine trial (section 4.2.2. ), a 
ph e nollchloro form method was used which developed Into the final procedure as 
described in secdon 3.2.1.. During the development of this technique comparisons wcm 
made against a guanidinium thiocyanate based "traction proccdum described In SCction 
3.2-2- (166). 
The phenol/chloroform ethod was modified from the procedure described by 
Clemens (164). Ile technique used two extraction buffers which had a high pit to allow 
poly(A)+ RNA to partition Into the aqueous phase and Inhibit RNAases pmsent 0 64) as 
well as large volumes to dilute these degradative enzyme&. At a pit below 5 the 
poly(A)+ RNA would be lost into the organic phenoVchlororonn phase (165.193). The 
detergents (especially SDS) in the extraction solution mildly inhibited RNAascs and 
promoted dissociation of the proteins from the RNA. ne EDTA had the action of 
preventing aggregation of the RNA to each other and pnxeln. by chclating the nugnesiurri 
ions (165). Deproteinization of the homogcnate was carried out by shalcing It with an 
equal volume of phenol: chlomform 1: 1 (v: v). Ile denatured protein was removed by 
centrifugation at high speed. The subsequent re-extraction of the phenol-chlorofom and 
protein interface allowed the release of trapped RNA fmm the dcwtumd Protein. 
In these initial experiments after the RNA was p=ipitued -*ith ethanol (section 
32-1. ) it was differentially precipitated, i. e. 'cleaned'. In a high salt concentration. 3M 
sodium acetate PH 6. Ws was reported to remove Contaminant DNA, polysaccharides 
and small RNA, which all remained in solution whilst the RNA prcipimted (164). 
1Me guanidinium thlocyan3te method used phenollchlomform as well as the 
guanidinium salt in acidic conditions (section 3.2.2. ) (166). 711s procedure was 
employed because of its relative speed compared %ith other guanidinium thlocyanate 
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methods. which often involved the use or c3esium chloride 'cushions' (190). nc 
gu3nidinium salts am suggested to be mom effective than phenol/chlotorortn against 
tissues containing high levels of RNAase (191). 
ne homogenizing buffer (solution D) contained guanidinlum thlocyAnate which 
solubilised and denatured the protein. 2-mercaptoethanol that cnhanccd deproteinitation, 
by breaking disulphide bonds and sodium dodecyl samosinate which had the umc cffcct 
as SDS (192). Extraction of the RNA was a one step process as dcscribod In wtion 
3.22-. DNA and protein were reported to be rtmoved In the Interface and the organic 
phenol phase. whilst the aqueous phase contained the RNA which was precipitated with 
isopropinol. 71cre were no high salt concentration cleaning steps In the rnethod. 
CI)offx-zynski and Sacchi (166) suggested that the isolated RNA was sufficicsidy cku to 
be used for Northern blot analysis and dot/slot blot hybridization. 
Using the two methods outlined above tot3l, RNA was extracted from chicken 
breast muscle which, %-as ground to a powder in liquid nitrogen to that the cxtr3ctions 
were from a uniform source. Assessment of the quantity of nucleic acid and the protein 
associated with it was made on the total RNA extracted (section 3.2.5. and 32.12. ). 
There %%-as a largerquantity of nuckic acid isolated by the guanidiniurn thlocyanateb&W 
Tnethod than by phenol/chloroform. but the protein associated with it %h-as also "ter, 
Table 3. 
Although there was more nuckic acid extracted by the guanidinium thiocyanste 
method it is impossible to distinguish between RNA and DNA using absorbance at 
260nm as an assessment (section 3.2.5. ). When a sample was subjected to 
clectrophoresis on a 1% nondenaturing agarose gel (Figure 13) It was appa=t that the 
high absorbance of the 'RNA' prepared by the guanidinium method was due to a high 
content of DNA which %iLs clearly visible as large amount of the low mobility DNA band 
and smear compared with the 28S and I SS TRNA b3nds in the samples. 
Ile phenol/chloroforrn method contains steps that are purposely Included for 
removing DNA after the RNA has been precipit3ted. High saltcleaningof the extracted 
RNA appears to be necessary to remvc DNA cwTiod over from the extraction procedum 
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Table 3. Comparison of total RNA extraction procedures. Total RNA was cxtracted 
from chicken skeletal muscle using a phenollchlomform or guanidinlum thlocyanate 
method, as outlined in the text. 
Extraction method 
Phenol Guanidinium 
Chloroform Thiocyanatc 
(n=3) (ni3) 
Nucleic acid 266 ± 28 780 ± 61 
(ug/g muscle) 
Protein 9.6±0.8 91 17.2 
(µglg muscle) 
Nucleic acid : Protein 28: 1 9: 1 
(ratio per g muscle) 
(values are the meant SEM) 
Figure 13: Nondenaturing 1% agirose gel cleorolihorc-0% (if toill RNA lirrpve(I an(I 
'clcincd' by different pr(wedurcs. Lanes 1-4 gimnitfinium 1him)-anme prrparrd iotil 
RNA with varlou% 'clel"1119 stclW: I. 'tic I I%%o 1\1 vxhum acclaic 1416 cleaning wp%. 
lanc 2 mo 3\1 %odium acclatc 11116 pIw% 1%%o 
. 
1\1 Chloride sicp%. 1.111C 
.1 1%%(1 4\  
11thium chloride %teps and Line 
-1 nodcaning steps. 1ýmcs 6and 7 arr RNA prepared hN 
plicnol/chloroform and 3\1 mximm imate pl 16 rrprrcipiiation Fach Line \o, -.i% loaded 
wlih 1plimmillately tile (111-11,111y of 1"CICIC ", 'Id (1119) 
28s 
18s 
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Removal or DNA from RNA samples. 
As the guanidinium prepared S: Implc shown in lanc 4 or Fgum 13 had large 
quantities of DNA present it was uscd to determine a method of rtmoving DNA from 
RNA samples. Iligh salt concentrations differcritially prtcipit3le RNA whilst leaving the 
DNA and small RNAs In solution (164,165). The msults of high salt 'cleaning' am 
shown In Figure 13. Both sodium acetate and lithium chloride high salt pmcipitation 
procedures qualitatively reduce the amount of DNA present In the RNA Umples. 
JjLhium chloride was the most effective method (desmibed In section 3.2.1. ). Ile two, 
salts appear to have specific effects. solubilising and prccipitating different sizes of 
nucleic: acids. 
To compare the effect on the yield of RNA of the cleaning steps on the same 
muscle source, RNA was extracted using phenoVchlorofonn then cleaned %ith the two 
different methods. 71c results of the extractions, am shown in Table 4. 'McM was a 
reduced yield when sodium acetate and lithium chloride were used compared with sodium 
acetate alone. When the samples were subjected to clectrophorcsis it could be seen, by 
comparing the relative intensities of the RNA to the large DNA band, that them was less 
DNA in the samples cleaned using sodium acetate and lithium chloride, Figure 14. The 
reduced yield was probably due to the removal of the DNA remaining In the samples 
cleaned with sodium awate alone. 
Further qualitative wenmcnts on the effectiveness of the two salts am indicated 
In Figure 15.7be luge DNA fragment in the total RNA remains after 3M sodium &ccute 
washing which is virtually completely removed by subsequent 41 lithium chloride 
precipitation. With bovine samples it was later found thit two 4M lithium chloride 
cleaning steps could remove all the DNA present as assessed by nondcnituring agamse 
gel clectrophoresis. Figure 16. Ills was the method adopted for all subsequent 
extractions and cleaning of total RNA, including the bovine trial (section 4.2. ). as 
described in the methods (section 3.2.1. ). By eliminating the 3M sodium accute step the 
possible losses caused by reprccipitition and sample handling were docrtaso& 
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Table 4. The effect of RNA high salt repreCipitation ('cleaning) on the yield of nuclclc 
acid. Total RNA was extracted from the same chicken breast muscle source (2g per 
extraction) by the phenoVchloro form method. The extracted nucicic acid was then 
cleaned by two differtnt subsequent cleaning procedures: 
A. cleaning twice with 3M sodium accutc p116. 
13, cleaning once with 3M sodium acclatc p116 then once %ith 4%, 1lithium chloride. 
Nucleic add concentration was determined by absotbancc at 260nm. 
Extraction Proccdurc 
A 13 
(nu4) (n«4) 
Nucleic acid 470 ± 21 359 t 19 
(µg/g muscle) 
(Values arc the mean ± SEAT) 
I ()" 
Figure 1-1: Nonderialu ring 1% agam%c gel clecimphorom (if tolal RNNA fsom thickcii 
%kelcial mu%cle prepired by the plicnol/chlor-ofonii ckir-aclion 'cleaned' by diffctcrit 
prmcdurc% Gel A: cleaning twicc wiih 1\1 wKIIIIII, aCc,., IC , It(, (Oct 11. 
rctirecipitation once \%Ah 3\1 %odiun, acclaic ill R, Ilien 4\1 lithium chloride oi-, I) Fach 
. the ý 2-Apg) line was I(xided w0h IPPRMT1111d) 
. 
imc quantity (if nucloc acid Q 
A 
B 
1-1glitc 15: Nonden. Iming Igarose gcl clwrxiph(-)r-c%i% (if itlial RNA purpurd by 
plicnoUchlorofOr"' C\Mlcti(ill fl-c'm bovine s-kelcial 111t1wic and 'CIC'mcd, by dif(cmit 
prxxx(furev Lancs 1-4 'ý. 11111)lcs 'Cleaned, Imvicc %% )III 1\1 %oKlium ICIC. 11C pH6 I . 11w% 5N 
%amples from lancs 1-4 relirccipitatcd tvicc \kith AM h0mim chloride Fjk I, 1.1tic %,, % 
lo; I(Ic, l with appm\immely 2lig of ni,, clcic acid. 
ith approximn? lv 2- of n,.! clcic icid. M, d ed %% I.. fC. .1 
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Although phcnoVchlomfomi Is not as striong a dcnatuting agent as guanidinium 
salts It appcarcd to be competent In pmducing RNA %hich wis Intact and (me of protein 
(192). Ile effectiveness of the phenolic Mom forni nxthod was cnhancci by the use of 
high silt precipitation of the RNA. Extraction or RNA (tom skeletal muicle cncounicts 
dirfcmntproblcrnsthan thatorcitraction frorn tissues such ashver. Inskeletalmustle 
then Is lazge quantity of pnxcin %%hich Is physically mtwvcd as Iniciface material In the 
phcnoVchlororonn extraction. Guanidinium silt nxthods am suited to tissues In %hich 
them art rclativcly high levels or RNascs such as the puscmas %%hc: t this icchnique h" 
been effective in producing Intact RNA (190). Them appcamd to be no advantage In 
using the guanidiniurn thiocyarute tnciboJ for c%tracting RNA from skeletal muscle. 
4.0.2. Extraction or Total RNA from Skelct2l Ntusclc or Various SpccIcs. 
Skelctal musclc total RNA for Notthern blot analysis was cxtracted using the 
basic phenollchloroform prx)ccdure (smion 3.2.1. ) then cleaned %ith the two high salt 
mprecipiudon methods. The quantity of nuclcic acid msulting from the exuUtion after i 
each of the tv%v subsequent *cleining' steps is shown in Table S. The effect of 3M 
sodium acetate p116 followed by 4M lithium chloride washing on the Nwinc s1clail 
muscle RNA sarnples can been wen in Figure IS. 
lie content or toul RNA In limb and bovine umples Is vinually the urne. 
Chicken muscle conWns considenbly woore total RNA thin the other simples. This Is 
probably due to the extraction being from young birds, approxinutely 3 %-ccks old. 
which are gro%king rapidly. The data on the effects of cleaninj the RNA shows the loss 
of nuclcic acid with differential prtcipitation 'cleaning'; sonx of the lots was due to the 
r=wal of contarrdnant DNA but also bwause of the mpe-aiod prrcijimion. 
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Table 5. Total RNA extraction from i1cletil muscle of various species using 
phcnollchloroform followed by two diffctvnt subsequent high salt mprcciphationt. first 
with two 3M sodium accute p116 reptecipitst Ions then two 4M lithium chloride steps. 
The nucleic acid pmsent was assciscd by Asotbance at U&M Ue percentage yield of 
the nucicic acid after lithium chloride tmztnxnt of the sodium acewe clcincd RNA pellet 
is also shown. 
Nucleic acid prtcnt oälct 
Source Ocaning Vwcdurc 
of muscle (lt/g muscle) 
3M Wium 
acetate 
Lamb 
(Ldori1) 
171110 
Bovine I 
(Ldonl) 
Bovine 2 
(Ldorsi) 
Chici: en " 
(Pocuxali$) 
167 110 
152± 2 
470±21 1 
41 lithium 
chlo&le 
119+7 
107 =9 
1091 9 
3591 192 
riew 0( 
Nucick acid 
bciatocn 
ckardng licpi 
6S% 
64% 
72% 
76% 
* nese samples %= fnxn two sepanic prepantions, of the umie muscle powder swck-. 
I %k-as cl=cd mice %ith 3M sodium ccule, 2 %. ýjs clancid ooct %ith 3M sodium ucuic 
folk)wcd by one prcdpiution %kith 4M IiLhium chlcxide. 
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4.0.3. III--Vitro Translation of MIONA by a Rabbit Rcllculoqle L)JOIC 
SYSICM. 
In V1, translation was used to dctcnninc %% hethcr the RNA cittracud was lnwt 
by its ability to produce pnxcins twnitorrd with 1,135SI. melhionine Inctwporallon. -Mls 
was detected as TCA ptccipit: blc protein and/or autorsdioCfs,, ph% or the translation 
products on SDS-PAGE Scls (section 3.2.10. and 3.2.11. ). 
Initial translations wem carried out on chicken skeletal muscle total RNA usins 
the reticulocyte lys3te provided by the John Inncs Rcscarch institute (tcctlon 32.10) In a 
translation cocktail. developed by the Plant Physiology section within the Faculty. 
optimized for the translation or plant total RNA. 7be system conWned Mutium (on% at 
112mNi. magnesium ions at 3.4m1M. %hich am critical In the In %J translation, and the 
lys3te at 66% WO. The total RNA gave no detectable Incorporation of 35S Into TCA 
precipit3ble protein above the backsmund blank and no translation producu spccific to 
the muscle total RNA %hen the samples were analysed on a 10% SDS-PAGF. Beta- 
globulin mRNA (BoChrin9cr) also failed to give any 33S Inaxporalion into protein so It 
was assumed that the lyswe mix wn incffccdve. 
For all the tmnslations using the System them was a high lc-. vl of b1ank activity in 
the TCA pmcipitatod 35S labelled ptuicins fmm the translition mix (ux6on 3.2.10. ). 
Typically blink umples with no RNA present Ivid Incotporadon values of 41MO3 
cpmj2jd c=pued %ith 36x 103 cpmf2jil when 49g of toul RNA %%u pms=L Mu"S 1C%'d 
of incorporadon was the fim in all the tmnslations. the blink was slightly AIXA-C of 
below that of the rest of the samples. Normally a rht fold grutcr Incorporation was 
cxpected to be ptodoced from total RNA abo%t he blank. 
As the rtdculocYte lYS31C system was suspected of ncK being c3luble of In vilm 
transl3tion It %%-as changed to another %% hich lud been optimired for Tobxw Mosaic 
Virus CRIV) mRNA (Anvershim). This h3d optimum Ion coxcntndons of 178aLxf 
potisslum, 1.6mNl nugnesium, the optimum rsngc being 10CW35mINI and 2.5-3.5mki 
respectively (176). and lysite at 64% (vjv). Wing this systcm., Ahich wiz employed 
ciscntWly In the same nunneras dr-wribcd In section 3.110, onch; dcn skeletal musck 
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total RNA It ptWuccd similar mults to the John Innes lytaic. that Is no Incotim'StIon of 
35S In the test sampicsabove the blink. 
Using a (msh b4tch of John Inncs l)-taic the translation cocktail was nWlincd to 
include the andblotic chloramphtnicol. at lRiCAW. to Inhibit butctial Ctow0i In the 1)UIC 
during the I=b4tion pctio& 7be RNA was Initodmd to the trantlation mix its a pellct 
to allow the rcticulocytc lys4te to be at a highcr conctnuation. 71% (vjv) And the 
nugneslum and ponmilum tons were at 2.1mM and 105mM rcipccilvdy. *Me In vI 
translation was carried out c-stmially as dmtibcd In smion 3.2.10.1"his rmthod 
produccd the greatest Incorporation of 33S in the Icst saimpIcs of chicken muscle 
pol)JA)+ RNA that had bcc-n seen so far. shown inTable 6. Them was also a mdoction 
in the bxkgtound. the TCA precipitablc ptWocts of the blink. to bclow 5 %103 cpnV201 
1) $41C. 
AldmSh thctc %,, as 35S Incotporation Into TCA pmipiublc pnxcin. It was w 
scen in all the umplcs. -[be 35S pmcin prodocts could not be cvaluatcd fnxn SDS- 
PAGE because of technical difficultics in ptoducing dticd gets of sufllcicnt quality. 
Ito, *-cvcr improvcd translation appcatcd to have takcn plam ptobably cau" by 
inhibition of b=cri&l poulh in the I)-wc. 
Gmata incorpomtion was achieved %hen the RNA %-a% &MW to the lyssic mix tu 
a solution as described in section 31.10 and the type of L-35S. mcthionine used was 
altmd to an "in Nivo libelling trade' type isotope (Amersham). In changing the 
auslition nU'X the pot=ium and nugntslum Ion conctntrations %%= mEned to those 
In section 3.2.10.. but this was rxx a substantial alteration. Although an autoradiogriph 
of the truslition products %-as not produmd due to poor gel d: )inS It appeared that the 
translitiOn cocktail provided the approprive conditions for effective In vltr2 translation,, 
", wm In Table 7. These conditions %tre adVed to give the rinslited rmthod, desoibcd, 
In section 32.10. and ustd for the sub"uent translations of the boAne trial total RNA 
umples (section 4.7-3. ). 
Table 6. Asscitment of Incorporation of j,. j35Sj-mcth1onInc Into TCA prcclpitablc 
proidnMerinvit trinsl ation of chic kcn, liver tot A RNA and skelcul muscle poly(A) f, 
RNA. 
trxoqwadon 
RNA RNA of 35S Ova bic k gtxxmd 
sampIc (ps) qmqd 1)141C 
Blank a 3348 Im 
Chkktn 
nwsclc 0.4 6931 95% (pol)IA)+) 
U%, cr 10.0 6735 90% 
crow) 
T, ablc 7. Assesunent of incoq*ntion or 1,135SI. nxthionine Into TCA pmdpluble 
promin aftcr tk In vi UwWaSon of chidca sicicul made toul RNA. 
gýtIty a 
ToW RNA 
lrrcqxndon 
of 33S 
Ircm"don 
o%-a baclground 
(P9) cnr4d 1)-. WC 
3360 0 
3.2 14588 334% 
10.0 7293 117% 
20.0 4943 47% 
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4.1. The Selection, Generation and Use of DNA 11)1)rldloallon Probes 
for the muction or the C21paln S)slcni's tnRNA%. 
The aim of the pwjcct wat to examincany changet In the gene cxprcttlon of the 
components or the calpain system detected by alterations In the quantity of rnRNA 
spccirsc for the cilpain Isoforms and calpastatin %hen vatiout species. In particular farm 
species. %tre trtatcd %ith P-s&tnctg; c 2ronim. 
The cDNAs cc other complemcniary nuclcot'ide wqucncts to the calpain and 
calpasutin mRNAs werc mquircd as probes for Notthern anzlysis andlor &lot blot 
hybriditation to quintiry any change-t In thcir mRNA. In order to quintify chanjes In the 
gcnc expression of the cal; uin Isciforins pmbcs to the caliuin laxle subunit -*-cm mqulmd. 
ne small subunits am Identical in ulpiln I and 11 so they %%-cm notsuluble at cAlpain 
Isoform specific probes (22). 
Initi illy %%, oil- comntnt cd on the devc1opment of calpsin mRVA probcs as therc 
was cDNA sequenoc Infomution avail3ble but little on calpitutin. Subtcqucntly 
squences for the Inhibitor urm publithcd % hich allo%%vd the genmflon or a calpastitin 
cDNA by PCR (Section 4.1 
. 
5. ). 
4.1.1 The ust or an Oligonucleolide as a 113briditallon Probe to Cslpaln 
Larte Subunit mRNA; Oligonucloolide 1. 
At the time of co=xrocing the pmjcci scivnl cDNA% to the Imle subunit of 
calpaln W been scquenced W publiM In the litentint; they InclLuied. - 
1) Chicken calp: dn luge subunit cDNA %hich Includod the cxxnplctc unino acid 
coding sequeme (14). 
2) Rabbit cApain Urge subunit cD, 14A% to both o1juln I and It % hich %%= only ror 
pvt o( the an-ino wM codins squenct (151 
3) 1 lun= calpin I lup subunit ONA % hich was for the cmim arWno " coding 
04 
scqucncc (16) and &ýxlcr sule the cD. %'A to the complete ImIc subunit of calluin 11 (17). 
Itprovedimpoulbletoobuin m1pincl)NAs frtxn the libontoriesvibm they 
h3d oti&Wly be IsoUted. therefore an oli: onuckotkk %u uscd as a pmbe to the cadjuln 
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luge subunit mRNA. Oliconuclcolidc% hive bccn uwd at hybddiufloa ptubcs (cc the 
Itolation of cloncd Cenci and cDNA (194.193) and tubtcqucnily on Norihcm blots 
(196). 
It was decidod to nuke a complcmentity oligonuelmide to pw of the chicken 
c4lpain Urge subunit cDNA. nil scquenct was Chown rot scvc: rAl ltAwnl: 
1) A Patonist chickcn tjial %'a& bcIng canicd out %ithin the r-aculty. 
2) The cilpaln systern In chickcn sLclctAl muscle wls guggelled 10 conuin only one 
isofonn of calpain Wntificd on Nonhcrn blots and by Ion cichinge chwautogtaphy 
(14,12). 11=f= It was a rtlitivcly simple spicm to study c*mpatcd with "Ummalian 
muscle %% hen both isofomu had bccn isolatcd 0 5.16.17). 
3) ChicLen skclcW muscle calp2in had bccn clistified is a calpin 11-like hoform 
(12ý 7bis was the enzym activity that chinScd significantly In the Adcul muscle of 
lin-6s in a P-adrcncrric asonist ItiaJ camied out In our hbonwnics (114). 
Ald-ough the C41; uin symcm In chickcri skOcial muscle had r*t been antlyscd for 
chi, nscs in activity on mtrncni %ith [ý3dmnctticagonists. chickm skelcul muscle hid 
bccn rrponed to mspond to thcIr grouth pronxxing drccu (197). 
01'he isofonns of the calluin Imle subunit hive a high dep-ce of homology at the 
amino " (55-70%) and nucleotide Ic%tI (60. SD%). 11)c cDNAs avallsbic In the 
I itcraturc A= aligned to rind the tv giom particululy In calpain It. which had a hilh 
deg= of hornology to clikken calpin cDNA. In order to Identify a sequc= suitable as 
in oligonucleotide probe. Initially the rabbit Isofbrms wcm uszd for compadm It Wu 
csiviviged thit homology would be a6=u; cous If the oligonuckv; dc was to be ued to 
probe mRNA fnxn other sjv6cs. 
71c oligonucicotide %= sclecud frtxn donuin III of the cnz)mv as donuin 11 and 
IV have homology to thiol pmicinisc and c3lmodulin-like c4lclum bindinj pnxclns 
n3pccti%-cly (14). Domain I was nx sclcctcd. althoulh thisappean to be diffemm in the 
two lsofonns (17) W possibly gives the cnz)lnc its csklum sensitivity. as the r3bbit 
cDNA% did raDt contim any wquc= for donuin LA 'bem-rat" olitonucleodde sequence 
was ra m3de as the tnitW aim was to pmbe toul RNA Waled from a chldca m=1c. 
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*Me sclcctcd squence. oligmuclcoildc 1. Is thoAn In 11gutc 17 along %-Iih the 
com-sponding, rcgion of rabbit and hunun calp3in latge subunit Isofonns. Table 8 shows 
the homology betwcen the chicken cDNA ollSonuctconde se4ucncc and the (Xhcr 
sequcivm TI)c position of the oliganuclcotide In the cDNA% %hkh have ken Isolawd It 
shown in Ft Sum IS 
To be ustd as abyb6dinilcm p4obc the thickm wqucoce was made at andsme 
wxl utkd lionuc1cotidc I; 
Y AAA GOT GOA GGG CAC AAC GAT OTA CtC GCC AGO GGO CAa Y 
The oligonuclcotide I hasa high GC to AT ratio. 2413. thcttby Inctusing the 
hybtidiution subility to the coqpla=tmy wqucncr- 
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Figure 17. ne chicken calpAin Istge subunit scqucnce chosen for ollSonuckodde I 
aliSned to the corresponiding cDNA scalumcc, or othcr ipccics. Numbcts in braacts 
indicAtc the position or the oligonudcotlik tvgion In the cnNA. The ollgonucicolkic I Is 
complcmc. nt. uy to that of the cDVA. 
chkken u1juin cD. 14A 0 437-1473) 
Y CTO CCC CCr GGC GAG TAC ATC GIT GM CCC TCC ACC M 34 
I mbbit calpain I cDNA (229-267) 
Y CTO CCO CCC GGG GAG TAC GM GTO GTO CCC TM ACC TrC 3' 
rabbit calp; dn It cDNA (395-633) 
Y CtG CCO CCG GGaaAG TAC ATC CTO GTO CCC TCC ACC TTC Y 
hu=ncaJpilni cDNA(146S. 1503) 
5' CT`G CCA CCC GGG GAG TAT GTG GTG GTO CCC TCC ACC ITC 34 
hun= c4lpiin 11 cD N'A (14.1.9-1.0,67) 
Y CTG CCG CCA GOA GAG TAC AIT CTC GM CCr TCC ACC WC 3' 
Table S. Percent2ge honmlogy of the &cqucnce tclcctcd fnxn chickcn calplin 1, VIC 
subunit MIA for cligonucleod& I uith other CaJimin lute subunit cDNAs. 
I lomolosy of oli gonuclootwe wquc= 
rabbit rabbit hunun hunun 
c, 21=*n n c4ifl-2in F Call rl, I-- 'fl, 
dild-en 79% 85% 79% 79% 
coplin 
II(I 
I igurr 19 TNc relati%c poutim of olipmo, ic, %, 4, jc I in the c D. %*At 4 the (-Ahcr calpain 
large subunit i%ofonns from differrm spems (1.5,16.17) Thc wqtKmcA ur aligned &I 
the 3'ctxfin&/nmwodmt junctxm The rabbit wq%scrices uttv pulslothed invomptor (IS) 
CHICKEN CALPAIN LARGE SLIBuNIT 
IV 
5w tip 
RABBIT CALPAIN I LARGE 'MoptooT 
5' 
RAEOT CALPAIN 11 LAI- T 
5P 
HWAN CALPAIN I LAPGr 
5*FTT --I[- III -IV 3' 
KJ*AAN CALPAJN 11 LAWI-i +uLft T 
5' IV7 
 N-,. 
U3 
flon CA! N ýjt- 
Ej 
Codog nuciaoisao sequomo 
1ý It. IlL IV, Donvins of caomm 
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The oligonuclootide I was labelled using polynucicotide kinase and jyJ2PJ ATP. 
by which the Yhydroxyl group of the oligonuclcotidc had a phosphatc group added 
(section 3.3.2-). Estimation of Isotope incorporation was nude using denaturing 
polyacrylamide-urca gel clccuophorcsis (section 3.4.11. and 4.1.3. ). In order to achieve 
stable and specific hybridization between the oligonucleotide I and Its target mp-NA 
sequence in chicken mRNA. an estimation of the Incubation temperature (Ti) was made 
using the formula for the calculadon of the nxlting temperature (Tin) (198): 
11wTm"1S°C 
The forrnula for Tm is-, 
Tm a 16.6 1ogjN1 I+0.411 Pgcj + 81.5 - Pm - D/L . 0.65 JPfj 
where. 
N1 is the molar concentration of Na+, to a maximum of 0.5 (1 xSSC is 0.165M 
Na+). 
PgC is the percentage of GC bases. In oligonucleodde I this value Is 61.5%. 
PM is the percentage mismatches in bases. For oligonuctcodde I used against chicken 
calpain mRNA them should be no mismatches. 
Pf is the percentage formamide in the hybridization soludon. None was used in the 
experin=L 
B is 675 for synthetic probes up to 100 bases. 
L is the probe length in bases. 
From the calculation for a hybridization containing 2xSSC the Tm Is 81-40C 
giving a 71 of 66.40Q 71c standard hybridization solution conuining 6xSSC was used 
in the cxpc: rinv--nt with a Ti of 66-6SOC- Ilis increase In salt concentration would lower 
the stringency and help ensure hybridization. Subsequent wishing procedures were 
carried out with 2xSSC and 0.1% (w/v) SDS at the sa= temperature. 
Tbe oligonucleotidc I end-labelled probe was first used on a Northern blot of 
chicken skeletal muscle and liver total and poly(A)+ RNA. Migure 19. Ilere was clear 
hybridization to it single band in the pol)IA)+ RNA from muscle %ith none to total RNA. 
Figure 11). Northern Not of chick-en s' clet. il mu--dc and ll%-cr total RNA and 
RNA prolled \%. Illl 5' C... ' 
- 
I:, "- I Ilyhridliallorl and 
omditiowý \\cre cartied oot In thc tc\l. Thc jxmilom (if dic 2SS and INS 
rl! 'o"ollml R'N* \% ". -? 
b 
-35kb 
I-anc No. 
1 
2 
3 
4 
5 
6 
7 
v 
12345 
-- 
'ý 
-18S 
67 
Simple 
]jig Ifind III lamKU DNA maricirv 
511g Ivl)(A)+ RNA. chicken &kdetal mu%clc, 
4pj; jvlý(A)+ RNA. chiAcn Imm 
15pg 1otaIRNA. chjJcnh%cr. 
2(81j; total RNA. Lhickcn liver. 
C11114Y 
15jig total RNA. L hickcri %kelcul mu%ck-. 
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Ile size of the calpain large subunit mRNA wasapproximately 3.5 kb. In ogmment with 
other rtscarch groups (14-17). 1 
Chicken calpain large subunit mRNA Is a low copy number species at picogram 
amounts per microgram total RNA. for example 60pg/50pg skeletal muscle total RNA 
(199). This may explain the lack of hybridization to the calpain mRNA In the total RNA 
loaded. The poly(A)+ RNA had bccn prcpared by double pass-age through oligo-dM 
cellulosc and approxim3tcly 5pg had been loaded (section 3.2.3. ). so was an cnriched 
source of calpain mRNA. Uvcr has the lowest quandty of calpain large subunit mRNA. 
less than half that of skeletal muscle, but the lack of a hybridixadon signal In the liver 
pol)JA)+ RNA %-as probably due to its poor quality. 
The me3gre quantity of calpain mRNA in muscle could be seen by comparison 
when the Northern blot was reprobed with chicken myosin light chain 2 (NiLC2) cDNA. 
Figure 20.71c chicken MLC2 probe is described in appendix A. The mcmbMne was 
hybridized at 550C then washed at increasing stringency to 650C with O. IxSSC and 
0.1% (w/v) SDS. It can be seen that the strength of the hybridization signal is much 
greater than that for calpain which was washed at slightly lower stringency, although the 
the hybridization bands in the muscle total RNA are obscured by nonspecific 
background. MLC2 mRNA transcripts are expressed in a higher copy number than 
apain in skeletal muscle total RNA. 
In subsequent experiments in order to detect calp3in large subunit mRNA In 
skeletal muscle total RNA Northern blots up to 50pg was used. Total RNA was 
favoumd because it would be relatively easier to handle and prepare thin poly(A)+ RNA, 
especially when dealing with samples from an animal trial. 
The use of the oligonucleolide I probe across species. 
At this point in the project the chicken trials with ý-admnergic agonist were not 
producing a predicted growth msponm 11cm %%= no changes in the activity of Calpain 
and calpastitin in skeletal muscles examined. although there h3d been rcporied growth 
effects in P-agonist4reated poultry described in the literature (197ý A bovine P-agonist 
trial was being carried out within the department using the P-3drencrgic agonist cimaterol. 
Figure 20: Northern blot of Figurc 19 rcim-Awd %%fill chid, C11 111ýo', 111 III-lit chaill 2 
I Nil C2) cDNA 'Ilic condmon% mc olillified if) thc 1c\1 
, 
Thc I-xv, 1114111% of the I Ss and 
2SS ntvA)mal lkNAs; itv Indiclited. 
IP 
ý-28S 
ý (ý 
.: a 
p 
1 
t-w No. 
1 
2 
6 
7 
234567 
sallipic 
Spg rKil)-(A)+ RNA. chickcn %kcicial numc1c. 
4lig ix)l), (A)+ RNA. chickm liva. 
l5lig IoUl RNA, chickcn liva. 
2(ýIg ltVI RNA. duckcn li%vr. 
emr4y 
I Slig toul RNA. chkkcn %Lck-tal mu%cic. 
2cýlg to4al RNA. chkkcn !. kc-k-tal mu%cic, 
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Beta-agonist, Induced skeletal muscle hypcnrophy had been observed In bovine species 
by other research gmups (118,200) and in expcrinicnts carried out %kithin our laboratories 
(unpublished observations). Also the calpain and calpastatin activities were known to 
respond to 0-adrenergic agonists (unrcponcd observation) similar to those seen In lambs 
(114). Therefore attention was focused on detecting calpain large subunit mRNA In the 
skeleW muscles of this species. P 
7be oligonuclcotide I probe had been made to have high homology to the calpain 
large subunit cDNAs of other species. therefore it was possible that It would detect 
bovine calpain large subunit mRNA at low stringency probing and membrane washing. 
A decrease In the stringency is necessary as the stability orduplex, of the two strands Is 
reduced as the number of mismatches increases. As the bovine sequence was expected to 
have approximately 20-25% mismatch to the oligonucleotide (Table 8) the formula uscd 
to calculate the hybridization temperature was employed assuming that the mismatch was 
20% and the hybridization solution contained 2xSSC The value obtained for Tm was 
560C A 150C reduction in this temperature for Ti would have resulted in the possible 
precipitation of the BSA and SDS in the hybridization solution. In order to elevate the 
temperature the salt concentration of the hybridization solution was Increased to 6xSSC 
(the standard hybridization salt concentration) which allowed 11 to be mised to 50-550C. 
Although the Tm equation does not hold at these salt concentrations (6xSSQ it does give 
an indication of the temperature and hybridization solution composition which should be 
used for the degree of rnismatching expected. 
By carrying out hybridization at low stringency then subsequently washing the 
membrane in steps of Increased stringency (decreased salt and Increased temperature). 
with the analysis of the results of each wash, Identification of calpain large subunit 
mRNA hybridization signals across pecies would hopefully be achlevedL 
A Northern, blot was made of bovine and chicken total RNA, up to 100pS. and 
poly(A)+ enriched RNA, prepared by a single PASS3SC through a oligo-dM (3.2-3. ). 
'Me Northern blot was probed with oligonuclcotide I (30pmol) libelled with 20pmol of 
jyJ2P) ATP (>5000 Ci/mmol) using pol)mucleotide kinase ;% low stringency 
Figure 2 1: Northem blot (if chickcii alld KwInc lotal mul I-K)I). (A)+ RNA probcd wlilt ilic 
5, clid-labelled oligollildcondc 1. I'lic condillon% arr cmilincd In Ilic Ic\t '111C of 
thc 2SS and ISS ribosmul RNAs are indicated. 
dab%, 
S 
" f 
" 
I 
6 
'S Ø 
0 
ti 
_",; 
S., "'J': ' 
r, (kig total Ki% inc 
. 
4cicul mu%., Ic. 
2 25og total RNA, N1% toe %Lclcul mu%cle. 
3 64ig Ivl)(M+ RNA. lv%mc %kcicial muw1c. 
4 6pg ix)l)(A)+ RNA., likken sicictal niuwlc. 
-5 
Výig Imal RNA. t hik kcn sLelcul muw1c. 
6 5(ýig total RNA. chiJen %LcIcLal niuwlc. 
7 10"Jg IOUI RNA, chikkcn %kcicial niu%: Ic. 
9 RNA. 0uýkcn,. kcIcuImuwIc. 
9 ', Ng imal RNA, chicken liver. 
10 25: ig 1c4A RNA. checkcn li%-cr. 
II I ýig Hind III lainhda DNA n%aikcc-. 
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hybridization conditions (500C) (section 3.4.12. ). Ile membrane was washed to 550C 
with 6xSSC to give the autoradiograph shown in Sgure 2 1. 
ne oligonucleotide I did not pick up a specific hybridization band for calpain 
large subunit In chicken or bovine RNA; however the signal may have been obscured by 
the high background probably caused by lowering the hybridization stringency. 
There was a weak hybridization signal visible at the proposed position of the chicken 
calpain large subunit mRNA at approximately 3.5kb which can just be seen In the bovine 
RNA samples (Figure 21). 11cm was no double band detectable in the bovine sample 
indicating hybridization to the two large subunit Isoforms mRNAs. I lowcvcr, they were 
reported to be of similar site in rabbit and human (15-17). 
The Erfectiveness or MLC2 and ct-actin cDNAs as hybrIdiallon probes 
across species compared with oligonucleolide 1. 
To check the poly(A)+ enriched and total RNA had not been degraded during 
extraction the membranes were stripped of the oligonucleotide I probe (section 3.4.13. ). 
then reprobed. 
Figure 22 shows the membrane probed with nick manslation-labelled chicken 
MLC2 cDNA at 550C then u2shed to 2xSSC plus 0.1% (w/v) SDS at 650C 7be probe 
hybridized strongly to chicken muscle RNA. at the cxpccicd size of 0.7kb, and this was 
not lost on higher stringency washing. Ile-re was high nonspecific hybridizadon within 
the chicken total and poly(A)+ RNA samples, but this was removed at higher stringency 
washing unlike the b3ckground seen in the oligonuclcotide I probed Northern blot 
(Figure 21). The autoradiogmph shown in Figure 22 was also selected to illustnte that 
the chicken WX2 cDNA could hybridize to the bovine muscle total and poly(A)+ RNA. 
although this was not as stron& as that to the chicken RNA, unlike the ct-actin cDNA (see 
below). 
Figure 23 is the membrane of Figure 22 reprobed with the nick translation 
labelled mouse pt-actin cDNA. ne mouse wactin probe Is described in appendix A. 
71e Northern blot %%-as hybridized at 550C and, %-ahed with 2xSSC plus 0.1% (w/V) 
SDS: it65OC 71c mouse a-actin cDNA bi rids to both chicken and bovine a-actin 
I'4 
hpirc 22: Northern Not of figurc 21 rrprobcd with chickcii MI. C-1 cDNA. The 
" 1, condmon% arc dc,, crlbcd In thc tcxt. Ilic samillc% in the lanc% nrr indik-mcd in figurc 'A 
The 1xismom (if the 28S aiul I SS ribosomal R, NA,. are nuirked. 
23456789 10 11 
a lop ;, AS 
hybriduition and wishing conditions arc dc. wribcd in the tcxt. Sampics in lancs are 
, 
-, i flp; rc 
-'I and Ox i-xl,, Itions of the ribosomal RNAs arc marked. 
1,,, 14r567891011 
11 ii it i 
-28S 
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mRNA sit approximately the expected size of 1.7kb with the same specificity unlike the 
NILC2 cDNA. This suggests that the mouse ct-actin cDNA his the same degree of 
homology to both chicken and bovine a-actin mRNA, which w-ould be expected for this 
highly conserved protein. The bovine ct-actin mRNA appears to be slightly larger than 
that of the chicken. 
Both the chicken NILC2 and mouse a-actin cDNAs were subsequently used on 
total RNA samples from the bovine cimatcrol trial (section 41. ) to monitor the effects of 
the Jýagonist on their respective: mRNA expression in the skeletal muscle. 
Because the oligonucteoildc I probe would not spcciric, 211y doect calpain large 
subunit mRNA in chicken muscle total RNA and bovine muscle total plus poly(A)+ 
RNA. I attempted to make a calpain large subunit cDNA probc by the polymer= chain 
ruction. 
4.1.2. The Attempted Generation or the Chicken SkcIc12I Muscle Calpain 
Urge Subunit ONA by the Polymcr2se Chain Rc2clion. 
In the Polymcrase Chain Reaction a DNA sequence is amplified between two 
oligonucleotide primers which flank the region. using the thermostible enzyme Taq DNA 
polymerase in repeated cycles of beat denaturation of DNA, annealing and extension of 
the PCR oligonucleotides (184). At the time of the attempted production of a calpain 
large subunit cDNA by PCR there were several reports of the preparation, of cDNA by 
PCR directly from total RNA via first strand cDNA without the need for purification of 
the first stmnd cDNA, after its synthesis by reverse transcriptase (IS 1.201). 
PCR was to be used to amplify pan of the chicken skeletal muscle calp. 21n large 
subunit mRNA sequence to produce a parti3l cDNA. 71c m. 3sons for this appro3ch %%= 
1) At the time of this work there was only one reported calluin large subunit Isoform 
at the protein and mRNA level in chicken skeletal muscle (12.14), therefore the PCR 
product would be only for one Isofonn other than possible multiple products from a 
nurnrnalian muscle. More recent reports in the litenture have suggesteJ there Is a calpain 
I along with a third isoform, cnz)rme activity in chicken breast muscle (13). 
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2) Oligonucleotide 1. which hybridized to the chicken muscle calp3in mRNA 
sequence. could be used as one or the PCR ol igos. 
3) The PCR cDNA product was predicted to be an l3rSc subunit Isoform which Is jk 
calpain 11-like in action (14) but has a high homology to human calpain I and 11 at a amino 
acid level, 70% and 66% respectively (17) (see Table 1). This calpain PCR cDNA could 
possibly be used to detect both large subunit isoforms from mammalian species on 
Northern blots. Although the sequence may have the sarrie percentage misnutch as the 
oligonucleodde Ia longer sequence would be morc stable In hybridization. Alicynadvcly 
it could be used to isolate large subunit clones from other ipecies'cDNA libraries. 
Oligonuclcotide I (39mer) was antisense to the chicken large subunit cDNA 
sequence at 1437-1475 bp, therefore it became the YPCR oligo. Using the protocol as 
described in section 3.3.4. (i) and shown in Figure 24. first strand cDNA was generated 
using ANIV reverse transcriptasc and oligonucleotidc I or oligo-dm on chICkcn skeletal 
muscle total RNA. 
Ile choice of 5? CR oligo was dctcnnined by the position of the oligonucloodde 
1, the YPCR oligo, Figure 18. According to advice given by groups using PCR. a 
region Ikb upstream of the 3*PCR oligonuclcotide was suitable. However this meant the 
5'PCR oligo was within Dom3in 11 of the cDNA so may have h3d, homology toward 
other cysicine proteinases (14), see section 2.1.1 
- 
7be 5PCR oligo, (oligonucleotide 11) selected as 'sense' chicken Calp3ln large 
subunit sequence and consisted of 30 nucicotides show below; 
Oligonucleodde Il 
chickcn calpain luge subunit cDNA 469-498 bp. 
Y GTU GAC GAC CTG CTG CCC ACC AAG CAC GGG 3' 
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Figure 24: I'lic aniplifica6on of the chicken %kcictal muu Ic calpain large subunit cDNA 
bY the Polymcraw Chain Rcaction (11('R) 
calpain large subunit mRNA 
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Using the first strand cDNA generated from either oligo-dM or oligonucleodde I 
primcrs. PCR was carried out (section 3.3.4-6)). An outline or the two PCR methods 
used is shown In rigure 24. In the pathway marked JAI first strand cDNA was made to 
the general pool or skeletal muscle mRNA using oligo-dM primers. 7be calpain large 
subunit cDNA was then selectively amplified using the calpain-spccific 5' and 3' PCR 
oligos. In route JBI first strand cDNA was made complementary to only calpain large 
subunit mRNA by specific priming using the TPCR olijo (oligonuclcotide 1). The 
calpain large subunit first strand cDNA was amplified using the 5'PCR oligo 
(oligonucleotide 11) and PCR. 
Analysis of the PCR products failed to show a predicted fragment of 1007 bp, 
corresponding to 469-1475 bp of the chicken calpain large subunit cDNA on 
nondcnaturing agarose c1carophomsis. 
lie failure of PCR on chicken calpain was possibly due to several masons: 
1) Oligonucleotide I failed to prime reverse transcriptase S)*nthcsiS of calpain laige 
subunit first smind cDNA. It has been found to be difficult to prime MvcrW transCriptase 
with certain oligonucleotides In mid mRNA sequence, although they may be 
complementary with no mismatches (Dr. R.. S. Gilmour. personal cocnmunicadon). 
2) Reverse transcriptase primed by oligo-dM failed to produce a first stmnd cDNA 
which reached the. VPCR oligo (oligonucleotide 11). A first sawid cDNA >3kb would be 
required. 
3) 7b= rnay have been carry over of rnagnesium ions after precipitation of the ru-st 
strand cDNA products. This carry over could be possible with the chelation or 
nugnesium ions by dNTPs and their precipit. 2tion. Attempts w= made to try to avoid 
this by using arrinrionium acetate In the precipitation or the first strand cDNA soludons 
(section 32.4. ). High magnesium Ion concentrations am known to effect Taq DNA 
polymemse (167). 
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4.1.3. Synthesis of an Oligonticleolide Probe to Calpain Large Subunit 
mRNA by Primer Extension. 
Although the cxpcrinicnt to gcncratc a cDNA to chicken skclcul muscle calpain by 
PCR failcd, the oligonucleotidc 11 had bccn sclcctcd carefully so that it could be used to 
produce: a new oligonuclcotidc pmbc, within the constraints spcciricd by PCR dwribod 
in the previous section. 
Ile chicken specific calpain large subunit oligonucleoildc It (30met) was chosen 
to have high homology across pecies to human calpain I and It Urge subunit cDNAs so 
that the probe could be used to detect sequences In other species particularly bovine 
sarnples. Rabbit large subunit cDNAs did not cover this arca of the sequence (15). The 
oligonucleotide adopted, oligonucleotide It is shown in Figure 25 along with 
corresponding regions in the human isoforms. 
Table 9 shows the homology of oligonucleotide It to the sequences In the hunun 
calpain isoforms. 
Using a 12mer. 
3' TGG TTC CTG CCC S' 
complementary to the 3'cnd of oligonucleonde 11 an antisensc probe was made using 
Klenow fragment and (CE-32P]dCTP (3000 Cilmmol) (Anvenhim). (S'ection 3.3.3. )
(179). 
lie advant3ge of generating a probe by this method was It could be nude to a 
higher specific activity than an Y end 13belled probe, such as oligonucleotide 1. When 
making and labelling oligonucleotide 11 by primer extension the specific activity of the 
[CE-32P]dCrP was reduced by half by adding an equimolir quintity of 'cold' dCrP to 
5NCi of Ict-32P]dCTP (3000 Ci/mmol) (16.6 pmol). In Ycnd I-abc1ling up to one mole 
of 32p or less May be incorporated into one mole of oligonuelcotide whilst In primer 
extension, using diluted isotope, 3 Moles of 32p could be Incorporated Into one Mle of 
andscnsc oligonucicotide 11. By diluting the isotope rnore antiscrisc oligonuckodde 
probe was probably nude and it still may have been or higher specific activity thin the 
end-labelled probe. With such a probe IMS 10(31 RNA would be required on Northern 
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Migure 25. The sequence of the chicken muscle calpain large subunit cDNA (14) chown 
for Oligonuclootide If and the corresponding region In other calpain lugc subunit cDNAS 
(16.17). The numbers Indicatcd in brackets In base paim 
Oligonucleodde 11 
from chickcn muscle calpain cDNA (469498) 
5' GTG GAC GAC CTG CTG CCC ACC AAG GAC GGG 3' 
hun= calpain I cDNA (490-519) 
GTG GAT GAC CrG CrG CCC ATC AAG GAC GGO Y 
hunm calpain 11 cDNA (460-489) 
5' GTGGATGACAGGCTGCCCACCAAGGACGGG 3' 
Table 9. Percent3ge homology of Oligonuclcotide 11, with the cDNAs for the hum: Ln 
calpain large subunit Isoforms (16.17). 
Homology of oligonucleotide scqtxnoc 
hunun bun= 
calpain I calp. -in 11 
0 
Chicken 93% 9D% 
calpain 
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blots to detect calpain large subunit mRNA, hopefully reducing b3ckground caused by 
nonspecific hybridization. 
A comparison of labelling techniques was nudc: 
Reaction 1: 30pmol of oligonucleotide I was labelled using loopCi of ly-32111 ATI, 
(>5000 Ci/mmol) equivalent to <20pmol using polynuclcotide kinasc (section 3.3.2. ). 
The products of the reaction were separated by chronutography on Scphadex G-50 
(section 3.4.10. ) 2gi of each fraction was counted for the acdvity present and the results 
plotted on a graph, Figure 26 A (1). Also 5pI of each fraction was run on a denaturing 
polyacrylirnide-urca get (section 3.4.11. ) and autoradiographed. rigum 26 A (H). 
Reaction If: 5.5pmol of oligonucleolide It was copicd Into the complementary strand 
using 22pmol of the specific oligo primer and 50gCi of jCx-32PJdCrP (MOO Ci/mml), 
which was diluted to 1500 Ci/mmol equivalent to 33piml (section 3.3.3. ). 7be products 
of the reaction were analysed as described for traction It above and am shown In Figure 
26 B (i) and (ii). 
It can be clemly seen that the incorporation of impe, from the mlitive intensities 
of the labelled oligonuclootidcs to the unincorporated nucleotidcsý using prin-cr extension 
method gives probes of high specific acti%ity and 32p Incorporation. 
Ile labelled chicken calp3in large subunit oligonucleoddes %tre used to probe 
Northem blots of chicken skeletal muscle total and poly(A)+ RNA. The blots were nude 
from a gel which was clectrophoresed with replicate RNA samples on it to give two 
separate Northern blots which were identical. 
Ile antisense oligonuclcotide 11 primer extension product had to be heat 
denatured to Mingle stranded DNA before being used for hybridization. To help cns= 
that the labelled antisense oligonucleotide mmained single stmnded In the hybridintion 
solution the formamidc system was used (section 3.4.12. ). 
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Migure 26: Comparison of oligonuclccKidc labc1ling tccliniqucs: 
A. Rcaction 1; Y end laWling of oligonuclcotide 1. 
J) Scphadex G-50 climinalography of labcllcd products. 
ii) Autoradiograph of dcnaturing polyacrylamide-urca Ccl c1cctrophorcsis of 
chronutogaphically scparatcd products. 
i) 
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Figure 26: Compamon of oligonocleocKk labelling tc% hniquc% 
A. Reaction 1.5' c"d labelling of oligonucicimidc I 
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chn'TIMIOgTaphically %cp. tralcd products. 
°T 
0 
Z; E 
E 
cl 
0 
S 
S 
. 
S 
S 
f 
10 
Fraction No 
origin- 
6aa 
.. 
I 
III 
ranNo5 10 S 
133 
Migurc 26: Comparison of oligonucicotide labelling tccliniqucs: 
B. Rcaction If-, labelling antisensc oligonur-Icotide It by spocific primer extension. 
j) Sephadex G-50 chromatography of labelled products. 
ii) Autoradiograph of denaturing polyacrylamide-urca get c1carophorcsis of 
chrornatographically separated products. 
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The autoradiographs of the two different probe hybridirations are shown In 
Figure 27 (i) and (ii). A faint band is visible at the approxinuic position of the 3.5kb 
calpain large subunit mRNA In both autondiographs as Indicated In Figure 27.17he 
hybridization signalappcm relatively stronger. particularly In the poly(A)f RNA tracts, 
when using the oligonucleotide 11 probe tmde by specific prinict cmcnsion. although the 
signal is still very weak. 
it was apparent that poly(A)+ RNA would ha%v to be used to detect calpain large 
subunit mRNA in skeletal muscle as it was difficult to distinguish In toul RNA. 7U 
poly(A)+ RNA used in the blots in Figure 27 was prepared by single pastage through 
c)ligo. d(*I) cellulose so although more was loaded than the Northern In II-gum 19. whcre 
a strong hybridization signal was seen. it was less enriched with pol)JA)+ RNA. 
Further development of the primer extension method of labc1ling may have gi%vn 
I)ctlcr results thin seen in these initial experiments. llo%%-Cvcrat this st3ge the cDNAs of 
hurnan calpain I and 11 large subunits were nude available so bmune the probes ustd In 
the subsequent expejiments. 
In sununary there %%-crc several problems with using oligonucleoildc probes to 
detect the low copy nurnber cal pain rnRNA: 
1) Oligonuclcotides had a tendency to bind nonspccirically to noncomplcrivntaxy 
nucleic acid sequences (195). Probing total RNA with calpain large subunit 
oligonuclootides at low stringency Save high Imckground of nonspecific hybridization. 
particularly to rRNA, in all the rmthods used. 
2) Any significant mismatches In the olisonucleolide probe to the nuckic acid 
sequence to be detected was sufficient to prevent hybridization. As a Msult It wAs 
difficult to use an oligonucleodde to probe the s, 3me isoform sequenice across species. 
3) 'n= were difficulties in cnd-13belling the oligonucleotide using polynuclcoilde 
kinase to a consistent specific activity as assessed from polyacryi3midelurcs gel 
clectrophorcsis. Ibis problem, has been experienced by other gmps %ithin the r-sculty 
and may have been due to the quality of the enzyme. Polyntickofidc kinase Is known to 
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be affected by ammonium ions (165) and the water or the tamplc may have been 
contaminated 
4) When the specific primer extension method was used to produce a probc of 
apparent higher spccific activity there was a possible problem of the DNA manncaling 
after being denatured. This could be overcomc by separating the two suands on 
denaturing polyacrylanUe Scl Occtrophoresis if the complcmcntaq oligonucleodde was 
used with its Y oligonuclcodde synthesis 'blocking- group' still attached (167,179). 
4.1.4. The Use of Human Calpain I and 11 Large Subunit cDNA In the 
Detection or the Bovine Calpain Large Subunit isoromm 
The plasmids containing the human calpin I and 11 large subunit panial cDNA 
inserts, p42 and p21-16 (described in appendix A). were provided by Dr Emson, of the 
Institute of Aninul Physiology and Genetics Rcscamh. Dabratum. Cambridge. The 
cDNAs were isolated by the appropriate restriction endonuclease digest of the plasmids 
and cicctroclution (section 3.4.6. and 3.4.7. ). Iley were charicterised by restriction 
cndonuclcase mapping (appendix A). These cDNAs %h-cm then us-cd to try and detect the 
calpain large subunit mRNAs In bovine skeletal muscle samples as a 0-agonist trial In this 
species was to be analysed. 
Bovine skeletal muscle total RNA samples. a range up to 5ogg. wCrC 
clectrophorcsed on a fornuldehyde aprose gcl (section 3.2.7. (ii)) wherr- prCvIously 
glyoxal3tion of the RNA h3d been used to dCn3turc RNA (section 3-2-7.6)). By using 
formaldehyde, clectrophoresis could be carried out overnight to CAs= good rclaution of 
the RNA within the s=ples. 7bis method %%-as used for all subwquent den3turing gds. 
The resulting Northem blot was probed with hum3n, calpain 11 large subunit 
cDNA. then reprobed with human c3lp3in I large subunit cDNA Migure 28 and 29). 
Both probes were 13belled by nick translation (section 3.4.9.0)). 1 lybridintion was at 
550C for both probes and filters %%=, %-aAcd to the sanx suingemy. 6xSSC at 60D,, I 
I jurnan calpain 11 large subunit cDNA hybridized 10 a specific mRNA species t 
approximmely 3.5-3.6kb (Figure 28) the suggested site fOr MIPIIII 11 I-arge subunit 
1 
. 
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Figure 28: Northern Not (if hovine , kelet: ll inwcle lotal RNA prohcd with human calpaill 
11 large suhmilt cDNA. I lyhridizalloll "d wa, 01ing conditions are described in the text. 
The samples loaded are 20,10,40 and 50pg total RNA Lines I to 
.1 respectively, along 
w, ith I Ilild III lanit)(1a DNA markcrs, 0.5p. g, lane 5. The positions of the 28S and ISS 
ribosomal RNAs are indicated. 
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Figure 29: Northern blot in Figure 28 reprobcd with the hunian calpain I large SLIbUIIIt 
cDNA. The conditions were the same as Figure 28. The locations of the r1hosorrial 
RNAs are indication. 
0 
-3-5kb 
1-. t. ,0'0«0 
0 
Aý. lt 
i' ýÄ 
MIAV 
288 18S 
A 
0 
4 
139 
mRNAs (15.17). The cross-species hybridization of the human cDNA was not strong, 
as higher stringency washing, above 2xSSC at 600C, resulted in the loss of the signal. 
This was expected as the calpain 11 large subunit mRNA sequence is not 100% 
homologous across species. Ile mismatches lower the Tm from its value for the duplex 
formadon of 100% matching complementary sequences thereby requiring low stringency 
conditions for hybridization. 
Ile human calpain I large subunit cDNA probe was less specific (Figure 29). 
The Northem blot was reprobed under the same hybridization and washing conditions as 
the calpain II. Washing at a higher stringency, 2xSSC at 650C, failed to remove the 
background. However faint hybridization bands could be seen near the same position as 
those when probing with calpain 11 large subunit cDNA (Figure 29). 
To confirm the above observations bovine skeletal muscle poly(A)+ RNA was 
probed with human cDNAs (Figure 30). Approximately 9gg of poly(A)+ enriched RNA, 
selected by a single passage through an oligo-dM column, was electrophorcsed and 
blotted. Before using the calpain cDNAs on the membrane it had been probed once with 
a PCR cDNA to bovine calpastatin (section 4.1.5. ). 
Human calpain 11 large subunit cDNA hybridized to a specific band at 3.5-3.6kb 
when the filter was washed to a medium stringency. Using the same hybridization 
conditions the calpain I large subunit cDNA gave a band at approximately I. Skb along 
with nonspecific hybridization, possibly to the small quantity of rRNA which may have 
remained in the poly(A)+ RNA enriched sample. There was also a very faint band at the 
expected position of calpain I at approximately 3.5kb (16). 
The position of the hybridization band at 1.5kb suggested that calpain I probe 
may have hybridized to the 30kDa subunit of calpain. 71e cDNAs for small units of pig 
and rabbit hybridize to mRNA of 1.6-1.7kb and 1.5kb respectively (18,19), whilst the 
bovine cDNA is 1.4kb long, but was not reported to be have been analysed by Northern 
blotting (21). 
Figure 30: Northern Not of bovine skeletal muscle poly(A) i RNA probcd with the 
hunian calpain large subunit cDNAs. 
(i) membrane probed with human calpain 11 hIrge subunit cDNA. 
(H) mendvane reprobed %vhh the human calpain I large subunit cDNA. 
Lane I and 21 lind III lambda markers 4pg and 2pg rcspccti%, cly, lanc 3, Qpg 
1)ol), (A)+ RNA, both autoradiographs were h)lwhhzcd at 550C and washed in 2xSSC at 
600C, Tile loca6ons of 28S and 18S rlosonud RNAs are markcd. 
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7'he nucleotide sequences of domain IV in the rabbit calpain I and 11 large 
subunits have 61.9% and 57.3% homology respectively to the small subunit's domain 
IV' (19) (section 2.1.1. ). The clone p42 contains part of the 3' untranslated region of 
complete calpain I large subunit cDNA including all of domain IV and most of domain III 
(appendix A). 71c clone p2l-16 contains all of the 3' untranslated region of ihe complete 
calpain 11 large subunit cDNA including part of domain IV (appendix A). As calpain I 
large subunit cDNA from p42 contains more of domain IV sequence, and has a slightly 
higher homology to domain IV' (in rabbits), it may hybridize to the small subunit 
producing the band at I-5kb. However because of the homology of the primary 
sequence of Ca2+ binding regions in domain IV` to other Ca2+ binding proteins, such as 
troponin and calmodulin. the calpain I cDNA could be hybridizing to their mRNA In the 
low stringency condifions. 
As calpain 11 cDNA from p2l-16 contains all 3' untranslated region this may 
make it more specific to its corresponding isoform across species. Emori et al (15) who 
isolated the rabbit calpain large subunit isoforms reported problems when using cDNA 
nucleodde sequence from amino acid coding regions as probes to distinguish between the 
mRNA of the two calpain large subunit isoforms. Iley used Ynoncoding regions as 
isofonn specific probes, which were shown to have no significant sequence homology in 
rabbit. Although the calpain large subunits used in this thesis were across species this 
observation may account for the failure of the calpain I large subunit cDNA. 
7be specificity of the human calpain 11 large cDNA was assumed to be to its 
analogous isofonn in bovine total RNA for the reasons outlined above. However the 
cDNA may have been hybridizing to both calpain large subunit isoforms as the human 
calpain I and 11 mRNA are suggested to be approximately the same size (3.5kb) (16,17). 
There also may have been hybridization to the skeletal muscle specific calpain-like 
mRNA, p94 (28,29). However this has low amino acid sequence homology to calpain I 
and 11 large subunits. 
Ile cDNA for human calpain 11 large subunit was far more specific and sensitive 
than the oligonucleotide probes even though it was used tit low stringency. The human 
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calpain I large subunit cDNA was nonspecific and behaved like the oligonucleotides 
when used on total RNA giving high nonspccific background. Although the cDNAs 
were to be used across species for analysis or the skeletal muscle calpain large subunit 
mRNAs in a bovine P-agonist trial (section 4.2.5. ) they promised to be more sensitive 
than the oligonucleotide probes. particularly the human calpain 11 large subunit cDNA. 
4.1.5. Generation of a Bovine Calpastatin cDNA (a Partial Sequence) by 
the Polymerase Chain Reaction. 
As calpastatin cDNA sequences had been published in the litcratum (52-54) but 
had not been made available to our group, there were several possible strategies which 
could have been employed to produce a calpastatin mRNA specific hybridization probe: 
1) The use of oligonucleotides to the calpastatin cDNA sequence. 
2) Generation of a cDNA library then isolation of clones containing the cDNA for 
calpastatin. 
3) Ile use of PCR to generate a calpastatin cDNA. 
Option (1) would be difficult, given the problems described above in attempting 
to use oligonucleodde probes for calpain across species (section 4.1.1 and 4.1.3. ). As 
the calpastatin cDNA was required primarily as a hybridization probeý option (3) was 
considered the best way to proceed. Although option (2) would have generated a specific 
cDNA it was not likely to be as quick as option (3). 
Tbc calpastatin cDNA required was to the bovine mRNA, as samples from a 
bovine P-agonist trial were available. The cDNA sequences in the literature were to 
rabbit (52). pig (53) and human (54). It was reasoned that because of the homology 
between the cDNAS (68-78%) if PCR oligonucleotides were selected from conserved 
sequences across species they might be used to amplify the corresponding sequence from 
other species by PCR. It had been reported in the literature that oligonucleotides with up 
to 20% base pair mismatches to their target sequence could be used successfully (182). 
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Generation of a bovine calpastatin cDNA by PCR using first strand cDNA 
generated from mRNA was attempted (section 3.3.4. (ii)). The 3'PCR oligo was selected 
at the 3'cnd of the coding sequence and the 5PCR oligo 500bp upstream. The position 
of the PCR oligonucleotide primers was dictatcd by the ability of reverse transcriptasc to 
generate first suwd cDNA of sufficient lcngtlý which would reach the 5PCR oligo, and 
the selection of published cDNA sequences which were homologous in the amino acid 
coding region. Since the PCR sequence was to be 500bp and the calpastatin cDNAs 
reported in the literature had a long Ynoncoding region of approximatcly 1.5kb (52,53) 
reverse transcriptase would have had to generate a first strand of at least 2kb. A longer 
PCR sequence with its 5'PCR oligo toward the 5' end of the rnRNA would consequently 
result in reduced proportion of the first strand cDNAs reaching this region. 
The PCR oligonucleotides (17mers) were sense (5'PCR oligo) and antiscrise 
(3'PCR oligo) to the pig calpastatin cDNA and had been selected to have high homology 
to the corresponding sequences in rabbit and human as shown in Figure 31. 
Ibc position of the PCR oligonuclcotides in the pig cDNA are shown in Figure 
32, along with the relative sizes of the other calpastatin cDNAs, and the positions of the 
predicted PCR amplification products that would be generated using the PCR oligos. 7be 
selected PCR oligos spanned domain 4 in all three cDNAs so that the resulting PCR 
product would contain the sequence for a complete inhibitory domain, one of the four. 
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Figure 31. Selection of Yand 3' PCR oligonucleotides for the generation of a bovine 
calpastatin cDNA. Oligonucleotidcs were taken from the pig calpastatin cDNA (53) and 
are shown in comparison to the corresponding squenccs of the rabbit (52) and human 
(54) calpastatin with the mismatching nucleotidcs underlined. 
5'PCR oligo 
pig calpastatin cDNA 1609-1625bp 
5' GCT GCC GTC TCr GAA GT 3' 
rabbit calpastatin cDNA 1621-1637bp 
5' GCr GCC GTC TQ& GAA GT 3' 
human calpastafin cDNA 1504-1520bp 
5' GCr GCC ATC TCr GAA GT 3' 
3'PCR oligo 
(the complementary sequence tothat shown below was used) 
pig calpastatin cDNA 2071-2087bp 
5' AAA GCA AAG GAT TCC AC 3' 
rabbit calpastatin cDNA 2086-2102bp 
NAAA GCA AAG GAT TCA fiC 3' 
human calpastatin cDNA 1966-1982bp 
5' AAA GCfL AAG GAT TCA fiC 3' 
1.15 
Figure 32: The PCR cDNA that %ould he gcnerated from pig rabbit and human 
calpastatin cDNAs Lising the calpamatin IVR Ago%. The suMomain (-()n%cr-%? c(i rcgion% 
arc indicated in the PCR cDNA for cach spek: ics a% mvell as the P%t I recognition site 
position. 
Human calpastalin cDNA 
5' 
FA 
L4 
PCR cONA 
F RAG ME NT 
Psi I 
Rabbit calpastatin cDNA 
5L4 
PCR cONA 
FRAGMENT 
Pig calpastatin cDNA 
5, 
PI 
FI 
Pat I 
500 bg) 
2.3.4. DOMAINS OF CALPASTATIN 
5' NON COOING REGION 
3' NON CODING REGION 
3 
Pill 
At PHA 10 L IX F41 (if(--)N 
ki NIRAL INHIGITOAY 
CONSENSUS SEOLKNCE 
3. 
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To each of the PCR oligos a restriction endonuclease recognition site sequence 
was added, a Hind III to the 5'PCR oligo and an Eco RI to the 3'PCR oligo. 
- 
Using the 
PCR oligonucleotides on pig first strand cDNA a PCR fragment of 479bp would be 
expected. Applying them across species, on the rabbit and human, would gcncrate 
sequences of 482 and 479bp respectively. Therdore on an unknown calpastatin mRNA 
sequence asimilar sized fragment was expected. 
Bovine skeletal muscle total RNA (2Cýig) was used to generate bovine calpastatin 
cDNA according to the method described in (section 3.3.4. (11)) and similar to that 
outlined in Figure 24 A, using the oligo-d(T) first strand cDNA synthesis then 
subsequent specific sequence PCR amplification with PCR oligos. Ills work was 
carried out in the laboratories of Dr R. S. Gilmour in the AFRC Institute of Animal 
Physiology and Genetics Research. Cambridge, whose advice and assistance I gratefully 
acknowledge. 
7be PCR product was subjected to nondenaturing agarose gel clectrophoresis, 
Figure 33. The fragment size is slightly Icss than that of the smallest fragment of the 
Hind III and Hind III/Eco RI markers at 564bp. and is between the 514 and 468bp 
fragments of the lambda DNA Pst I markers (appendix B). On the same gel are products 
of the restricdon cndonuclease analysis digest of the PCR fragment with Pst 1,1 lind III 
and Eco RI, Figure 33. Only the digest with Pst I gave discernible fragments, of which 
the large one was estimated to be near the 334bp fragment of the Pst I lambda DNA 
markers. 
Of the three known cDNA sequences to calpastatin (52-54) two, human and 
rabbit, have Pst I sites within the corresponding PCR region as marked in Figure 32. 
Table 10 shows the size of the corresponding cDNA which would be generated if the 
PCR oligos successfully amplified the calpastatin first strand DNA of these species and 
the size of the Pst I fragment from a digest of the predicted PCR cDNA. This restriction 
cndonucleasc data partially confirmed that the PCR cDNA was that of bovine calpastatin. 
To verify this the cDNA was sequenced after being cloned Into the plasmid vector 
pGEM3 (Promega). 
I, 1 -0 
Figure 33: Nondcnaturinv 117c agarose ýcl clcctrophorcwý (if the Ilck I*l; jgIIjcjjI 
generated from hovine sk-cictal muscle lotal RNA along w0h tile pj-cKItIL. t, ý (if it% 
cildollucicaw a 11.11 ysis. TIlc markers are II ind III Fco R III I int IIII and I I,, II fragmcm% (it" 
lambda DNA (appendix 11). 
1 
, 
lot 
Ifind III lamIxti DNA nwkcv, 
I Eco IZI digest of VCR fragnictit 
Ilind III (Ilgc%t of PCR fragnicni 
Psl I digest of PCR fi. ignmit 
5 PCR fiagnicia 
6 I'm I Limbda DNA matkas 
7 Eco R1,111nd III lamIxIa DNA mitkcr\ 
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Table 10. Ile size of the PCR fragment which would be generated from the published 
calpastatin cDNAs, their position in the full length cDNA and the location of the Pst I 
site. 
Species 
pig 
human 
rabbit 
Size of Position Size of PCR Position of 
PCR in cDNA Pst I Pst I site 
fragment* fragrncnts* in cDNA 
479bp 1608-2087bp 
479bp 1504-1982bp 
482bp 1621-2102bp 
425+54bp 1662bp 
327+152bp 1830bp 
327+155bp 1947bp 
* Ile values do not include the restriction cndonuclease sequences added to the 
Nend of the PCR oligonucleotides which would be amplified with the cDNA sequence, 
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Taq DNA polymerase has no proof reading capability Yto 5'. and this generates 
a base substitution and one base framcshift error at a rate 1/9000 and 1/41000 
respectively during a single round of DNA replication (202). Therefore the PCR rcaction 
was repeated but with replicates. From three replicates the cDNA was treated with Ifind 
III and Eco RI to produce 'sticky ends' which were ligated into the multiple cloning site 
of the inyin transcription vector pGEN13 (Proincga), between the SP6 and T7 RNA 
polymcrase promoters (section 3.4.1. ). The map of the plasnW containing the cDNA 
insert is shown in Figure 34. The three separate vectors were then transfected into the 
E. coli strain JM 109 (section 3.4.2. ). One of the ligation reactions failed resulting In two 
clones pG3pI3 and pG3p2I containing the PCR products of two reactions. 7be 
complete insert was successfully removed from the clones by Ilind III and Eco RI 
restricdon endonucicase digest. 
lie Tand 5'PCR oligos and the oligonucleoddes complementary to the SP6 and 
@17 promoters were used as primers in dideoxy chain termination sequencing (section 
3.4.8. ) to give the complete sequence, including the PCR oligo primer regions, of the 
bovine calpastatin PCR cDNA. Sequencing was carried out on both pG3p2l and 
pG3pl3 plasmids. Ilere were incompatible bases within the novel cDNA sequence 
possibly produced by PCR errors. However they were at 'wobble positions' and do not 
cffect the deduced primary sequence as shown in Figure 35. 
The novel bovine sequence between the PCR oligo primers consists of 451bp 
equivalent to 150 amino acids. The corresponding regions from pig. Mbbit and hun= 
cDNAs were aligned to give the best homology to the bovine calpastatin PCR cDNA 
novel sequence. All the corresponding calpastatin cDNA regions had high homology to 
the bovine PCR cDNA, particularly the pig and human sequences (Table 11). 
I S() 
Figurc 34: The plasmid map of pG3p2I and p63pI3. Numbus in Itic diagrann arc ill 
basc pairs. 
PCR-CDNA position in pig ralpaslatm mANA 
AAAA 
i 300 bl 
10.50 bp 
Esfýý-- -: ] [: jGým 
333-1-152- 
I inserted into multiple 
Pst I clontng site of pGEM 
3, 
Nontranslated region 
ýAuitiple cloning site Pvu 
Restriction endonui: ease 
site. 
pGEM 3 
2867 bp 
Ampr 
ON 
I, Bgl I 
Sca I Pvu I 
Hind III Eco RI 
0 485 
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Figure 35: The nucleotide sequence of the PCR generated bovine calpastatin partial 
cDNA. The deduced primary sequence is aligned with the corresponding primary 
regions of pig. human and rabbit cDNA (52-54). The dashes indicate Identical residues 
across the species, asterisks indicate gaps introduced to achieve maximum homology. 
ne se ucnce shown is that of the pG3p2I cDNA insert with nucleotidc mismatches to 
pG3p11 insert shown above. The conserved alpha-helical and Inhibitory central 
consensus equences are highlighted and are the regions predicted by MAI et al (59,61). 
Saying PCR cDNA 7 ECT SCC STC TCT SAA SIB 61T ICC CAA ACC CCA 6CT CCA CC ACC AB 6CA 6CC 66T CCA 7 
saying I. a. Sig ? 
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Hum a. s. Sig 502 Ala Ila ill Sir flu Val ------ ter .... Ill Ala - 321 
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--- %or -- Sir ill - arl - thr Ali - $60 
? CCC CC ABC ACT 6CS CAC 66T SAC AAC AAA 6AA CTI SAC SAT Scc CIO SAT CAA ETT TCT SAC "I CTC 661 7 
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Table 11. The homology of the bovine calpastatin PCR cDNA at the nucleodde and 
amino acid sequence level to the corresponding rcgions in the pig. human and rabbit 
calpastatin cDNAs- 
Species 
Corresponding region to the 
Bovine 
cDNA calpastatin primary 
sequence sequence 
(bp) (aa) 
pig 1626-2070 
human 1521-1965 
543-690 
508-655 
Homology to Bovine 
calpastatin 
Nucleodde Primary 
sequence sequence 
MM 
82.2 73.3 
78.2 74.6 
mbbit 1638-2085 547-695 72.2 66.0 
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Within the calpastatin sequence there arc regions that are conserved bctwccn the 
four domains and across species (56,59-61). Each domain has a central Inhibitory 
consensus sequence, which has been shown to be essential for inhibitory activity, as well 
as two cc-helical regions either side suggested to be involved in stabilizing the Inhibitory 
sequence in the terdary structure (59), as described in section 2.2. L. These thrce regions 
have been identified in all the cDNAs so far isolated (59,61). Using the positions of the 
a-helical and central consensus regions proposed in other species they were Identified in 
the partial amino acid sequence deduced from the bovine calpastatin cDNA 
. 
17he regions 
arc shown in Figure 35 as bold type above corresponding amino acid sequences from the 
other calpastatin cDNAs. 
The two research groups, led by Nfurachi and Suzuki, have ch=cterised the 
central inhibitory consensus equences in the domain structure of calpastatin. as 
discussed in section 2.2.1.. The bovine central inhibitory consensus equence is 
indicated in Figure 35, and can be written as-, 
LGERDDTIPPKYQ 
based on the sequence suggested by Maki et al (59) Kawasaki et al (60) and Ucrnori 
et al (56). 7bere is substitution from an arginine to a glutaminc residue in the "%, clj 
conserved" sequence (60) of. - 
Thr Ile Pro Pro X Tyr Arg 
From sequencing, in either direction in pG3pl3 and pG3p21 there was no 
difference in this codon, it always appeared as CAA, a codon for glutamine. The 
implications of this amino acid substitution arc considered In the discussion (section 
5-1. ). 
Ile bovine calpastatin cDNA sequence was isolated from the 2 clones 
pG3p2l/pG3pl3, the plasmid inserts were mixed and used to probe a Northern blot 
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of bovine skeletal muscle poly(A)+ enriched RNA Isolated by a single passage 
through a oligo-d(T) cellulose column. The result of the probe hybridization Is 
shown in Figure 36. At low stringency washing, 600C with 6xSSC, there were three 
hybridization bands visible. Two of the bands. at 5.1-5. Okb and 3.8-3.7kb. were 
clearly visible whilst a third "was diffuse between 2.9-2.6kb. Increasing the 
stringency of washing up to O. IxSSC plus 0.1% (w/v) SDS at 650C left the two 
intense bands, but there was still a very faint but detectable region of hybridization at 
2.9-2.6kb. Although the signal at 5.1-5. Okb overlapped the region of any rRNA in 
the poly(A)+ RNA sample the hybridization is strong even at high stringency 
washing, suggesting a specific hybridization product was prcsenL 
Figure 36: Northern blot of' bovine skeletal nimcle 1)()]). (A)4 RNA piohed mvlih 
ho%, I lie citipastatin I VR cD NA. Lane I and 2.11 ind III laniMa markers . 1pg am I 2pg 
respectively. Imic 3.9pg 1)ol), (A)+ RNA. I lyhrldlmd at 5511C and wa%hcd to a 
,II -SSC plus 0. I"T (w/V) SDS. Ilie local'(111% (If' tile 28S str ngency of' 650C \vith 0.1 \I 
and 18S ribosonial RNAs arc marked. 
28S- 
. 
--5-1 kb 
_--3-8kb 
--2-9kb 
1 
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4.2. Beta-Agonist Induced Skeletal Muscle Ilypertrophy: Examination 
or the Effects or the Agonist Ciniaterol on Skeletal Musclc mHNA with 
Particular Reference to the Calpain System. 
An examination of the effects of P-agonlists on the mRNA cxpmssion for the 
components of the skeletal muscle calpain system was made using the cDNA probes 
whose application in Northern blot analysis had been developed as described in the 
previous secdon. The samples used were provided from a bovine P-agonist growth 
uial using the agonist cimatcrol. Ile experiment was carried out by Dr J. Dawson and 
I acknowledge her help in kindly making the muscle samples available for analysis as 
well as providing the details of the growth data which are describcd bricfly bclow. 
The trial was carried out on Friesian steers which were fed a 70% dry grass 
30% barley pellet diet from 9 to 12 weeks of age. At 12 weeks the animals were 
divided equally into control (n=6) and treated groups (n=6) c3ch group being of 
similar average starting weight. Both groups received the original diet but the treated 
group's included the P-agonist cimaterol at 1.5ppm. After 16 weeks the animals 
were slaughtered, the muscle samples dissected and frozen Immediately in liquid 
nitrogen. Samples analysed were from five control and six cimaterol treated animals 
as one of the control animals died during the course of the experiment; however this 
did not alter similarity of the average starting weight of the two groups of steers 
(Table 12). Frozen muscle samples were stored at 400C for up to 4 months until 
required for extraction of total RNA and assessment of enzyme activity. 
The Longissimus dorsi (Ldorsi) muscle was examined for the effects of 
agonists on the expression of calpain system components mRNA. Previous studies 
had shown it to be a responding muscle to the growth promoting effects of p. 
agonists, which also had been linked to the changes een in the activities on the 
calp3in system in lambs 0 14), see section 2.4.0.. The effects of P-agonists on the 
calpain system had also been confinned In an wher steer P-agonist growth trial 
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Table 12. The effects of cimatcrol trcatmcnt on the weight gain and longissimus dorsi 
characteristics in Friesian steers. 
Control Cimaterol 
(n=5) (n=6) 
Starting body wt. (kg) 
Final body wt. (kg) 
Longissimus dorsi: 
Wet wt (g) 
N (mglkg wet wt) 
Wet wt /unit empty body wt 
(g/kg empty body wt) 
SED p 
79.8 ± 4.8 79.9 ± 5.5 4.29 > 0.05 
200.7 :t6.7 226.7 + 8.8 11.41 < 0.05 
2050± 67 2817 183 211 < 0.01 
35.88 ± 0.30 36.83 0.24 0.38 < 0.05 
13.35 ± 0.32 15.59 0.42 0.55 < 0.01 
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carried out within our laboratories (unpublished observations), see section 5.3.1. and 
Table 28. 
The cimaterol treated animals had a significantly greater live weight (LW) at 
the end of the trial than the controls, Table 12. From the growth data It was apparent 
that the cimaterol induced skeletal muscle hypcrtrophy in the trial, Table 12. The 
L. dorsi was significantly heavier and was proportionally a larger part of body weight 
in the treated animals. The greater nitrogen content (N) of Ldorsl In the cimatcrol 
treated animals reflects a increased protein accretion, a characteristic of P-agonist 
induced muscle hypertrophy. 
The observations described above indicated that the cimaterol had induced 
muscle hypertrophy in bovine L. dorsi. The following sections describe the 
examination of the activities of the calpains and calpastatin, isolation of total RNA 
from the L. dorsi samples and the subsequent analysis for the effects of cirnatcrol on 
the expression of certain mRNAs. 
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4.2.1. Calpain and Calpastatin Activity. 
Ldorsi muscle samples were ground to a powder under liquid nitrogen. Part 
of the sample was used for the extraction of total RNA and approximately 2g taken 
for the assessment of calpain and calpastatin activity. The calpain and calpastatin 
activity was isolated using the modified method involving phenyi-sepharose 
chromatography followed by FPLC on a Mono, -Q anion exchange column (section 
3.1. ). Calpain and calpastatin activities were determined from the 
chromatographically separated enzymes and inhibitor (section 3.1. ). 
The isolation and the tests for calpain and calpastatin activity tests were carried 
out by Mrs Y. Lassictt whose help I gratefully acknowledge. 
Ile effect of the P-adrenergic agonist. cimaterol. treatment on the calpain 
system in L-dorsi is shown in Table 13 and Figure 37. There was a st3tistically 
significant increase in calpain 11 and calpastatin activity with a decrease In calpain I 
which was not significant. This followed the trends seen in trials carried out 
previously in our laboratories on the effects of P-agonists in steers (unpublished 
observations) and lambs (114). 
160 
Table 13. The effect of cimaterol treatment on the calpain system wtivitics In bovine 
Ldorsi 
. 
Activity % 
(U/kg musclc) 
Control Cimaterol SED incm= p 
(n--4) (n--4) 
Calpain 1 1073 767 198 
-29 > 0.05 
Calpain H 813 1036 64 28 < 0.05 
Calpastatin 2138 3759 636 76 < 0.05 
Figure 37: Ile effect of cimaterol treatment on the activity of the bovine Ldorsi 
calPain system. 
[= CONTROL n=4 
EM CIMATEROL n=4 
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4.2.2. Extractable Total RNA. 
Total RNA was extracted from 8g of ground muscle powder from Cimatcrol 
treated and control Ldorsi samples (section 3.2.1. ). Ile resulting total RNA was 
dissolved in water and the concentration evaluated by its absorbance at 260nm 
(section 3.2.5. ). The quanfity of total RNA extracted is shown in Table 14. 
There is less extractable intact total RNA present in the cimaterol samples than 
the controls but it was not a stafisticallY significant difference. 
To give some indication of the quality of the RNA extracted three samples of 
each group were subjected to denaturing agarose gel clectrophoresis (section 
3.2.7. (i)). As can be seen in Figure 38 the samples appeared to be of good quality, 
since the 18S and 28S rRNA bands were clearly visible. There were definite bands 
between the rRNAS which could have been large quantities of particular RNA 
species. 
The negative of the photograph in Figure 38 was scanned on the Ultrascan 
XLTM Lascr Densitomctcr and the scanning data analysed on the Gc1scan XLTht 
Software Package (LKB) (section 3.4.14. ). The scans wcre used to try and assess if 
there was any change in the expression of the rRNA in the skcletal muscle total RNA 
extracted from the treated and untreated anirnals. 
7be mRNA makes up a small proportion of the total RNA, the cytoplasmic 
mRNA being approximately 34%. 71c rRNA is by far the greatest constituent of 
total RNA being up to 75% (215). By assessing the area under the clearly 
distinguishable 18S and 28S peaks above background using a manually selected 
baseline only a small specific part of the rRNA is being examined for changes (Figure 
39). However, as the total RNA concentration did not significantly alter between 
control and cimaterol-treated Ldorsi then the combined I 8S and 28S peak areas did 
give an indication of the relative expression of these RNA species to othen In the total 
RNA of control and treated animals. An increase in the I SS and 28S combined peak 
area would have been an indication that there was augmented expression of the RNA 
making up the ribosonr-S which may have implications on the capability for enhanced 
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Table 14. ne effcct of cimatcrol treatment on the quantity of total RNA extracted 
from bovine L. dorsi 
. 
Control Ciniatcrol 
(n=5) (n=6) 
Total RNA 
(jig/g muscle) 
S M. 
172 ±7 152 ± 10 12.8 
(values am tile mean ±S C- NI) 
0.05 
Figure 38: Glyoxal denaturing 1% agarose gel c1carophoresis of total RNA extracted 
from the cimaterol treated and control bovine Ldorsi. 11c Hind III lambda DNA 
(0.511g) lane is marked M and the cimaterol samples arc indicated by "XI. 711c 
ribosomal RNAs 28S and 18S are shown. 
28S 
NI M 
I (I 
Table 14. The effect of' cimater0i tl'c-lllllcllt ol, tile quantily of" lotal RNA cxtiactcd 
from bovine Ldorsi 
. 
Control cillialcrol 
01=5) (n--6) 
Total RNA 
(pg/g niuscle) 
SID 
172 ±7 152 4 1() 
(valties are the 111c. 111 
1) 
- 
0.05 
Figure 38: Glyoxal denaturing I I-; 
- agarow ocl clectrophoresis of total RNA extra. cicd 
from the ciniaterol treated and control bovine Ldorsi. The Hind III laml-K]a DNA 
(0.5ýig) lane is marked M and the cimaterol samples are indicated by 'X'. Thc 
ribosorrial RNAs 28S and 18S are shovvii. 
, 
I'tý 
11 1 
I, "" 
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Figure 39: A representative scanning densitometry trace produced from the 
denaturing gel in Figure 38. The trace shows the position or the 28S and 18S rRNA 
peaks and the selected baselini for peak evaluation. 
0.2 A 
I 
III 
IBS 28S ORIGIN 
Aa ABSORBANCE UNITS 
Table 15. Ile effect of cimaterol on the amount of 18S and 28S rRNA species 
present in total RNA 
- 
Densitornetry signal 
area under peak (Arbitimy units) SED p 
Control (3rmtcrd 
rRNA (n=3) (n=3) 
18S 0.188 ± 0.007 0.171 ± 0.002 
28S 0.153 ± 0.002 0.159 ± 0.003 11 
Combined 0.341 :t0.009 0.330 ± 0.001 8.8xlO-3 > 0.05 
ribosomal 
(values are the mean ± SEM) 
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t=slational capacity. 
The an-alysis of the rRNA content of the muscles by this method gave a seml- 
quantitative assessment. Table 15 displays the values for the peak areas calculated by 
integrating the area under 18S and 28S peaks. From the combined areas or the two 
peaks there was no significant difference between the cinuterol and control samples. 
4.2.3. In Y'tro Translation of Total RNA. 
The bovine skeletal muscle total RNA from the cimaterol and control samples 
was subjected to in vitro =slation using the rabbit mdculocyte lysate system (section 
3.2.10. ). 
initially in vi translation was carried out using a total RNA concentration of
24pg per translation. All the samples tested showed incorporation of 35S into TCA 
precipitable protein, as assessed by the filter dotting method using 21LI of the 
translation mix at a level that was 4 to 6 times that of the blank. 71e remaining 
volume of the samples were run out on a 10% SDS-PAGE (section 3.2.11). ne 
autoradiograph of the gel showed protein products with 35S incorporated (data not 
shown). Ilis indicated that the RNA isolated from the bovine Ldorsi was intact. 
There was a significant incrcase in the 35S incorporated into TCA prccipitable 
protein for the translations carried out on total RNA from the cimaterol trcated animals 
(Table 16A). However when the values obtained were expressed per pg of total 
RNA the difference in the incorporation was not significant (Table 16B). It was not 
known whether the concentrations of total RNA used in the experiment were 
saturating. 
In order to try and confirm whether the total RNA isolated from the cirnaterol 
treated bovine Ldorsi had the capacity for enhanced in vitro U=13tion capability the 
translations were repeated using a non-swurating concentration of total RNA, which 
was determýlned by a dilution assay of a sample from a cimaterol Mted animal (Table 
17). it appeared that a total RNA concentration of I pg per translation was on the 
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Table 16: Tbc incorporation of L-[35S]-methioninc into TCA prvcipitable proicin of 
cirnaterol trcated and control Ldorsi total RNA subjected to invitto Ira slaflon. 
Control 
(n--4) 
A. 
35S 
Incorporadon 
(cpnV2ýd) 
B. 
35S 
Incorporadon 
(cpmt2gVllg) 
16028 ±1726 
5502 ±1348 
Cimaterol S M- p 
(n=4) 
21557 ± 837 1918 < 0.05 
7162 ± 1142 1766 > 0.05 
Table 17: The incorporation of Lý5jrncthioninc into TCA precipitable 
protein generated by in vitro translation with increasing concentration of total RNA 
present. 
Incorporadon Acdviry 
Diludon RNA of 35S loaded onto 
(jig) (cpnv7gl) gel (Cpm) 
0 0 2399 9596 
118 0.46 9012 36048 
1/4 0.93 13083 52332 
1/2 1.85 23276 93104 
1 3.70 25574 102296 
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Figure 40: The change in L-[35S] methionine incorporation into TCA precipitable 
protein by increasing the concentration of total RNA prcscnt in the in vitro translation 
mix (data from Table 17). 
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Figure 41: A 101; '( SDS-PAGE. gcl of tile in N, itr(, ) translation proKlucts gencrated from 
total RNA at various dilutions. The samples loaded are the in N, Itrf, ) Ir. 111%L111011 
products from 0,3.7,1.85,0.93 and 0.46pg Ldorsi total RNA, lanc% () w .1 
respectively. The (IL1,11,111Y Oflctlvity loaded is shown In Table 17. 'llic position% M 
nonradioactive markers are indicated. 
')O5kDa 
- 116kfl, 
- 
97kDa 
- 
66kDa 
low dome 
. 
1, i. 
I, , 
"qkp, i 
01234 
168 
linear part of the total RNA translation saturation curve (Figure 40). 71c remaining 
translation products, as indicated in Table 17, were subjected to SDS-PAGI: (Figure 
r 
41). 71c autoradiograph con+cd that there was incorporation of 35S-methionine 
into protein as well as sho%6ng the level of activity required which gave clemly visible 
protein products on autoradiographcd SDS-PAGE. which was in the range of 90- 
1 OOx 103cp m per lane. 
Using Ilig total RNA per translation an assessment of the translation 
capability of the cimatcrol and control samples was made. lie stock of total RNA 
used in the first translation was diluted to I Pg1jil then the concentration redetermined 
by absorbance at 260nm. The translation was carried out as described In section 
3.2.10.. There was no significant difference in the incorporation Into TCA 
prccipitable protein per pg of total RNA present between the control and cimatcrol 
samples at nonsaturating total RNA concentrations Crable 18). 
Ile in vitro translations were repeated using 2.0-2.5pg of tot: d RNA per 
translation (Table 19), concentrations which were believed to be near saturating, see 
Figure 40. There was no significant difference between the s3mpics although the 
cimaterol samples seemed to show a higher incorporation per pg than the controls. 
From this translation the equivalent of 9ox 103 cpm was taken from each sample and 
subjected to SDS-PAGF- The resulting autoradiographs am shown in Figure 42. 
There appeared to be no major changes in the protein produced from the total 
RNA of the cimaterol treated and nontreated muscle total RNA samples. The 
probable translation products of actin and myosin can be smn. At the bottom of the 
gel are the smaller muscle pmteins. possibly the myosin light chains, which do show 
some slight size shifts between the controls and cimaterol-tre3ted groups In some of 
the samples. 
Ile in vi translations indicated that the mRNA was intact. The proteins 
encoded by the mRNA present were not appreciably different in this qualitstive 
esamation or was there an increase in the protein of particular transcripts between the 
treated and control animals. 
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Table 18. The effects of cimaterol on the translational capability of bovine Ldorsi 
total RNA determined at 'nonsaturating' concentrations. 
Control 
(n=3) 
35S 
Incorporadon 
(cpml2giffig) 
12440 ±3430 
Cirmtcml 
(n-3) 
12470± 3680 
(values are the mican i SENI) 
SED p 
5030 > 0.05 
Table 19.7be effects of cin-aterol on the incorporation of 05S)rncthionine Into TCA 
precipitable protein in the ja_yjup-translation at "saturating' levels of bovine Ldorsi 
total RNA (2.0-2.5pg). 
Control Cinuteml 
(n=5) (n=5) 
35S 
Incorporation 9620±1050 12730± 1040 
(cpmj2Wpg) 
(values are the n=n ± SEM) 
SED 
1480 > 0.05 
I 
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4.2.4. Determination of Changes In Speciric Bovine Skeletal Muscle 
mRNA. 
Northern blot analysis 
Using mouse a-actin cl)NA and chicken myosin light chain 2 (SILC2) cl)NA 
(appendix A) skeletal muscle total RNA from the cimaterol treated and control aninuls 
was probed to assess whether there were changes in the equivalent bovine mRNAS. 
71c two cDNA probes had been used with success on bovine total and poly(A)+ 
RNA; they had hybridized to a specific mP. NA species in each case under relatively 
high stringency washing conditions 2xSSC plus 0.1% (, A, /v) SDS at 650C (section 
4.1.1. and Figure 22 and 23). 
A Northern blot of control and cimaterol treated total RNA (25pg) samples 
was probed with the mouse a-actin cDNA labelled by nick translation (section 
3.4.9.0)). lie membrane was hybridized at 550C and washed to a stringency of 
O. IxSSC plus 0.1% (w/v) SDS at 650C as shown in Figure 43. After scanning 
densitomctry of the autoradiograph the peak areas of the trace produced was 
determined using the data analysis integration programme (3.4.14. ). The scans of the 
autoradiograph and the results of the assessment of their peak am by Integration are 
shown in Figure 44 and Table 20 respectively. neremas an apparent statistically 
significant increm in the mRNA for a-actin in the cimaterol samples. 
The cx-actin cDNA was removed from the Northern blot (section 3.4.13. ). 
The Northern blot was reprobed with the chicken MLC2 cDNA labelled by nick 
translation. Hybridization was carried out at 550C and the membrane was washed at 
increasingly stringent conditions to 2xSSC plus 0.1% (w/v) SDS at 650C. The 
autoradiograph, Figure 45, was scanned on the densitometer and the a= under the 
peaks of the trace determined as for the a-actin probed Northern blot 
. 
as Indicated in 
Table 2 1. 
As with the a-actin cDNA probe hybridization experiment here was a 
significant increase in the mRNA transcripts for MLC2 In the skeletal muscles of the 
cimaterol mated animals. 
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FI gure 43: A Northem W(it (it-ciniatcrol I mated and coil iml Kwine 1. (1()r%, Itq. j I RN A 
(25pg) Probcd with mouse a-actin cDNA. The hybridi; ration ind waOmig dclaik Irc 
in the tem. Positions of the ribowmal RNA%. 29S and I 8S. ; ire indicated and the 
cimatcrol samples are inarkcd with 'X*. The suc (if wacim hybriduati(in signal i% 
Indicated 
. 
kb dom- 
-- *, moo, 
-18S 
-111W -- 
x xxxx 
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Figure 44. Scanning densitometer traces produced from the Nonhem blot (Figure 
43) probed with mouse ct-actin cDNA. Traces used for the assessment of the 
intensity of the hybridization signals (Table 20). 
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Table 20. Ile effect of cimaterol on the hybridization signal produced from the 
Northern blot (Figure 43) of bovine Ldorsi total RNA pmbed %ith mouse a-actin 
cDNA. 
Ama by 
Integmtion 
(Arbitrwy units) 
Control 
(n=S) 
0.708 ± 0.140 
Cimatc. rol 
(n=S) 
1.164 ± 0.125 
(values am the n-can ± SENI) 
SED 
0.186 < 0.05 
Figure 
-15: The Noilhan Not of cim. 11CIO] 11c, 11cd and colluol boville I, dol%1 lotal 
RNA smnp I cs (25pg) probek I wIt hch iAcn N11. C2 c DNA. 'III c III oI S114 I%% [I tic Imv \\.; I% 
Figure 43 rcilrobcd. I Iý bridlidtion and \% a0ung tIctails are in tile tc\t. llwmons. of 
the 28S and I SS ribosonmi RNAs are shown and tile cimaterol samplc% are nim ked 
by X. The 
, Izc of tile Ilyhridumion signal for tile \11 C2 I,, inklicatcd. 
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Table 21. Ile effect of cimaterol on the hybridization signal produced from the 
Northern blot (Figure 45) of bovine Ldorsi total RNA probed with chicken MLC2 
cDNA. 
Control 
(n=5) 
Area by 
integration 
(Arbitrary units) 
3.172 ± 0.287 
Citnaterol 
(n=S) 
4.264 :t0.364 
SED 
0.464 < 0.05 
(values arr. the mean ± Sal) 
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11owevcr from previous Northern blots the distribution of the samples and 
uneven transfer of the RNA had resulted in variation of hybridization signal on 
membranes. To confirm the changes seen in the Northern blots. slot and dot blots of 
total RNA were used. 
Dot and slot blot analysis. 
Scrial, half dilutions of total RNA were used In dot and slot blots using a 
fonnamide/fonnaidehyde naturing system (section 3.2.9. ). Two samples from 
each group were applied on to a dot blot appamtus in half dilutions from 15pg of total 
RNA. It was difficult to apply the 15pg to the dot area onto the 1.1ybond-N 
membmne (Amersham) as the sample was too concentrated for the area to be loaded. 
The blot was probed with chicken hlLC2 cDNA at 550C and washed at increasing 
stringency to 2xSSC plus 0.1% (w/v) SDS at 650C The resulting autoradiograph is 
shown in Figure 46. Analysis of the dot blot scans was carried out by scanning 
densitometry of the autoradiograph and subsequent evaluation of resulting peak area 
by integration of the scan (Table 22). The 15pg sample was distcgardcd ue to its 
inconsistent application onto the Hybond-N mcmb=c. 
lie data in Table 22 was used to determine the relationship between the 
amount of total RNA in each dot and the area under the densitometer peak for each 
dot, Figure 47.7be curve was only linear over a restricted range of total RNA loaded 
from 0 to 2pg above which the curve reached aplateaux. Linearity Is achieved where 
the quantity of the sequence being probed on the dot is less than that of the 
concentration of probe present in the solution. From the linear part of the curve them 
apparently was no difference between the samples. 
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Migurc 46: Dot blot of total RNA frorn cinutcrul treated and control bovine Ldorsi 
probed with MLC2. cDNA. A loading plan for the quantity of total RNA present is 
shown along with positions of the convols dots of NILC2 and ct-actin cDNA. Ilic 
cimatcrol samples are marked X. Hybridization and washing details are described in 
the tr-XL 
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Figure 46: Dot blot of total RNA from Cilliatclol trcalcd aild comfol 1xiville I 
, 
(10t%l 
probed with NILC2 cDNA. A loading plan for file ipiamily of iouil RNA pirscm i% 
shown along with positions of the controls (lot-, (if NiI. C2 and ot-actin d)NA The 
clinatcrol samples are marked X. I lybridization and washing details arc dcscrilvd m 
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Table 22. Area under the absorbance peaks of the densitomctcr trace from the chickcn 
NILC2 cDNA probed dot blot (Figure 46) of chaterol treated and control bovine 
L. dorsi total RNA. 
Densitormter signal 
(Area under curve, Arbitrmy units) 
DUution RNA Control Cimaterol 
(pg) (n=2) (n=2) 
1 7.50 1.552 2.008 
1/2 3.75 1.236 1.537 
1/4 1.88 0.882 1.102 
w 0.94 0.547 0.591 
1/16 0.47 0.276 0.404 
1/32 0.23 0.262 0.274 
1/64 0.12 0.095 0.109 
(values are the mcan) 
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Figure 47: Ile relationship between the total RNA present In each dot and the 
intensity of the hybridization signal for the MLC2 cDNA probed dot blot (Figure 46). 
Ile data is from Table 22. 
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The analysis was repeated using slot blotting (section 3.2.9. ) which gave 
more distinct sample loading and resulting autoradiograph pattern than the dot blot 
apparatus. Samples were loaded in a series of half dilutions from 7.5pg downwards. 
The membrane was probed with MLC2 cDNA at 550C then washed to a stringency of 
2xSSC plus 0.1% (w/v) SDS at 650C. The resulting autoradiograph Is shown In 
Figure 48. 
Ile average area from the integration of the traces is shown in Table 23. the 
ggraph produced 
from the data is shown in Figure 49. However it was difficult with 
the parameters selected to obtain an integration value from the 7.5pg total RNA peak 
on the densitometer trace so this was omitted from Table 23. There appeared to bea 
stronger hybridization of the chicken NILC2 cDNA probe to the total RNA of the 
cimaterol samples than the controls. This was apparent at the higher loadings of 
total RNA in both the dot and slot blots. The relationship between the intensity of the 
hybridization signal and the quanitity of total RNA in each slot did not reach a plateau 
in Figure 49 as seen in Figure 47. This may have become apparent at higher loadings 
of total RNA which were not analysed. 
it must be remembered that the chicken NILC2 cDNA probe when used on 
bovine total RNA did not give a strong hybridization signal in comparison to that of 
cc-actin (Figure 22 and 23). This may have affected the hybridization to the total 
RNA on the dot and slot blots, although there did not appear to be much nonspecific 
hybridization in the Northern blot probed with chicken NILC2 shown in Figure 45. 
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Figure 48: Slot blot of total RNA from cimaterol treated and control bovine Ldorsi 
probed with MLC2 cDNA. The controls of NULM and a-actin cD\, 'A. as well as the 
quantity of total RNA in each slot, are marked. Mw-- cinnicrW sxmplcs; = indicated 
by X. Hybridization and washing details = described in the tcxL 
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Figure 48: Slot Not of total RNA from ciniaterol treated and control IX)vlnc I., (ior-%. l 
probcd with MI-C2 cDNA. 'I'lic controls of MI. ('2 and (-x-actin cDNA. a% wcll as Ilic 
quantity of total RNA in each slot, are marked. The cimaterx-)l %-arnpIcsarc Indicated 
byX. llybridizationand washingdetails are dcwribcd in the tcxt. 
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Table 23. Area under the absorbancc peaks of the densitomcter traces from the 
chicken MLC2 cDNA probed slot blot (Figure 48). 
DOudon 
1 
1/2 
1/4 
1/8 
1/16 
1/32 
1164 
RNA 
(lig) 
7.50 
3.75 
1.88 
0.94 
0.47 
0.23 
0.12 
Densitormter signal 
(Area under curve, Arbitrary units) 
Control Qrnaterol 
(n=3) (n=3) 
1.736 ± 0.304 
1.005 ± 0.189 
0.526 + 0.147 
0.226 ± 0.053 
0.095 ± 0.022 
0.039- 
* n=2 
(all values are the mean SENI) 
2.116 ± 0.054 
1.232 ± 0.111 
0.595 ± 0.104 
0.273 ± 0.021 
0.091 ± 0.014 
0.039 ± 0.010 
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Figure 49: The relationship between the total RNA present in cach slot and the 
intensity of the hybridization signal for the NILC2 cDNA probed slot blot (Figure 48) 
of cirriaterol treated and control groups. The data is from Table 23. 
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xCimaterol n--3 +SEM 
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Using the slot blotting technique the extracted total RNA was examined for 
changes in the ot-actin mRNA. The mouse cx-actin cDNA used for the analysis had 
been shown to hybridize at a higher stringency than the chicken MLC2 cDNA, 
O. IxSSC plus 0.1% SDS at 650C compared with 2xSSC plus 0.1% SDS at the same 
temperature rcs pectivcly (Figure 43 and 45). so would prob 
- 
Y. be more effective In 
this type of mRNA quantification. The higher stringency washing would reduce the 
possibility of nonspecific hybridization. 
Serial half dilutions of five samples from each group were made from Mpg 
of total RNA. Three samples of each group were loaded onto one slot blot 
membrane, whilst the remaining two samples from each group were loaded onto 
another. Ile filters were prchybridized in the same volume and had the equivalent 
quantity of the nick translated labelled mousc cc-actin cDNA probe loaded into the 
hybridization solution. The hybridization was carried out at 550C, the filters were 
washed to the same stringency of O. lxSSC plus 0.1% (w/v) SDS at 650C Ile 
autoradiograph was scanned as previously described and the results of the 
integration are shown in Table 24. The data was used to plot the graph In Figure 50. 
71C same type of curve was produced as in the slot and dot blots probed with 
chicken MLC2 cDNA. Ile linear part of the curve appeared to be from 0 to 2pg of 
total RNA. As with the MLC2 data there appeared to be mom cc-actin mRNA In the 
cimaterol samples than the controls especially at the higher loadings of total RNA but 
on the linear part of the curve there was no apparent di ffcrcnce. 
From the slot and dot blots there was no apparent large shifts in the number of 
mRNA transcripts of two skeletal muscle proteins, hILC2 and ct-actin. From this 
data and the qualitative examination of the in vitro translation protein products 
generated from cimaterol treated and control bovine Ldorsi total RNA (section 
4.2.3. ) it appeared that the increased protein accretion in 0-adrenergic Agonist 
treatment was probably not due to an large increase in these muscle protein mRNA 
transcripts. 
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Table 24. The effect of cimaterol on the hybridization signal produced when probing 
the slot blots of total RNA from treated and nontrcated bovine Ldorsi muscle samples 
with the mouse (x-actin cDNA. 
Diludon 
1 
1/2 
1/4 
1/8 
1/16 
1/32 
1/64 
RNA 
(11g) 
7.50 
3.75 
1.88 
0.04 
0.47 
0.23 
0.12 
Densitometer signal 
(Area under curve, Arblawy units) 
Control Cinuteml 
(n=5) (n=5) 
0.206 ± 0.022 
0.156 ± 0.018 
0.095 ± 0.014 
0.051 ± 0.005 
0.023 ± 0.004 
(values are the nxm ± SEM) 
0.227 10.017 
0.179 ± 0.015 
0.095 ± 0.010 
0.051 ± 0.006 
0.028 ± 0.002 
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Figure 50: The effect of cimaterol on the relationship between the total RNA prcscnt 
in each slot and the intensity of the hybridization signal for the slot blots probed with 
mouse cc-actin cDNA. The data is from Table 24. 
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4.2.5. Assessment or Changes In the mRNA Transcripts for the 
Calpain Large Subunit lsoforms. 
Ile cDNA inserts from plasmids p42 and p2l-16 for human calpain I sind 11 
large subunits respectively were used to try and determine any changes In their 
corresponding mRNA in the bovine L. dorsi total RNA samples. 
From earlier work it had been found that to visualize the calpain large subunit 
rnRNA on autoradiographs the optimum quantity of total RNA required on Northern 
blots was 50pg (section 4.1.4. ). To confirm this for the bovine samples 10,30 and 
50gg of total RNA from two samples of each group were clectrophorescd on a 
formaldehyde denaturing gel then Northern blotted (section 3.2.7. (ii) and 3.2.8. ). 
lie resulting blot was probed with human calpain I and thcn calpain 11 large subunit 
cDNAs. 
7be Northern blot was first probed with human calpain I large subunit cDNA 
labelled by nick translation, hybridized at 550C and washed to a stringency of 6xSSC 
at 600C. There was no clear hybridization signal and the high background on the 
filter persisted even after washing at higher stringency (Figure 5 1). Probing of other 
Northerns of the bovine total RNA samples with the calpain I large subunit gave a 
similar result as was seen when the human calpain I large subunit cDNA was first 
characterised (secdon 4.1.4. ). The I. 5kb signal seen in the poly(A)+ enriched RNA 
(Figure 30) was not visible in this experiment. It may have been obscured by the 
high nonspecific background. Due to this lack of success in using this probe it was 
not persisted with. 
Ile Northern was reprobed at 550C with the human calpain 11 large subunit 
cDNA labelled by nick translation. The blot was washed to a stringency of 6xSSC at 
600C A clear hybridization signal could be seen to a mRNA species (Figure 52) as 
was shown in section 4.1.4. The autoradiograph was scanned using the Ultroscan 
XLTM Laser Densitometer. Assessment of the area under the calpain 11 large subunit 
cDNA hybridization peak was made by integration using a manually selected baseline 
(section 3.4.14. ) (Table 25). 
Figure 51: A., 'orthern 11](11 (11' 1 rmioc of quantities (if' lotal RNA fiom citmoviol 
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Figure 52: The Northern Not of' Figure 51 reprobcd with the human callmin 11 large 
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Table 25. The effect of cimaterol, on the intensity of the hybridization signal for 
bovine L. dorsi total RNA probed with human calpain 11 large subunit cDNA. Tile 
Northern blot (Figure 52) was assessed by scanning densitometry. 
Densitometer signal 
(Area under curve. Arbiu-w-y units)) 
RNA Control Ciniaterol 
Ou 9) (n=2) (n=2) 
10 0.401 0.488 
30 0.777 0.842 
50 1.066 1.216 
(values are the mean) 
Figure 53: The effect of cimaterol. on the relationship between the total RNA and the 
intensity of the hybridization signal for the Northern blot probed with human calpain 
11 large subunit cDNA (Figure 52). The data is from Table 25. 
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Although there was high background on the autoradiograph the hybridization 
signal for the calpain 11 large subunit cDNA was linear with respect o the quantity or 
RNA loaded (Figure 53). The intensity of the hybridization signal in the cimaterol 
samples appeared greater than in the controls but it was not significantly so. 
A further Northern blot using 50pg of total RNA from the trial samples was 
made and probed with the human calpain 11 large subunit cDNA at 550C. 7be probe 
was labelled using a random primer labelling kit (Bochringer) instead of nick 
transladon (section 3.4.9. ). This gave a probe of higher specific activity. Activity of 
labelled cDNAs by nick translation are typically 5xlO8 dpm/gg whilst random primer 
labelling gives probes of 5xIO9 dpnVgg, when using the procedures uggested by the 
manufacturers of the kits (Amersham). Because of the low copy number of calpain 11 
large subunit mRNA, higher specific activity of the probe was advantageous. Figum 
54 shows the Northern probed with the calpain II large subunit cDNA and washed to 
a stringency of 2xSSC at 650C, after hybridization at 550C. 
In order to obtain a clear signal of hybridization, the membranes probed 
with the calpain H large subunit cDNA had to be autoradiographed for 5 days, due to 
the low copy number of the calpain mRNA transcripts. As a result there was high 
background on the autoradiograph. This was compounded by the lower stringency of 
washing than was required for the actin and MLC2 cDNA probes. 
The autoradiograph was scanned. The traces produced are shown in Figure 
55. The intensity of the hybridization signal was quantified by integration of the peak 
area, Table 26. 
Although their was a higher value for the cimaterol samples to that of controls 
the difference was not significant. Probing Northerns of total RNA from treated and 
control L. dorsi with the human calPain H large subunit cDNA in similar experiments 
to the one described above gave similar results, although they tended to have higher 
nonspecific background. There was an increase in the intensity of the signal for 
calpain II large subunit mRNA in the treated samples but this was never signiricanL 
I () ý; 
Figure 54: 11 unian ca I pain 11 Liroc subunit cD NA prc! ), d Northern I) It it )I' t,, ja I RN A 
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Figure 55: Traces of the densitometer scanned human calpain 11 large subunit cDNA 
probed Northern blot (Figure 54). 
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Table 26. The effect of cimaterol on the intensity of the hybridization signal for the 
human calpain II large subunit cDNA probed Northern blot of Figure 54. 
Control 
(n=5) 
Area by 
integradon 
(Arbiamy units) 
0.234 :k0.023 
Cimatcrol 
(n=6) 
0.313 ± 0.032 
SED p 
0.041 > 0.05 
(values are the mean ± SBI) 
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Attempts were made to quantify the changes in the expression of calpain 11 
large subunit between the samples by slot blotting. This was not possible as not more 
than 15pg of skeletal muscle total RNA samples could be loaded successfully onto the 
Hybond-N membrane via the slot blot apparatus. Northern blots had to be used as a 
means of quantifying changes in the calpain mRNA in total RNA samples as over 
30gg of total RNA was required to give a clear hybridization signal, as seen on 
Figure 52. 
4.2.6. Changes in the Expression or Calpastafln mRNA. 
The PCR generated bovine calpastatin cDNA was used to probe Northern blot 
of 50gg of L. dorsi total RNA samples from the bovine P-agonist trial. 71e 
calpastatin PCR cDNA insert mixture, from pG3p 13 and pG3p2l, was labelled using 
the random primer method (section 3.4.9. ). Hybridization was at 550C and the 
Northern was washed to a stringency of 2xSSC plus (w/v) 0.1% SDS at 650C In 
order to obtain a clear autoradiograph of the hybridized calpastatin PCR cDNA the 
probed Northern was left for 7 days to develop. 
As with the probing of the bovine poly(A)+ RNA Northern blot (section 
4.1.5. ) there were three hybridization bands at approximately 5.1-5.0,3.8-3.7 and 
2.9-2.6kb (Figure 56). The 2.9-2.6kb hybridization band was more distinct than in 
the poly(A)+ enriched RNA Northern blot (Figure 36). Ilerc was a clearly visible 
difference in the strength of the signal at 3.8-3.7kb and to a lesser degree at 5.1- 
5. Okb. ibis was not due to a discrepancy in the loading of the total RNA samples as 
this filter was reprobed with the human calpain 11 large subunit cDNA probe and there 
was no significant difference in the hybridization signal between the samples (Figure 
54). 
Figure 56: Bovine callmstmin PCR cDNA probcd Northern bloi of toiýd RNA (50pg) 
from the cinlaterol treatedand control bovine I-dorm. I lind III lambda DNA maik-cus 
(1.5pg) are indicated by tile letter N1 and the clinaterol samples are mark-ed with 'V. 
Conditions of llybrid I zat loll and washing Ire Outlined ill tile text. The poollon of tile 
28S and 18S ribosonial RNA, -, are shown along with the size (if tile hylirldliation 
signals for calpastatin. 
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Figure 57: Traces of the densitometer scanned bovine calpastatin PCR cDNA probed 
Northern blot shown in Figure 56. 
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The autoradiograph was scanned and the resulting traccs are shown In Figure 
57. Mie difference between the cirnatcrol and control samples was clear. Areas under 
the two definite peaks at 5.1-5.0 and 3.8-3.7kb were integrated along with the area of 
the speculative peak in the 2.9-2.6kb region (Table 27 and Figure 27). 
Although for all three hybridization bands the cimatcrol samples were of 
greater intensity, this was only significant with the signal at 3.8 kb. 
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Table 27. The effect of cimaterol on the intensity of the three hybridization signals for 
the bovine calpastatin PCR cDNA probed Northern blot of Figure 56. 
Densitometer signal 
RNA (Area under curve, Arbitrary units) 
Size Control Cimaterol 
(n=5) (n=6) 
5.1-5. Okb 0.230 ± 0.054 0.346 ± 0.085 
3.8-3.7kb 0.351 ± 0.042 0.915 ± 0.118 
2.9-2.6kb 0.139 ± 0.073 0.157 ± 0.043 
SED p 
0.105 > 0.05 
0.135 < 0.05 
0.810 > 0.05 
(values are the mean ± SEM) 
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Figure 58: Ile intensity of the hybridization signals for calpastatin mRNA In 
cirnaterol treated and control bovine L. dorsi total RNA sampIcs. 
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Chapter S. Discusslon. 
5.0. Introduction. 
Previous observations from within our laboratories have shown that there Is an 
effect on the activities of the calpain system components (calpain I and 11 aný calpastatin) 
associated with fýagonist induced skeletal muscle hypertrophy. The work carried out in 
this thesis was undertaken to further examine this effect by moving the attention toward 
the possible means by which the changes in act-ivity could be brought about. 'Ibcrefore 
this thesis concentrated on whether the changes in activity could be brought about by 
alterations in the mRNA expression of the calpain system components. During the 
course of these experiments observations were also made on the effects of the P-agonist 
cimaterol on the expression of mRNA species for myoribrillar proteins cc-acdn and 
MLC2 along with the translational capabilities of the isolated total RNA. 
These observations are considered in the following sections and are related to 
previous studies which suggested that augmented protein accretion was brought about by 
decreases in protein degradation (115-118). Particular attention is focused on the tole of 
the changes in calpastatin mRNA expression and its probable subsequent effect on the 
inhibition of the calpain proteolytic system and the relationship of this to the decline In 
protein breakdown. 
However the first sections of this discussion deal with the observations made on 
preparing total RNA from skeletal muscle and the use of different types of nucleic: acid 
hybridization probes for calpain. This is followed by a detailed examination of the 
bovine calpastatin cDNA generated by PCR, how it relates to the calpastadn cDNAS 
already isolated and the implications of the rnRNA hybridization signals seen when the 
PCR cDNA was used for Northern analysis of bovine total and poly(A)+ emiched RNA. 
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5.1. Isolation of Total RNA and the use or Hybridization Probes to 
Calpain mRNA. 
Extraction of total RNA. 
The development of techniques for the isolation of intact total RNA from skeletal 
muscle were a result of ongoing work carried out on the detection of various mRNA 
species. As shown in the Figures of section 4.0.1. the quality of the total RNA Improved 
during the experiments canied out to compare extraction methods and assess various 
cleaning procedures. The main objectives of total RNA isolation was the physical 
removal of protein by denaturing with phenol/chloroform then the adoption of effective 
reprecipitation techniques which removed DNA from the samples. Although the method 
may not have been absolutely quantitative it did give reproducible results which allowed 
comparison of extractable intact total RNA in the bovine trial (section 4.2.2. ). 
Ile improvement in the quality of the RNA extracted was essential for the ability 
to produce proteins from mRNA by in vitro translation (section 4.0.3. ). 71is was also 
achieved by the modification of the in vitro translation 'cocktail'to give an environment 
where the rabbit reficulocyte lysate was Wective on skeletal muscle mRNA. 
Oligonucleolide probes for calpain large subunit. 
71c mRNA for the calpain isoforms and calpastatin = expressed at very low 
levels in most 6ssues(159,199). approximately I picogram of chicken skeletal muscle 
calpain large subunit per microgram of total RNA, so they are difficult to detect. When 
the oligonucleotide I was used as a probe on poly(A)+ RNA prepared from chicken 
skeletal muscle a clear hybridization signal of the expected size for the calpain large 
subunit mRNA at 3.5kb (14) was detected (section 4.1.1. ). 7bis hybridization took 
place at relatively high stringency. Although the oligonuclootide I probe had been chosen 
to have high homology across species and was selected from domain III, which was 
believed to have no homology to non-calpain cDNA sequences, It was difficult to 
produce a specific hybridization signal to calpain large subunit mRNA across species 
even when it was used in low stringency conditions (section 4.1.1. ). These 
hybridization conditions were chosen to encourage hybrids to form to related sequences 
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across species, as the mciting temperature (Tm) of the hybrid would be lower than that of 
a 100% matching sequence. 
The failure of the oligonucleotide I probe was very likely due to mismatches 
between its sequence and the appropriate region in bovine calpain large subunit mRNA 
which would seriously effect hybridization capability of such a short probe, only 39 
nucleotides. Although reducing stringency enhanced the possibility of detecting calpain 
large subunit mRNA across species the likelihood of hybridization to similar unrelated 
sequences increased. Ile chicken calpain large subunit is believed to be a calpain It-like 
isoform (14) so the oligonuclcotide I probe was expected to hybridize to bovine calpain 11 
large subunit mRNA. However, the oligonucleotide I probe tended to hybridize 
nonspecifically, particularly to the rRNA, so that the high background masked any 
calpain mRNA bands (Figure 21). There was faint band at approximately the size 
expected for calpain large subunit but the two isoforms are reported to be near the same 
length so it would in any case be impossible to decide which large subunit isofonn had 
been detected (15,16,17). 
Griffiths et al (196) successfully used end labelled oligonucleotides (33mers) to 
detect the mRNA encoding closely related proteins. They examined the mRNA 
expression of G-protein subunits in streptozotocin induced diabetes in rats. Although the 
mRNAs they detected were closely related they were able to produce specific 
hybridization without nonspecific background on Northern blots of total RNA. Their 
oligonucleotide probes were selected from the cDNA of the species in which they were 
examining the changes in mRNA. They observed that a 30% mismatch between 
oligonuclootides was sufficient to prevent cross-hybridization. For chicken large subunit 
oligonucleotide I probe the percentage mismatch to other species was between 15 and 
21% (Table 8). This may have been sufficient mismatch to prevent hybridization In cattle 
but could be complicated by the distribution of the mismatches, closely grouped 
mismatches trongly affecting hybridization. 
Tic problems of nonspecific hybridization may have been the result of 
overloading the hybridization solutions with labelled pmbe. 11ovmver the quantities used 
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were within the guide-lines recommended by textbooks and labelling system 
manufacturers (167,175,195). Reprobing the Northern blots with mouse cc-actin and 
chicken myosin light chain 2 cDNAs gave no acute nonspecific hybridization, even 
though they were not specific to the bovine total RNA probed and were used in higher 
concentrations than the oligonuclcotide I probe, see Figure 22 and 23. This was because 
of the length of the cDNAs used, the proteins being conserved between species and the 
relatively high expression of their mRNA in skeletal muscle. 
In order to try to detect the mRNA for calpain in total RNA samples and across 
species using oligonucleotides a different labelling technique was employed. This was 
attempted after PCR generation of a cDNA had failed for the reasons outlined in section 
4.1.2.. Ile technique of specific primer extension clearly gave a oligonucleotide probe 
of higher specific activity (section 4.1.3. ). This would make it more effective In the 
detection of low copy number calpain mRNA. But as with the end-labelled 
oUgonucleotide it was unsuccessful in producing specific hybridization to the mRNA in 
chicken skeletal muscle total RNA in low stringency conditions. By development of this 
technique a better oligonucleotide probe possibly could have been produced but the 
effects of nonspecific hybridization would probably still have been a problem in low 
stringency condifions due to the probe binding unrelated sequences. Production and 
refinement of bovine poly(A)+ RNA may have improved hybridization signals, but 
insufficient issue was available in the trial. 
The human calpain I and 11 large subunit cDNAs 
Even given clear hybridization signals it would have been difficult to distinguish 
between the two isoforms for calpain large subunits using oligonucleotide probes derived 
from the chicken skeletal muscle isoform because of lack of high homology specifically, 
toward either calpain I or calpain 11. By using the human calpain I and 11 large subunits 
cDNAs (16,17) it was expected that a greater degree of specificity could be achieved. 
The human calpain I large subunit cDNA failed to detect convincingly the expected 3.5kb 
signal in bovine skeletal muscle total and poly(A)+ enriched RNA Northern blots (17igure 
29 and 30). Ile possible reasons for this were discussed in section 4.1.4- The human 
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calpain I and 11 large subunit cDNAs were subjected to restriction endonucleasc analysis 
(appendix A) before use and results agreed with the data of Aoki et at (16) and Imajoh et 
at (17) respectively. Full characterization could only have been achieved by sequencing, 
but insufficient firne was available for this. 
As a result of nonspecific hybridization the use of calpain I large subunit cDNA 
was abandoned for the bovine trial. The calpain 11 large subunit cDNA weakly 
hybridized to a mRNA species in bovine skeletal muscle total RNA (Figure 28 and 30) 
which was in agreement with the 3.5kb size predicted for the isoform (15,17). A weak 
signal was probably expected because of its cross-species application and the low copy 
number of the mRNA. Similar hybridization signals were shown in autoradiographs 
from the the original publication (17). There was a possibility that the human calpain 11 
large subunit cDNA probe did cross hybridize to bovine calpain I or the skeletal muscle 
specific putative 'calpain isoform' p94 (28,29) at the low stringency used in the 
hybridization experiments. However, it had been reported that by using the 3' non- 
coding region of the full length cDNA the probes were specific to their own isoforms 
(15). The clarity and sharpness of the hybridization band when using the calpain 11 large 
subunit cDNA suggests it was specific to its analogous isoform in bovine skeletal muscle 
total RNA. Had time permitted, the generation of derivative probes. perhaps in the 
noncoding region may have given enhanced signals for the calpain I large subunit (see 
section 4.1.4) 
S. 2. The Bovine Skeletal Muscle Calpastatin mRNA PCR cDNA Probe. 
Calpastatin PCR cDNA sequence analysis. 
'ne cDNA probe to bovine skeletal muscle calpastatin %%-as made from total RNA 
by PCR using the knowledge gained whilst a-ying to generate the chicken skeletal muscle 
calpain large subunit cDNA using PCR (section 4.1.2. ) and the calpastatin cDNA 
sequence information which had been published in the literature (52-54). From these 
cDNAs PCR primer oligonucleotide sequences for calpastatin were selected (section 
4.1.5. ) which subsequently have been used to generate calpastatin PCR cDNAs from rat, 
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pig and sheep total RNA (work carried out by Dr R. S. Gilmour, AFRC, Institute of 
Animal Physiology and Genetics Research, Cambridge. ). 
The cDNA produced was not full length but was predicted to cover domain 4 of 
calpastatin. The bovine PCR cDNA did align with domain 4 of the calpastatin cDNAs for 
rabbit (52), pig (53) and human (54). There is high homology across the four primary 
sequences (66-75%) particularly in the two (x-helical regions and inhibitory central 
consensus sequence (59) (Figure 35, Table 11). However there Is an amino acid 
substitution at a critical position in the central consensus sequence. As outlined in the 
review of the literature (section 2.2.1. ) both groups led by Murachi and Suzuki have 
shown there is a 'core' central consensus equcnce; 
Thr-lie-Pro-Pro-(X)-Tyr-Arg 
which appears to be critical for inhibitory activity (56,60,61). In the amino acid sequence 
predicted from the bovine PCR cDNA (Figure 35) the above appeared as; 
Tlir-lic-Pro-Pro-Lys-Tyr-Gin 
'T'he lysine residue is in a non-conscrved position X but in domain 4 of the other 
primary sequences this is glutamic acid (Figure 59). The subsdtudon of glutamine for 
arginine is in a posiflon which is highly conserved. Arginine residues am present in this 
posidon across all the domains in all the previously examined species, Fig= 59. 
In the bovine calpastatin PCR cDNA the glutamine codon is CAA whilst the 
possible arginine codons are CGT, CGC, CGA, CGG, AGA, AGG. As the position of 
the glutarnine in the central consensus sequence is against the trend seen In the calpastatin 
sequences so far isolated the codon change could be a result of a PCR induced mutation. 
However from the two PCR products, pG3pl3 and pG3p2l. the codon In this position 
was the same, CAA, in both central consensus sequences. The reported base substitution 
error for Taq polymerase is one in each 9000 nucleotides polymerized, whilst framcshift 
errors are one in 41000 (202). Ilese mutations are caused by Taq polymemses Inability 
to proof-mad Tto 5'sequences it has polymerised. A frameshift error Is unlikely in the 
calpastatin PCR cDNA as the predicted primary sequence In this region Is virtually 
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Figure 59: Amino acid sequence comparison of the inhibitory central consensus region 
of calpastatin. Regions shown are those as dcrined by Ucmori ct al (53), of all four 
domains in the pig, rabbit and human calpastatin. The residues not identical to the pig 
sequence are indicated in bold whilst the bovine amino acid sequence is shown aligned to 
domain four. Residues conserved or conservatively substituted across all the domains In 
the pig, rabbit and human sequences are indicated with an asterisk. 
DOMAIN I1 pig 195 LGKREVTLPPKYR 2(Y7 
rabbit 194 LGKREVTI PPKYR 206 human 172 LGKREVTJ PPKYR 184 
DOMAIN 21 pig 331 CGEDDETVP PEYR 343 
rabbit 331 CGEDDETVPAEYR 343 
human 293 CGEDDET JP! j EYR 305 
DOMAIN 3 pig 471 LGEKEETIPPDYR 483 
rabbit 474 LGEKEETIPPDYR 486 
human 435 LGEKEETIPPDYR 447 
DOMAIN4 1 pig 607 LGERDDTIPPEYR 619 
rabbit 611 LGERDDTIPPEYR 623 
human 572 LGERDDTIPPEYR 594 
bovine LGERDDTIPPKYQ 
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completely homologous to other sequences, apart from the two residues lysine and 
glutamine (Figure 59). 
As the two bovine calpastatin PCR cDNA sequences are in agreement at the 
glutan-ýine codon it is unlikely that the difference of these to the other species is caused by 
nucleotide substitution. This is further confirmed when this codon nucleotide sequence 
in domain 4 is examined in other species. The arginine residue is coded for by AGG, 
AGA and AGA in rabbit, pig and human calpastatin cDNAs resp=ively. If the presence 
of glutaminc is due to a mutation of an arginine codon the expected original codon would 
be AGX Assuming that the nucleotide sequence is conserved across species a double 
nucleotide substitution would have to take place in order to get a substitution to 
glutamine. However because of the low copy number of calpastatin mRNA mutations 
early on in PCR are likely to have greater effect in producing cDNA sequence mutations 
than amplifications on a more common sequence. 
As the arginine residue is conserved across the domains and species of the 
calpastatin sequences published in the literature (52-54) it may be critical for the 
inhibitory action of the sequence. Ile substitution to a glutaminc residue is not a 
conservative one. The glutan-dne side chain is polar but argininesisstrongly basic being 
positively charge at neutral pH. In order to confirm that the glutarnine residue predicted 
in the bovine calpastatin is not due to a PCR error the complete cDNA needs to be 
isolated, or the PCR generation of the cDNA repeated. 
Mie appearance of lysine in the position X of the central consensus equence Is 
different from the residue seen in domain 4 of the other sequences, glutamic acid. 
However examination of the other domains shows that this residue Is either acidic or 
basic and it is not conserved across domains (Figure 59). 
Although studies have identified the two ct-helical and particularly the central 
consensus region of the calpastatin domains as being involved in calpain inhibition (59), 
the residues that directly interact with the enzyme have yet to be elucidated. 71e 
experimental evidence does point toward the residues in the central consensus region, as 
pcptides from this inhibit calpain (56,60,61). Calpastatin's specificity toward calpain and 
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the lack of an absolutely specific synthetic calpain Inhibitor suggests that it inhibits the 
enzyme by some other means rather than just direct active site interaction as seen in the 
general cysteine proteinase inhibitors. However, the homology of calpain's active site to 
other cysteine proteinases is not high (203). A low level of simýilarity may be sufficient to 
allow the synthetic inhibitors to act on cysteine proteinases as well as calpain but the 
divergence is great enough to allow calpastatin to act specifically. The ability to achieve 
specific calpain inhibition, perhaps through the use of peptides from the calpastatin 
sequence, will aid the investigadon into the physiological role of the proteinase. 
Hybridization of the calpastatin PCR cDNA to multiple mRNA species. 
The cDNA was used as a specific probe to bovine skeletal muscle calpastatin 
rnRNA. The cDNA probe hybridized to three mRNA species. Ilose at 5.1-5. Okb, 3.8- 
3.7kb were clear bands whilst at 2.9-2.6kb there was a smear in both total and poly(A)+ 
RNA Northern blots (Figure 36 and 56). 
Multiple rnRNA signals for calpastatin have been identified in rabbit and human 
(52,55). The data obtained for the human was from the use of pig calpastatin cDNA on 
RNA from human haematopoictic cell lines and the autoradiographs produced were 
unclear (55). The mRNAS in both experiments were 3.8.3.0 and 2.5kb. 7be studies 
did not isolate a 5. lkb rnRNA species. The large rnRNA was found in Northem blots of 
bovine total RNA as well as poly(A)+ enriched RNA after high stringency washing 
(O. IxSSC plus 0.1% SDS at 650C), which suggests there is specific hybridization of the 
bovine calpastatin PCR cDNA probe. 
Examination of the Ynon-coding region of rabbit calpastatin cDNA showed that 
there were multiple poly(A) addition sites coded for by the sequence AATAAA. VMMC of 
these are located at appropriate positions to account for the multiple mRNAs (52). In the 
pig sequence there are a couple of alternative poly(A) addition sequences to those at the 3' 
end of the cDNA. located at approximately 3.2kb of the 4kb cDNA. However these 
consist of the less common sequence A*17AAA which Is found In 10% of poly(A) sites 
(204). In describing the isolation of the pig calpastatin cDNA. Takano et al (53) did not 
show any Northern blots of the cDNA used against pig rnRNA-. without this data It 
211 
impossible to state whether the observation of a 5.1 kb hybridization product to bovine 
calpastatin is an isolated occurrence, or pig calpastatin contains multiple mRNAs for 
calpastatin. The lack of as many poly(A) addition site sequences in the pig 3' noncoding 
region compared to the rabbit suggests that the positions of these sites and the resulting 
lengths of the mRNAs is not conserved from species to species. Confirmation of the 
existence of a 5. lkb bovine calpastatin mRNA awaits the isolation of the cDNA or the 
generation of cDNA to the Ynoncoding region by PCR. 
7be multiple calpastatin mRNAs identified in bovine skeletal muscle mRNA could 
be generated by three possible mechanisms: 
1) There could be more than one gene for calpastatin. 
2) The mRNAs could be from one gene and are the result of alternative splicing of 
transcripts. 
3) Alternative utilization of multiple poly(A) addition sites in the Yuntranslated region of 
the single calpastatin gene. 
The number of calpastatin genes has yet to be determined. The calpain subunits 
mRNAs are similarly expressed at low levels and are the product of single genes as far as 
is presently known (161). 
Alternative splicing can produce multiple mRNAs from a single gene (204,205). 
One of the mechanisms by which this can be achieved is through the us'e of alternative 
poly(A) addition sites which may dictate the selection of different exons making up the 
m. RNA (204,205). The resulting translation product is different from each alternatively 
spliced mRNA. 71is method of splicing seems to occur when the poly(A) addition sites 
are located in different exons and it usually results in the tissue-specific expression of 
only one isofonn of the mRNA. Although calpastatin exists as multiple isoforms, liver 
and erythrocyte sub-types as described in section 2.2.1., the different calp3statins 
identified are thought to be the result of post- tran sl ation a] modific3tion (30). Ile cDNA 
cloning experiments have not detected 5' truncated cDNA isoforms (52-54). If 
alternative splicing was the mechanism by which multiple calpastatin mRNAs were 
produced, it is Rely that there would be tissue specific expression of only one lsofonn of 
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mRNA and the several poly(A) addition sites would not be seen in the cDNAs isolated. 
as the alternative poly(A) site tends to be in the discarded exon (204,205). These 
observations tend to discount the possibility that the various calpastatin mRNAs are 
produced by alternative splicing. Isolation of the calpastatin gene will greatly aid the 
search for a possible muldple splicing pattern of exons, if they exist. 
Several genes have been shown to produce multiple mRNAs with different 
lengths of 3' non-coding sequence (206-209). The mouse dihydrofolate reductase gene 
produces seven mRNAs in a range from 750 to 5600 nucleotides (206). Two mRNAs 
are produced from both the single P2-macroglobulin and chicken vimentin genes which 
both have mRNAs that differ in the length of their 3' noncoding sequence (208,209). It 
is likely that the different sizes of mRNA for calpastatin are the result of an analogous 
effect as that seen in the chicken vimentin mRNAs (208), in which there are no detectable 
exon junctions in the Tnon-coding region and in the longer isoform the shorter mRNNs 
AATAAA sequence is present. The expression of the two vimentin mRNAs is not equal 
in cells although they originate from the same gene (209). Unequal expression is also 
seen in the three isoforms of calpastatin mRNA in bovine skeletal muscle. 71c 
mechanism by which the poly(A) site is selected in these multiple mRNAs is not known 
but it is presumably the most efficient one which is chosen. Factors have been isolated 
which mediate the cleavage and poly(A) addition reactions (204). Recent work has 
suggested that the stability of interaction of these factors with the poly(A) site, 
particularly downstream sequence lements, play a role in determining the efficiency with 
which the poly(A) site is used (210). 
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5.3. The Bovine Trial. 
5.3.1. The Effects of the P-Agonist Cimaterol on Calpain and Calpastatin 
Activities. 
The growth data and the activities of the calpain system showedý similar effects to 
those seen in previous studies in our laboratories (114 and unreported observations). 
There was an increase in L. dorsi muscle growth and protein deposition, measured as 
increased nitrogen (N) present, of the animals treated with the P-adrenergic agonist 
cimaterol (section 4.2. ). 
The effect on the activities of calpain system in the L. dorsi of the treated animals 
examined in this thesis was a significant increase in calpain II and calpastatin with a 
nonsignificant decrease in calpain 1, Table 28 A. There were similar effects on the 
calpain 11 and calpastatin activities of L. dorsi in a P-agonist bovine growth trial carried 
out within our laboratories by Higgins et al (unpublished observations), Table 28 B. The 
P-agonist in this trial was also cimaterol which was administered via a subcutaneous 
osmotic minipump at a dose of 0.06mg/kg bodyweight/day whilst the animals were fed 
grass silage ad libitwn.. Calpain I activity did not change significantly, but it increased, 
unlike the trial examined in this thesis. There were the usual changes in growth 
characteristics recorded, increased muscle weight and protein deposition in the L. dorsi. 
Comparisons with the studies in lambs show that P-agonists have analogous effects on 
their L. dorsi, Table 28 C and D (114,121). In the lamb trial carried out by Higgins et al 
(114) there was greater increase in calpain 11 activity than calpastatin. The variations in 
the activities observed in the four trials shown in Table 28 may have be due to the various 
P-agonists used having different potencies and the dose at which they were given. 
Beta-agonist induced hypertrophy is believed to be mediated through the 
secondary messenger cAMP (115,120). The changes in activity of the calpains and 
calpastatin could be through direct phosphorylation. Murachi (130) has suggested 
calpastatin is a phosphorylatable substrate but the kinase involved was not positively 
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Table 28: Comparison of the effects of P-agonists on the activities of the calpain system 
components in the skeletal muscle(L. dorsi) of farm species. 
Agonist 
A. 
Bovine trial I Cimateml Calpain I 
CaIPain Il 
Calpastatin 
B. 
Bovine trial 2 (unpublished 
observations) 
Cirmterol Calpain I 
CalPain 11 
Calpastatin 
C. 
Lamb trial 
Higgins 
et al, (I 14) 
Clenbuterol Calpain I 
CalPain 11 
Calpastafin 
D. 
Lamb trial 
Kretchmar 
et al, (121) 
L-644,969 Calpain I
Calpain 11 
Calpasmun 
Enzynic/Inhibitor Activity 
Control Treated 
(n=4) (n=4) 
(units/kg muscle) 
1073 767 
813 1073 
2138 3759 
(n=6) (n=6) 
(units/kg muscle) 
213 243 
827 1033 
1910 3302 
(n=6) (n=6) 
(units/kg muscle) 
570 490 
1250 2880 
2740 5440 
(n=ll) (n=ll) 
(units/kg muscle)a 
550 500 
650 950 
1250 2200 
change 
-29 
27 
76 
14 
25 
73 
-14 130 
99 
-10 
41 
74 
p 
NS 
<0.05 
<0.05 
NS 
< 0.05 
< 0.05 
NS 
< 0.05 
< 0.05 
NS = non-signiricance p> 0.05 
* 0.05 
* 0.05 
* 0.05 
a These values were expressed graphically by Kretchmar et al using different 
definitions of units so the values shown are approximations 
1 Results of study described in this thesis. 
2 mggins et al, unpublished observations from within our labomtories the details 
of which are outlined in the text (section 5.3.1. )
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identified (section 2.5.1. ). The effects of phosphorylation on activity are not known, but 
it appears to influence subcellular distribution which may result in altered recovery from 
cells and the activity measurements of the inhibitor. As described in section 2.5.1. 
calpain can also be phosphorylated in vitro (132). This was stimulated in the presence of 
cAMP and appeared to reduce the specific activity of the enzyme but had no effect on the 
calcium sensitivity. However Adachi et al (133) found that calpains would not undergo 
phosphorylation in vivo. The exact role of phosphorylation on the activity of the calpain 
system does require further investigation especially with respect to P-agonist mediated 
increases in cAMP and the possible subsequent possible events. 
in farm species treated with P-agonists there is an increase in calpastatin activity 
(114,121), which in bovine L. dorsi is greater than combined activities of calpain I and 11. 
Increasing the inhibitoes activity could be a means of decreasing the activity of the 
calpains thereby bringing about the P-agonist induced reduction in protein degradation. 
As cytosolic calpain IT appears to be inactive at physiological calcium concentrations ja 
vitro the effect of calpastatin would be to inhibit the physiologically active calpain 1. 
From recent observations on the activation characteristics of the calpains in their 
native and autolytically activated fon-ns and the interaction with calpastatin, the calpain 
system appears to be more complex than the simplistic model outlined above, reviewed in 
sections 2.1.2. and 2.2.3.. 
Tn vitrD calpastatin has diffemnt affinities for calpain according to the isoforres 
autolytic state. From the observations of various research groups, calpain 11 interaction 
with the membrane and the resulting autolysis is a possible means by which enzyme can 
increase its calcium sensitivity. The inhibitor also interacts with the membrane. So 
augmented calpain 11 activity at the calcium concentrations present in vivo may be 
possible, but increases in the inhibitor may have a buffering effect preventing large 
elevations in the calpain H activity at the membrane and also in the cytosolic activity of the 
membrane-dissociated autolyfically activated form. The increased calpain 11 activity may 
be a result of the need for membrane reorganization in growing cells as many of the 
substrates for calpain are membrane-associated proteins, some of which am cytoskelctal. 
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The interaction of calpastatin with calpain I may be the direct inhibition of the 
enzyme in the cytosol where it could be active at the higher range of physiological 
calcium concentrations. As described in section 2.1.2. the calcium dependence for 
activation of native calpain I and that required for inhibition is similar. Augmented 
inhibitor activity could also prevent calpain I's association to the membrane as this 
appears to be through its binding to membrane associated substrate proteins with which 
the inhibitor could be competitive. 
Although the above mechanisms are speculative, the overall action of P-agonists 
appears to be the reduction of protein degradation. Ile effects on the calpain system and 
the apparent reduction in their potential proteolytic action appear to fit this observation. 
There are other cytosolic proteinases which have been implicated in states of skeletal 
muscle atrophy as have the calpains (82). The cytosolic proteinases operate by various 
mechanisms uch as the ubiquitin-conjugated ATP-dependcnt/indcpendent system like the 
multicatalytic enzyme megapain. Others are ATP-dependcnt or ATP-stimulated 
proteolytic enzymes like the multicatalytic proteinase (1,2,211). What role the other 
cytosolic proteinases play in P-agonist induced protein deposition is not known. 
The effects of the P-agonist induced skeletal muscle hypcitrophy on the activities 
of the lysosomal cathepsins have also not been studied in any great depth (section 
2.4.0. ). These enzymes have a low pH optimum for activity and are unstable at neutral 
and alkaline pH so have to be compartmentalized in the acidic environment of the 
lysosomes (1,203). Although they have a definite role in proteolysis they probably 
require the 'loosening' of muscle myoribril structure by cytosolic enzymes, such as 
calpain, to become involved. 
5.3.2. The Effects of the P-Agonist Cimaterol on Gene Expression. 
Extracted total RNA and its in vitro translation. 
The quantity of intact total RNA extracted was not significantly different in the 
L. dorsi of treated and control animals expressed per gram of muscle (section 4.2.2. ). 
Although the method of extraction was semi-quantitative, unlike the chemical digestion 
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analysis of total RNA by the modified procedures originally described by Munro and 
Fleck (212), the results obtained from extractions were reproducible- so comparisons are 
valid. Smith et al (213) who extracted intact total RNA during their examination of the 
effects of P-agonists on specific L. dorsi mRNAs, also observed no significant effect of 
the agonist mctopamine on the quantity of RNA present in treated and control animals, 
which was in the range of 40-60gg/g muscle. 
Wu et al (214) had observed that the quantity of intact total RNA extracted 
decreased in the heifers given P-agonists, whilst there was no difference in the amount of 
'translatable' mRNA. This suggested that the poly(A)+ RNA made up a greater 
proportion of the total RNA in the treated animals. However, they did not quantify the 
poly(A)+ RNA directly. 
ne observations in this thesis indicated there was no difference in the quantities 
of the total RNA extracted. There was also no significant change in the in vitro 
translation capability of the isolated L. dorsi total RNA (section 4.2.3. ). Therefore, 
according to the rationale of Wu et al (214). there was probably no change in the 
proportion of poly(A)+ RNA in the L. dorsi total RNA. This observation was confirmed 
by Smith et al (213). who isolated the poly(A)+ RNA from L. dorsi total RNA of 
agonist treated steers. 
Analysis of in vitro translation products on SDS-PAGE from the total RNA of the 
bovine trial did not show any major shifts in level of mRNA expression indicated by 
increased protein products, nor in the types of proteins expressed (Figure 42). 
Examination of the total RNA on denaturing agarose gel clectrophoresis failed to 
show any qualitative changes in the total RNA isolated which may have suggested an 
increase in non-mRNA species such as rRNA. Comparison of the 28S and 18S rRNA 
intensifies on ethidiurn bromide stained gel by scanning densitometry failed to show any 
difference in their relative expression (section 4.2.2. ). T'his estimate was a semi- 
quantitative indication of whether the proportion of rRNA in the total RNA had increased 
as the concentration of extractable total RNA had remained the same in the control and 
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treated animals. Ilere appeared to be no difference between the samples suggesting no 
major shifts in the types of RNA expressed in the isolated total RNA. 
Several groups have reported P-agonist induced increases in skeletal muscle total 
RNA expressed as per gram protein or gram muscle (120,116,216,217). 71ese 
observations were based on the analysis of total RNA by chemical digestion (212). They 
gave no indication whether any specific mRNAs increased and whether there were 
changes in the RNA making up the translation machinery Le. the quantity of rRNA and 
tRNA. Analysis of the DNA content has not shown any increase in the P-agonist treated 
animals (216-218). Beerman et al (216) and Kim et al (218) suggested that satellite cells 
were not required to proliferate and be incorporated into skeletal muscle myotubes for 
there to be increased growth in the treated animals, although this is seen in certain types 
of muscle hypertrophy (219,220). Ille increase in skeletal muscle RNA suggests an 
increase in the capacity for protein synthesis. Various research groups, from their 
experimental evidence, have suggested that protein synthesis is also increased in 
agonist induced hypertrophy (115,118,217). 
To produce extracted total RNA results in the loss of some RNA species. 7le 
quantification of changes in total RNA by chemical means does give different results to 
those observed for extracted total RNA, but these are not directly contradictory. 
cc-actin and myosin light chain 2 mRNA expression. 
Using the two myoribrillar protein cDNAs, oc-actin and myosin light chain 2 
(MLC2), the total RNA was examined for changes in their mRNA expression to give an 
indication whether there was an increase in the translational capacity for these proteins in 
the bovine L. dorsi (section 4.2.4. ). Northern blot analysis showed significant increases 
in the expression of both the mRNAs between control and cimaterol treated animals. 
When the analysis was repeated using slot blotting there was no apparent difference 
between controls and cimaterol treated animals for both mRNA species over the linear 
part of the hybridization intensity curve. However, the samples from the trrated animals 
always had a greater hybridization signal than the controls at higher loadings of total 
RNA. 
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The discrepancy between the two methods of analysis is probably due to uneven 
Northern blotting as a large gel was used to accommodate all the samples. The quantity 
of total RNA used (25pg) probably meant that hybridization was nonlinear, as was the 
case in the larger quantities loaded on the slot blot. Although the two probes were not 
specific to bovine skeletal muscle they did cross hybridize, Figure 22 and 23.7be mouse 
(x-actin cDNA was the better of the two hybridizing at a high stringency than the chicken 
MLC2 cDNA. Ibis was expected as actin is a conserved protein across species as well 
as there being less evolutionary divergence between mice and the steer samples compared 
with chickens and steers. 
The slot blots indicated that there was no apparent large increase in skeletal 
muscle (x-actin and MLC2 mRNA in the cimaterol treated L. dorsi samples. However at 
the higher loadings of total RNA there was a greater hybridization signal in the cimatcrol 
samples. This may have been caused by nonspecific hybridization as it was observed in 
the nonlinear region of the relationship between total RNA loaded and hybridization 
signal intensity (see Figures 47,49 and 50) 
. 
The observations from the slot blots and 
the lack of any notable increase in the muscle 35S-labelled protein products from total 
RNA in vitm translation suggests that here is no major augmented expression of the 
muscle protein mRNA transcripts due to cimaterol treatment in the bovine Ldorsi. 
The increases observed in total RNA when it is analysed by chernical digestion in 
other laboratories may be in non-mRNA species. By augmenting translational efficiency 
(increasing the quantity of protein synthesised per unit mRNA) translational capacity 
could remain unaltered (units mRNA per unit protein). ne small increases in the level of 
mRNA for MLC2 and a-actin, seen in the slot blots (section 4.2.4. ), although apparently 
insignificant could be sufficient to increase the synthesis of protein enough to be 
significant at a post-translational level. 
Smith et al (213) have also examined the effect of P-agonists on specific mRNAs 
in bovine skeletal mRNA. Iley used the P-agonist ractopamine which they fed to steers 
at various doses. After extracting total RNA they probed it with a bovine myosin light 
chain 1/3 (MLC 1/3) cDNA. A significant increase in the intensity of the hybridization 
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signal for probed slots in the ractoparnine treated animals was observed. However single 
slots of 5gg total RNA were used for their analysis which may have encountered the 
problem of nonlinear hybridization. Also the cDNA probe used had not been fully 
characterised and did not appear to hybridize specifically in Northern blots (213). 
Babij and Booth (221) examined the effect of clenbuterol administradon to rats on 
the expression of cc-actin mRNA in atrophying skeletal muscle caused by denervation and 
limb suspension. 7bey found that the 60% decrease in ct-actin mRNA seen in 
dcnervation was prevented by the administration of the P-agonist. However, the 
complexity of the relationship between muscle atrophy and the effects of clenbuterol 40 
compared to P-agonist induced muscle hypertrophy makes it difficultkýraw related 
conclusions. In the recovery of the mRNA expression in atrophy the mRNA is induced 
back to the 'normal', whilst in hypertrophy it would have to be induced above this 
normal level which may be effected by innervation. 
Examination of the effects of P-agonists on the expression of myofibrillar 
proteins' mRNA requires careful analysis of cDNA probe hybridization data determined 
from the linear part of the relationship between hybridization intensity and quantity of 
RNA blotted. To achieve this the concentration of the probe used should be in excess of 
membrane bound target sequences and the cDNA should ideally be specific to the 
sequence being probed. Homology between the chicken and bovine MLC2 sequence is 
sufficient for hybridization between the cDNA and the target bovine mRNA. Ile MLC2 
cDNA probe did hybridize to a specific RNA species on Northern blots, although high 
stringency conditions were not used. The lack of complete homology between species 
does not effect the use for comparison between treatments although it does appear to 
produce more effatic values compared with the apparently higher homology probe cc-actin 
(section 4.2.4. ). 
Calpain mRNA. 
Ile human calpain 11 large subunit cDNA probe was effective against bovine 
skeletal muscle total RNA whilst the human calpain I large subunit cDNA was not, for 
the reasons outlined in section 4.1.4.. 
221 
The level of Calpain 11 large subunit mRNA did increase (34%) in the L. dorsi of 
the cimalerol treated animals (section 4.2.5. ). Although this was not significant it is 
comparable with the elevated proteolytic activity (27%) which was significant (section 
4.2.1. ). In order to confirm whether calpain 11 large subunit gene expression is induced 
by P-agonists a system where a greater response in enzyme activity is observed to the 
agonist needs to be examined, for example in lambs where the increase in calpain 11 
activity exceeded that of calpastatin (Table 28 Q, using species and isofonn specific 
probes. 
The nonsignificant increase in cimaterol induced expression of calpain 11 large 
subunit mRNA would be expected from the data available on the sequence of the human 
calpain 11 large subunit gene (159). The promoter egion of this gene appears not to 
contain a cAMP responsive lement (CRE) or a AP2 binding site (section 2.5.3. ). As P- 
agonists are believed to mediate their growth effects on skeletal muscle through cANIP the 
calpain H gene would not be expected to show increased expression. 
Although the promoter of the calpain 11 large subunit gene does not appear to 
contain any elements that are known to respond to cANIP the smaU increase in its mRNA 
could be through 'secondary' mechanisms. The mRNA expression from the c-jun and c- 
fos genes have been shown to be induced by P-agonists in rat neonatal myocardial cells 
(223) and c-fos mRNA expression was increased in various cell types including the rat 
submandibular gland (162) and BOHI nonfusing muscle cells (224). The products of 
c-fos and c-jun genes form heterodimers that bind to API sites which are known to 
regulate gene transcription (222). The promoter region of the calpain 11 large subunit 
gene does contain a putative API binding site. Several recent observations have shown 
that a cAMP responsive element binding protein (CREB) will form a dimer with a gene 
product of the jun family (152,153). The Fos-Jun protein heterodimers can bind to 
CREs suggesting the capacity for transcriptional 'cross talk' in these systems (225,226). 
Therefore it can be speculated that a low level of increased calpain 11 large subunit gene 
expression could take place by this P-agonist induced expression of c-fos and c-jun 
mRNA, which in turn activates the API site in the gene's promoter. Ilowcver, as with 
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most promoter sequence motifs, the API site reported is a putative one and there is no 
direct evidence for the stimulation of gene transcription through AP I binding sites via an 
indirect mechanism stimulated by cAMP, so this mechanism is speculative. API binding 
sites, alternatively called a phorbol ester (TPA)-responsive clement (TRE). have been 
identified in other genes by their ability to induce gene transcription via phorbol ester 
stimulation of cells (222). The calpain large subunit gene requires careful examination in 
order to determine whether the gene can be induced by phorbol esters through this API 
site. 
Although other promoter elements have been identified in the calpain 11 large 
subunit gene, such as an SpI recognition site and one characteristic of the P-globulin 
gene, the presence of a putative API is of interest because of calpain's identified role in 
the down-regulation of protein kinase C in vivo (227), which isý also activated by phorbol 
esters. A putative API binding site has also been identified in the calpain small subunit 
(160) suggesting some degree of co-ordinate regulation of the two subunits which may 
be linked to protein kinase C regulation. 
Hata et al (159) suggested that the calpain 11 large subunit gene promoter region 
was characteristic of a 'housekeeping' protein. The gene appeared t9 
ýunder the influence 
of negative regulatory elements 5' to the immediate promoter region to the gene, the 
implication being that there is tight control over the expression of calpain H large subuniL 
They suggested that because of the ubiquity of calpain distribution expression is possibly 
controlled by the negative regulatory promoter elements, which are regulated by a 
negative trans-acting factor. The expression of this factor would be expected to be cell 
specific thereby accounting for varying degrees of expression of calpain activity in 
different tissues, the housekeeping promoter being responsible for the ubiquitous tissue 
expression (9). Although this hypothesis suggests that the induction of calpain H large 
subunit gene transcription by secondary messengers, such as cAMP or through agents 
like phorbol esters is unlikely, Hata et al (159) did not examine the effects of agonists on 
cells transfected with the calpain II large subunit gene. Calpain I and 11 mRNA has been 
shown to be induced 4-6 fold in the biceps femoris of fasting rabbits so there must be 
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some mechanism by which the genes can be significantly induced (228). However the 
role of the proteinase would presumably be different in a state of muscle atrophy than that 
seen in P-agonist induced hypertrophy where there is a selective increase in only the 
calpain II isoform activity and the possible increase in the mRNA expression observed in 
this thesis has not been fully elucidated. 
The calpain I large subunit gene has not been isolated, therefore the possible 
relationship of increases in intracellular cAMP to its expression is not known. Further 
work is required to see if its mRNA expression is affected by fj-agonists. Mic type of 
promoter/enhancer sequences in the 5' flanking region of the gene would be expected to 
be different to the calpain H large subunit gene because of its own distinct level of protein 
expression compared to calpain 11; for example in erythrocytes calpain I activity is 
expressed whilst calpain Il activity is absent (9). This is an indication that there may be a 
different response of the calpain I large subunit gene to the Vagonists. 
As small subunits are required for the activity of both calpain isoforms then some 
common promoter sequences would be expected in both calpain I and 11 large subunits 
and small subunit to allow coordinate regulation. Similarities have been shown between 
the promoter regions of the calpain 11 large subunit and the small subunit genes (159). 
The effects of P-agonists on the gene expression of the small subunit also requires 
examination. 
The work carried out in this thesis failed to show a significant increase in calpain 
11 large subunit mRNA in L. dorsi in response to P-agonist treatment. Although the 
augmented calpain 11 activity may be due to increased gene expression the effects could 
be caused by cAMP-induced phosphorylation of the enzyme altering its activity. Adachi 
et al (133) observed no phosphorylation of the enzyme in vivo but they did not examine 
the effects of stimulating cells with various agonist. 7he involvement of phosphorylation 
as a means of altered calpain activity requires further investigation. 
Ile means by which calpain 11 activity is significantly increased in the skeletal 
muscles of 0-agonist treated animals. as observed in other experiments carried out in our 
laboratories (114), has yet to be explained. 
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Calpastatin mRNA. 
From Northern blot analysis of L. dorsi cimaterol and control total RNA samples 
there was a significant increase in the intensity of the 3.7-3.8kb hybridization signal 
(161%) (section 4.2.6). 7lic increase was greater than the change in the inhibitor activity 
(76%) (section 4.2.1. ). Similar effects were seen in streptozotocin induced diabetes 
where the expression of the mRNA to Gi-I in adipocytes was induced four fold whilst 
the protein increased by a factor of two (196). 
The increase in the calpastatin 3.8kb mRNA could be due to augmented gene(s) 
transcription or effects on the stability of the mRNA induced by cimaterol, or both. As 
the three mRNAs produced from the calpastatin gene are likely to be the result of different 
poly(A) addition site selection (section 5.1. ), if increased gene expression causes the 
significant increase in only the 3.8kb isoform this has to be achieved by differential 
selection of one poly(A) addition site above the others, assuming that the mRNA is not 
being selectively stabilized over the other calpastatin mRNAs. Augmented transcription 
of a single calpastatin gene without a selection mechanism for a particular poly(A) site 
would be expected to result in the three mRNAs increasing but remaining in the same 
expression ratio seen in the unstimulated state. 
Ile alternative xplanation is that cimaterol treatment induces increased stability 
of the 3.8kb mRNA thereby elevating its expression. Ilis may be acting in concert with 
the changes in the gene expression. The hybridization signal for all three calpastatin 
mRNAs did increase, although not significantly for all of them but by preferentially 
stabilizing the 3-8kb species its expression would be further enhanced above the others 
maldng its increase significant. 
Similar effects on the level of transcription and the stability of mRNA have been 
shown to be induced by cAMP (section 2.5.2). Increased expression of calpastatin 
mRNA could be similarly mediated as its gene expression is clearly affected in cimaterol 
stimulated bovine skeletal muscle hypertrophy. In order to directly respond to cAMP the 
gene(s) would be expected to contain a cAMP responsive element. either a CRE or an 
AP2 binding site. It is not known whether the 5' flanking region of the gcne(s) contains 
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such elements. If there is increased expression of the gene by cAMP-mediated events 
then the second messenger probably also has an effect on either the factors involved in 
the selection of poly(A) sites or those determining the stability of the particular mRNA 
species as one is preferentially selecting over the others. This presumably is achieved by 
interaction with a sequence located at the particular poly(A) addition site or in the 3' 
noncoding region of the mature mRNA in question. 
Most of the genes that have identifiable CREs are rapidly induced by cAMP 
within minutes of stimulation and are classified as group I responsive genes (134). Ile 
rat cystatin S gene in the submandibular gland only responds after a relatively longer 
period of four hours after the administration of a P-agonist (229) and is categoriscd in 
group 2, the slower responding genes (134). This suggests that the group 2 genes 
require the synthesis of factors for the effects of cAMP to be mediated on transcription. 
The group I genes probably need only the modification of already existing factors by 
cAW? mediated events. 
The gene expression of calpain activity appears to be under tight regulation. Its 
activity could be considered as constitutively expressed, a 'housekeeping protein'. 
Calpastatin gene expression appears to be under the regulation of secondary messenger 
cAMP, which is known to induce rapid gene response as well as long term effects as 
seen in the hypertrophy of the rat submandibular gland (162). Alterations in calpastatin 
activity could be increased or decreased epending on the requirement of calpain mediated 
proteolysis by the induction of its gene expression through different secondary pathways 
to those of calpain. The time course for the response to P-agonist and its relationship to 
the expression of calpastatin and calpain activity is not known. This may be the key to 
the understanding of the role of cimaterol induced increased expression of calpastatin 
mRNA. 
The biological significance of the various sizes of mRNA for calpastatin is not 
known. 77he single chicken vimentin gene has been shown to express two mRNA 
species which differ in the length of their 3' untranslated regions (208,209). Tissue 
specific differences in the relative expression of the two mRNAs suggests that the 
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selection of the poly(A) site has biological significance. Capetanaki et al (209) proposed 
that the different Yuntranslated region may affect the subcellular compartmental i sation of 
the rnRNA and thereby the location of protein expression, or alternatively the stability of 
the rnRNA could be affected, or both. 
The directed compartment expression of calpastatin activity would affect its ability 
to inhibit calpain mediated proteolysis. By selecting a mRNA species calpastatin 
synthesis may be shifted to a particular region of the cell. Calpain activity, especially 
calpain H, could be considered to be functionally compartmentalised in an membrane 
environment as it is required for autolysis inorder to achieve activation at physiological 
calcium concentrations (section 2.1.2. ). The effects of P-agonists may be to induce a 
change in the calpain to calpastatin ratio within a specific compartment thereby decreasing 
proteolytic potential. 
5.4. Summary. 
Ile exact roles of calpain I and 11 in skeletal muscle and their scope for activity ja 
vivo as well as their interactions with calpastatin are not known. From in vitro studies it 
appears that the activation mechanism for the two isofon-ns is different (section 2.1.2. ). 
Calpastatin has been shown to have distinct affinities for calpain I and 11 according to 
their autolytic state and location in the cell (section 2.2.2. ), which may be influenced by 
post-translational modification. 
One of the effects of P-agonists on skeletal muscle is beHeved to be a decrease in 
protein degradation (section 2.4.0. ). This would be expected to be as a result of 
inhibiting the proteolyfic activity within the muscle myoribrils. Calpain and calpastatin 
activities have clearly been shown to be altered in P-agonist treatment of farm species 
(section 2.4.0. ). There is an increase in the activity of the inhibitor calpastatin which is 
specific to the calpains, which have been implicated in muscle myoribrillar protein 
turnover. 7be changes in the calpain system are toward increased inhibitory capacity and 
a change in the status of the calpain isoforms' activity. Although calpain 11 can increase 
its calcium sensitivity in vitro. studies suggest hat it is not active at physiological calcium 
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concentrations. Autolysis at the membrane decreases the calcium requirement for 
activation (section 2.1.2. ), therefore changes in the activity may be localised and required 
for proteolytic mediated rearrangement of cytoskelctal proteins in order for growth to 
occur or down regulation of membrane associated enzymes and receptors, such as protein 
kinase C (227). 
Ile changes in calpain 11 activity may be induced by increased gene expression. 
There was an increase in the mRNA for calpain 11 large subunit (section 4.2.5. ), but this 
was nonsignificant although it matched the increase in the enzyme activity (section 
4.2.1. ). This augmented calpain activity may be caused by a cAMP stimulated 
phosphorylation of the protein, a post-translational event. However, calpains have not 
been conclusively shown to be phosphorylated in vivo (133). 
The elevation in calpastatin activity does appear to be due to increases in the 
expression of its mRNA, one species (3.8kb) being increased over the others (section 
4.2.6. ). Whether this is caused by increased gene transcription or by modifications of 
post-transcriptional events mediated by P-agonists through cAMP is not known. 
There appears to be no significant change in the mRNAs capable of producing 
contractile proteins or increases in the level of specific mRNAs from the examination of 
in vitro translation products and specific myoribrillar protein mRNA (section 4.2.2., 
4.2.3. and 4.2.4. ). Although the quantity of extractable total RNA did not change on 
treatment with cimaterol the observed increases in total RNA by other groups is not 
incompatible with the present results for reasons outlined in section 5.3.2.. Elevated total 
RNA observed could be due to an increase in the RNA required for the translational 
machinery, thereby giving P-agonist treated animals a higher translational capability. 
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5.5. Further Work 
Information on the number and the sequence of tho 5' flanking region of the 
calpastatin gene(s) is required in order to interpret the observations in this thesis. 
Identification of the promoter elements is necessary in order to understand what trans- 
acting factors could be affecting gene transcription. The entire cDNA to bovine skeletal 
muscle calpastatin is also required to confirm whether there am multiple poly(A) addition 
site sequences in the Yuntranslated region as in the rabbit sequence (52). 
The effects of P-agonists on the mRNA expression of the calpain isoforms needs 
to be repeated with specific probes for the species analysed using a more sensitive assay 
technique, such as S1 nuclease hybridization. In order to interpret completely 
information from such studies a detailed understanding of gene structure for both 
isoforms of calpain large subunits as well as the small subunit will have to be gained, as 
is required for calpastatin, so that the possible trans-acting factors can be identified. 
Cyclic AMP inducible genes respond relatively rapidly to the secondary 
messenger (134). As outlined above calpastatin may be the component of the calpain 
system which is inducible so that it can regulate the activity of calpain. 77he increase in 
expression of calpastatin mRNA that is mirrored by an increase in activity in response to 
P-agonist (presumably acting through cANT which is known to rapidly induce gene 
transcription by phosphorylation of trans-acting CREBs) further suggests that calpastatin 
is the controlling factor over the reported 'housekeeping' calpains (159). 77he time course 
of the calpain system's response to P-agonists needs to be carried out so that rapidity of 
the induction of calpain H and calpastatin activity and mRNA expression can examined 
and this hypothesis tested. 
The role of activators on the interaction of the calpains to calpastatin and their 
effects in altering the calcium sensitivity of calpain 11 may be another means of changing 
calpain activity without altering calpain or calpastatin gene expression. 7le activators am 
reported to increase calpain 11 sensitivity to calcium and also decrease the inhibitory 
potential of calpastatin. Alternatively changes in activity may be mediated through direct 
phosphorylation of the enzymes and inhibitor via cAMP-dependent protein kinase. What 
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role this plays in inhibitor activity is not known, although some preliminary 
investigations have been carried out by Murachi et al (130) which suggest it efrccts the 
subcellular distribution of the inhibitor (section 2.5.1. ). Further investigations are 
required on the post-translational mechanisms by which calpain and calpastatin activity 
could possibly be regulated 
The P-agonist induced hypertrophy has been described as being specific to 
skeletal muscle (115), although hypertrophy effects have been seen in the rat 
submandibular gland and cultured neonatal myocardial cells. An increase in mRNA for 
the calpain I and 11 large subunits was observed to be specific to the skeletal muscle of 
fasting rabbits (228). Whether the P-agonist induced changes in the calpain systems 
activity associated with skeletal muscle hypcrtrophy is also muscle specific requires 
investigation. If this is the case then there must be some tissue specific factor that 
regulates its expression in response to P-agonists, as both calpain and calpastatin are 
ubiquitously expressed and the P-agonist induced cAMP is a common secondary 
messenger in most cells. The understanding of the regulation of the calpain system at the 
level of gene transcription will be as at least as difficult as the that of its protein activity. 
Although the information available on the calpain system has expanded in the last 
five years, particularly with the isolation of the cDNA sequences, there is still little 
known about the physiological role of the enzymes and inhibitor or the activation 
mechanisms which take place in vivo. The use of specific calpain inhibitors, i. e. peptide 
fragments of calpastatin, has recently been employed in vivo (227) and will be a means 
by which calpain's physiological role can be partially determined. I'he understanding of 
the implications of altered calpain and calpastatin activity in P-agonist induced skeletal 
muscle hypertrophy may allow the more efficient manipulation of animal growth by the 
exploration of such promoters. 
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Appendix A. 
cDNAs Used for Probe Hybridization. 
i) Human Calpain I Large Subunit cDNA. 
Ile plasmid p42, containing part of the human calpain I large subunit cDNA, was 
a gift from Dr. P. C. Emson, Institute of Animal Physiology and Genetics Research, 
Babraham, Cambridge. 
Ile calpain I large subunit cDNA was a Pst I fragment of the complete cDNA of 
the clone p3l. in vector pUC8 (16). The calpain I insert was subcloned into pBR322 to 
give p42 which contains part of the coding nucleotide sequence and some of the 3' 
noncoding region extending from 1252 to 2517bp of the original cDNA in p3l, Figure 
60. 
Calpain I cDNA insert of p42 was removed by Pst I restriction endonuclease 
digest to give the 1265bp fragment. The insert can be identified between the 1375 and 
947bp fragments of the Eco RI/Hind III lambda DNA markers and was charactcrised by 
restriction endonuclease digest with Sma I and Pvu H, Figure 61 and 62. The predicted 
size of the Sma I digest fragments were 221,961 and 83bp. It can be seen in Figure 61 
that the Sma I digest gave a visible fragment slightly greater than that of 947bp of the Eco, 
RUffind III markers. Pvu 11 digest of the p42 insert gave fragments less than 564bp 
(Figure 62), the predicted sizes were 406,468,107 and 284bp. 
'Me Sma I and Pvu II sites are unique to the human calpain I large subunit cDNA 
insert and are not found in the similar sized human calpain 11 large subunit cDNA insert 
described below. 
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Figure 60: Plasmid map of p42. The map shows the position of the human calpain I 
large subunit cDNA insert relative to the complete sequence and the location of the 
relevant restriction endonuclease sites. 
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ii) Human Calpain H Large Subunit cDNA. 
Ilie plasmid p21-16, containing the calpain 11 large subunit cDNA, was a gift 
from Dr. P. C. Emson (see above). 
Restriction endonuclease digest with EcoRI of the clone XIISI, containing the 
complete cDNA for human calpain 11, gave a fragment with the sequence for a small part 
of the Yend of the primary coding sequence and all of the Ynon-coding region, 1866. 
3083 of the complete cDNA (17). This was subcloned into the Eco RI site of plasmid 
pUC8, to give clone p2l-16, Figure 63. The human calpain II cDNA insert of p2l-16 is 
1217 bp long and was excised by Eco RI, Figure 64. 
Restriction enzyme digest of the p2l-16 calpain 11 large subunit cDNA insert with 
Hind III was predicted to give fragments of 716,292 and 192 bp. Likewise digest with 
Barn HI would give 748,298 and 171 bp fragments. Analysis of the fragments from the 
two digests gave the large fragments predicted, the Barn HI fragment is slightly larger 
than the Hind 111, both fragments are between the 831 and 564bp products of the Eco 
RI/Hind III lambda markers, Figure 64. 
From the data produced on the restriction endonucicase digests of the cDNAs the 
similarity of the resulting fragments with those predicted suggested that the clones 
contained the cDNAs for human calpain I and 11 large subunits. 
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Figure 63: Plasmid map of p2l-16. I'lie map shows the position of the human calpain 11 
large subunit cDNA insert relative to the complete cDNA sequence and the location of the 
relevant restriction endonuclease sites. 
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ii) Mouse a-Actin cDNA. 
The plasmid containing the cc-actin cDNA, pAN191. was obtained through Dr. 
R. S. Gilmour. AFRC Institute of Animal Physiology and Genetics Research, Babraham. 
Cambridge from Dr. A. Balmain, Wolfson Laboratory for Molecular Pathology. Beatson 
Institute for Cancer Research, Glasgow. 
The plasmid was selected from a mouse skeletal muscle cDNA library cloned into 
vector pBR322 and contains a cDNA insert to a-actin, which is 1358 bp long (230). 
This was not the full length sequence for mRNA to cc-actin, which is approximately 1650 
bp. Ile clone pAM91 contains approximately 90% of the amino acid coding nucleodde 
sequence (88-1125 bp) of the complete sequence and part of the Tnon-coding sequence 
(1125-1358 bp) of the complete sequence. It is excised from pBR322 by Pst I restriction 
enzyme digest to give a cDNA fragment 1173 and 185bp (23 1), of which the longer of 
the two was isolated and used. The cDNA was characterised by restriction endonuclease 
digest carried out by K. Fairbrother within our laboratories. 
iv) Chicken Myosin Light Chain 2 cDNA. 
Ile plasmid containing the myosin light chain 2 (MLC2) cDNA, M13mpFXLC2, 
was a gift from Dr. F. C. Reinach obtained through Dr. J. Kendrick-Jones, MRC 
Laboratory of Molecular Molecular Biology, MRC Centre, Cambridge. 
The vector AgtI I/LIO containing the complete primary coding, Tnon-coding and 
part of the Snon-coding sequence of chicken MLC2 was isolated from a cDNA library 
cloned into %gtlI (232). The cDNA insert of Xgtll/LIO was subcloned into 
M13mpllFX to give plasmid M13mpllFXMLC2 (233), which contains the anýno acid 
coding sequence and the 3' non-coding region of the chicken MLC2 cDNA. The 
M13mpllFX plasmid is an adapted Ml3mplI plasmid containing a sequence coding for 
a recognition site of the blood coagulation factor Xa, called the FX site (234), into which 
the MLC2 cDNA sequence was linked when cloned into the plasnýd (233). 
Ile cDNA of MLC2 cDNA was excised from M13mpl IFXMLC2 by restriction 
endonuclease digest with Hind III and Eco RI to give a fragment of 700 bp, which 
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included the FX recognition site. I'lie cDNA sequence was characterised by restriction 
endonuclease digest carried out Y. Lasslett within our laboratories. 
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Appendix B. 
Lambda DNA Markers Produced by Restriction Endonuclease Digest. 
The size of the DNA fragments produced by various restriction endonucleasc 
digests of lambda DNA (NBL) are shown below. 
Size of fragments produced by digest (kb) 
Hind III EcoRT/Hind III Pst 1 
(7 fragments) (12 fragments) (29 fragments) 
1 23.130 21.226 11.501 
2 9.416 5.148 5.077 
3 6.682 4.973 4.749 
4 4.361 4.268 4.507 
5 2.322 3.530 2.838 
6 2.027 2.027 2.556 
7 0.564 1.904 2.459 
8 1.709 2.443 
9 1.375 2.140 
10 0.947 1.986 
11 0.831 1.700 
12 0.564 1.159 
13 1.093 
14 0.805 
15 0.514 
16 0.448 
18 0.339 
19 0.264 
20 0.247 
21 0.216 
22 0.211 
23 0.200 
24 0.164 
25 0.150 
26 0.094 
27 0.087 
28 0.072 
29 0.015 
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Appendix 
Commonly Used Solutions and Buffers. 
20xSSC 
IOM sodium chloride 
0.3M sodium citrate pH7 
20xSSPE 
3.6M sodium chloride 
0.2M sodium phosphate 
2OmM EDTA pH7.7 
lOxTBE 
0.89M boric acid 
0.89M Tris 
25mM EDTA pH8.3 
l0xMOPS 
0.2M 3-[N-morpholino]-propane-sulphonic acid (MOPS) 
50mM sodium acetate 
10mM EDTA pH8.3 
TE 
lOmM TrisHCI 
O. ImM EDTA pH8.0, pH7.6, pH7.4. 
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Appendix D. 
Media for E. coli Cultures. 
LB broth 
1.0% (w/v) Bacto-Tryptone (Difco) 
0.5% (wtv) yeast extract (Difco) 
0.5% (w/v) sodium chloride pH7.2 
Autoclave then add the appropriate antibiotic from a x1000 stock (12.5mg/nil 
Tetracycline in 50% ethanol or 50. Omg/n-d Arnpicillin in water) when cool. 
LB agar 
LB broth plus 1.0% (w/v) Bacto-Agar (Difco) 
Autoclave, cool to 500C before adding the appropriate antibiotic from stock then 
pour into culture plates to a depth of approximately 3-5mm. 
Minimal agar 
0.6% (w/v) disodium orthophosphate (Na2HP04.7H20) 
0.2% (w/v) potassium dihydrogen phosphate (KH2PO4) 
0.05% (w/v) sodium chloride 
0.1% (wtv) ammonium chloride pH7.4 
1.5% (w/v) agar (Difco) 
in 950 m1s; 
Autoclave, to 600C and add the following-, 
10ml 20% (w/v) glucose 
Iml O. IM calcium chloride 
Iml LOM magnesium sulphate 
50tfl 100pgIml thiamine 
Adjust the volume to I litre and pour into the culture plates. 
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